Ensembl_ID	Gene_symbol	logFC	FDR	Comparison	LncBook ID	Type	Conservation	miRNA	GWAS	nearest PC	Top correlated gene
ENSG00000273387	ENSG00000273387	-3.03199764747305	3.65152894120191e-6	M1_vs_M2	HSALNG0134940	anti_sense	Q75	hsa-miR-762,hsa-miR-4447,hsa-miR-4505,hsa-miR-6735-5p	Fev/fec ratio,-	SELENOM	HS3ST1
ENSG00000290418	TPTEP1	-1.2956609964889	1.56308548830487e-14	M1_vs_M2	HSALNG0133819	integenic	Not conserved	NA	-	IL17RA	DBNDD1
ENSG00000245552	LNCRNA-IUR	3.01309090265999	8.42780546022785e-7	M1_vs_M2	HSALNG0086562	anti_sense	Q90	hsa-miR-483-3p,hsa-miR-619-5p,hsa-miR-3960	Mean reticulocyte volume; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Red blood cell distribution width,Eosinophil count,Common carotid intimal medial thickness,-	ENDOD1	AGK
ENSG00000254027	LNMICC	-1.64906008321988	4.5390378102908e-6	M1_vs_M2	HSALNG0066560	anti_sense	Not conserved	hsa-miR-3195,hsa-miR-4508	-	PMP2	MARK4
ENSG00000248932	COPB2-DT	-1.29928063197178	4.85497848740466e-5	M1_vs_M2	HSALNG0029337	integenic	Not conserved	hsa-miR-765	NA	MRPS22	CDKL5
ENSG00000203497	PDCD4-AS1	-1.06825835044016	0.0140666213677778	M1_vs_M2	HSALNG0080613	anti_sense	Q50	hsa-miR-6089	Aspartate aminotransferase measurement,-	BBIP1	DLEC1
ENSG00000267197	ENSG00000267197	3.7458241587493	0.00228027562006948	M1_vs_M2	HSALNG0123939	sense	Not conserved	NA	NA	KEAP1	DLEC1
ENSG00000257027	ENSG00000257027	1.47010053574224	4.6160422910762797e-11	M1_vs_M2	HSALNG0089164	integenic	Not conserved	NA	NA	CLEC2D	ZNF200
ENSG00000248323	LUCAT1	1.27595957823927	1.11727823909781e-14	M1_vs_M2	HSALNG0043427	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4270,hsa-miR-4290,hsa-miR-5006-5p,hsa-miR-6089	Melanoma,Cervical carcinoma,Hematocrit,Red blood cell density measurement,Erythrocyte count,Body height,Uric acid measurement; Cystatin c measurement,Lean body mass,Hip geometry,Colorectal health,Adolescent idiopathic scoliosis,Colorectal cancer,-	ARRDC3	CALCOCO1
ENSG00000267397	ENSG00000267397	-2.11850151925916	0.0471470556739514	M1_vs_M2	HSALNG0120911	integenic	Not conserved	NA	NA	GALNT1	MDH1
ENSG00000287123	ENSG00000287123	-3.59630572286393	2.7626503625555e-4	M1_vs_M2	HSALNG0146118	integenic	Q50	hsa-miR-619-5p,hsa-miR-4437,hsa-miR-6124,hsa-miR-6813-5p	-	SLC1A4	ZMYND11
ENSG00000273145	ENSG00000273145	-1.00824516241226	0.0176091759564789	M1_vs_M2	HSALNG0135987	sense	Not conserved	hsa-miR-3622b-3p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-6132,hsa-miR-6803-5p,hsa-miR-6870-5p,hsa-miR-10394-5p	Risk-taking behaviour; Smoking status measurement,Body height,Dupuytren contracture,Unipolar depression,Birth weight,Wellbeing measurement; Dupuytren contracture,Alcohol use disorder measurement; Alcohol consumption measurement,Body weight,Body height; Body weight,Smoking status measurement,Ovarian carcinoma,Sex hormone-binding globulin measurement,Chemokine (c-c motif) ligand 27 measurement,Protein measurement,Electroencephalogram measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Alkaline phosphatase measurement; Igf-1 measurement,Triglyceride measurement,Behavioural disinhibition measurement,Eosinophil count; Bmi-adjusted hip circumference; Body height; Eosinophil percentage of leukocytes,-,Attention deficit hyperactivity disorder; Bipolar disorder; Major depressive disorder; Autism spectrum disorder	PPARA	RNF10
ENSG00000290927	ENSG00000290927	2.0943477547466	2.3549170053792e-34	M1_vs_M2	HSALNG0110892	integenic	Not conserved	hsa-miR-210-5p,hsa-miR-320a-5p,hsa-miR-4289,hsa-miR-6132,hsa-miR-6722-3p,hsa-miR-6776-5p	-	KRBOX5	EIPR1
ENSG00000232053	ENSG00000232053	1.00865730018654	0.00835227288270126	M1_vs_M2	HSALNG0061598	integenic	Q75	hsa-miR-663b	NA	STMP1	FUT8
ENSG00000205414	ENSG00000205414	-3.53940400800261	2.59254002405069e-25	M1_vs_M2	HSALNG0144931	anti_sense	Q50	NA	NA	SNX20	RFC1
ENSG00000223704	LINC01422	-1.41588847002521	0.0121018053192195	M1_vs_M2	HSALNG0134677	integenic	Not conserved	hsa-miR-7108-3p	-	CRYBA4	MYOM2
ENSG00000255197	ENSG00000255197	-1.99878663616518	2.16572785406858e-58	M1_vs_M2	HSALNG0143174	anti_sense	Q90	NA	Alcohol consumption measurement	SPI1	PHKA2
ENSG00000234394	LINC03025	7.0812504944911	6.5563956659968e-7	M1_vs_M2	HSALNG0071679	sense	Q50	hsa-miR-762,hsa-miR-4447,hsa-miR-5787,hsa-miR-6124	-	PGM5	DKK3
ENSG00000286176	ENSG00000286176	-3.12788896310791	0.00286371915079514	M1_vs_M2	HSALNG0032624	anti_sense	Not conserved	NA	High density lipoprotein cholesterol measurement,Drugs used in diabetes use measurement,Glucose measurement,Hba1c measurement,-,Cholesteryl ester 16:0 measurement,Longevity	PPP2R2C	PIK3CB
ENSG00000291104	BTN2A3P	1.21048254904593	4.52333866591308e-5	M1_vs_M2	HSALNG0048771	integenic	Not conserved	NA	NA	BTN3A1	KCNQ1
ENSG00000253320	MAILR	2.91373673716077	8.33138984281446e-32	M1_vs_M2	HSALNG0067488	integenic	Q50	NA	NA	ATP6V1C1	EIF2AK2
ENSG00000234432	LINC02983	-3.35108265178051	2.90887791298382e-5	M1_vs_M2	HSALNG0149872	integenic	Q50	hsa-miR-4733-3p	-	TNRC18	SOAT1
ENSG00000226137	BAIAP2-DT	-1.8409811600456	2.4352424381074297e-69	M1_vs_M2	HSALNG0119226	integenic	Not conserved	hsa-miR-3943	-	AATK	USP13
ENSG00000291091	SDHAP4	-1.24406774042378	1.0473689208365e-34	M1_vs_M2	HSALNG0032044	integenic	Not conserved	hsa-miR-4281	NA	BDH1	TBXAS1
ENSG00000234506	LINC01506	-1.32970095810908	0.022828934504066	M1_vs_M2	HSALNG0071693	integenic	Not conserved	hsa-miR-5787	NA	TMEM252	SFSWAP
ENSG00000246640	PICART1	-2.74214580451469	6.49482312582494e-6	M1_vs_M2	HSALNG0117242	anti_sense	Q90	hsa-miR-3178,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-10392-3p	-	SAMD14	ABCA7
ENSG00000253838	ENSG00000253838	7.97541456200008	1.68242609588619e-78	M1_vs_M2	HSALNG0150187	sense	Q50	NA	-	IDO1	NTN1
ENSG00000235314	LINC00957	-1.11157747749235	1.8606587325308e-4	M1_vs_M2	HSALNG0057613	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4466,hsa-miR-4505,hsa-miR-5585-3p,hsa-miR-6747-3p,hsa-miR-6784-5p	-	DBNL	LRRC40
ENSG00000287978	ENSG00000287978	-2.15302260718244	0.0165916086536393	M1_vs_M2	HSALNG0141895	integenic	Not conserved	NA	NA	POLR3GL	MYO9A
ENSG00000232656	IDI2-AS1	1.08693473588653	0.00558246709598833	M1_vs_M2	HSALNG0075528	anti_sense	Q75	hsa-miR-3940-5p,hsa-miR-4433a-3p	Response to candesartan,-	GTPBP4	DNTTIP2
ENSG00000274422	ENSG00000274422	-2.43431231961912	2.77122987457324e-5	M1_vs_M2	HSALNG0134310	integenic	Not conserved	hsa-miR-6132,hsa-miR-8072	-	ZNF280B	PDK3
ENSG00000287778	ENSG00000287778	-2.05181930318272	6.19995795619934e-7	M1_vs_M2	HSALNG0032926	integenic	Not conserved	NA	NA	DRD5	ACSL4
ENSG00000273828	ENSG00000273828	1.64216613332161	0.00174667451232292	M1_vs_M2	HSALNG0130476	anti_sense	Q50	NA	-	CD40	SIRT2
ENSG00000180066	LINC02870	-1.28143962362547	0.0146325536917776	M1_vs_M2	HSALNG0081790	integenic	Q50	hsa-miR-1227-5p,hsa-miR-4485-5p,hsa-miR-4514,hsa-miR-4763-3p,hsa-miR-5001-3p,hsa-miR-6813-5p	-	PWWP2B	DGCR2
ENSG00000287736	PTCSC1	-1.20920535703794	0.012838167644806	M1_vs_M2	HSALNG0068717	anti_sense,sense	Not conserved	NA	Eosinophil percentage of leukocytes	TG	ATP6AP1
ENSG00000235910	APOA1-AS	2.55003079647901	0.0138757062072004	M1_vs_M2	HSALNG0087417	anti_sense	Not conserved	NA	Blood protein measurement,High density lipoprotein cholesterol measurement,Sleep duration; Triglyceride measurement,Serum metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; High density lipoprotein cholesterol measurement,-	APOC3	ACAP1
ENSG00000272068	BCAN-AS1	-1.94519377423043	1.3887092443912e-4	M1_vs_M2	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	MAP3K13
ENSG00000267751	BSG-AS1	-1.98261333221391	1.03303352336225e-6	M1_vs_M2	HSALNG0122891	integenic	Not conserved	NA	NA	POLRMT	MAP3K13
ENSG00000288927	ENSG00000288927	-2.18297963219776	0.00513219397372306	M1_vs_M2	HSALNG0000949	anti_sense	Q90	NA	-	AADACL4	SLC24A1
ENSG00000230943	LINC02541	2.38200361860075	1.95569165498652e-10	M1_vs_M2	HSALNG0052910	integenic	Not conserved	NA	NA	HDAC2	VPS9D1
ENSG00000229331	GK-IT1	3.19629454710467	1.4894849359843e-4	M1_vs_M2	HSALNG0137205	intronic_sense	Not conserved	hsa-miR-619-5p	NA	GK	MARK3
ENSG00000284633	ENSG00000284633	3.48201457239269	8.016667227485789e-13	M1_vs_M2	HSALNG0135492	anti_sense	Q50	hsa-miR-4463,hsa-miR-4776-5p,hsa-miR-6769b-5p	Fev/fec ratio,Ulcerative colitis; Crohn's disease; Inflammatory bowel disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Body weight,Platelet crit,Biliary liver cirrhosis,Hair colour measurement,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SYNGR1	DLG1
ENSG00000286004	ENSG00000286004	1.56127211277681	0.00109145667530013	M1_vs_M2	HSALNG0031856	anti_sense	Not conserved	NA	Creatinine measurement; Glomerular filtration rate,-	MUC20	SEC31B
ENSG00000290873	LINC03009	1.74669826042643	1.79955846016017e-5	M1_vs_M2	NA	NA	NA	NA	NA	UPK3B	KIFAP3
ENSG00000289173	ENSG00000289173	5.70759326217712	0.00242985636182192	M1_vs_M2	HSALNG0092178	integenic	Not conserved	hsa-miR-619-5p	-	CPM	CAPN6
ENSG00000222032	ENSG00000222032	-5.74853670253619	0.00433092372552716	M1_vs_M2	HSALNG0023343	integenic	Q75	hsa-miR-6865-5p	Body height,-	COL6A3	FAM76B
ENSG00000230479	ENSG00000230479	-2.09431017812514	0.00918915843606683	M1_vs_M2	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	SLC25A43
ENSG00000273143	DUSP5-DT	-1.01780689289728	0.0341612713350464	M1_vs_M2	HSALNG0080582	integenic	Q50	NA	Heel bone mineral density,Bone density,-	SMNDC1	N4BP2
ENSG00000289880	ENSG00000289880	3.96901332698755	2.46884357202911e-10	M1_vs_M2	NA	NA	NA	NA	NA	FAM177B	THOC1
ENSG00000260101	AFTPH-DT	-1.44373924220619	3.25280934330137e-10	M1_vs_M2	HSALNG0015480	anti_sense	Q90	NA	Epithelial cell adhesion molecule measurement,Gut microbiome measurement,-	SERTAD2	SLC35C2
ENSG00000251432	LINC02615	-1.34425075477938	0.0320935802469218	M1_vs_M2	HSALNG0037069	integenic	Q50	NA	NA	LARP1B	EXD2
ENSG00000270164	LINC01480	-3.65740982491338	1.9945014180522095e-60	M1_vs_M2	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	TRAF5
ENSG00000254872	LINC02688	-4.98395005261533	3.19514816214258e-7	M1_vs_M2	HSALNG0082072	integenic	Q50	hsa-miR-874-3p,hsa-miR-4463	NA	MUC2	TRAF5
ENSG00000205444	KU-MEL-3	6.55246478150122	7.35537524633925e-6	M1_vs_M2	HSALNG0047755	integenic	Not conserved	hsa-miR-3619-5p	Balding measurement,-	CDYL	P2RX5
ENSG00000291005	NBPF25P	-1.91701412572155	7.2489391552857e-5	M1_vs_M2	HSALNG0006737	anti_sense	Not conserved	NA	Breast carcinoma,-	PDZK1	DIS3
ENSG00000227039	ITGB2-AS1	2.14149505239361	8.60176623812126e-31	M1_vs_M2	HSALNG0133581	anti_sense	Not conserved	hsa-miR-4456,hsa-miR-5090,hsa-miR-6732-5p	Heel bone mineral density,-	SLX9	SF3B2
ENSG00000253891	ENSG00000253891	6.86190967628682	1.24774522298166e-6	M1_vs_M2	HSALNG0064035	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1249-5p,hsa-miR-4447,hsa-miR-4463,hsa-miR-4505,hsa-miR-7106-5p	Bmi-adjusted waist circumference; Body height; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Body height,Ankylosing spondylitis,Cleft palate,Necrotizing enterocolitis,Hair colour measurement,Susceptibility to scarlet fever measurement,White matter integrity,Corneal endothelial cell measurement,Idiopathic dilated cardiomyopathy,Mathematical ability,Age at onset,Nicotine withdrawal symptom count,Pallidum volume,Myopia,Brain volume measurement,Seasonality measurement,Interleukin-6 measurement,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Myocarditis; Response to clozapine,Cingulate cortex measurement; Amyloid-beta measurement,Brain volume measurement; Neuroimaging measurement,-	STC1	RFX2
ENSG00000204044	SLC12A5-AS1	1.09928780221773	1.82882414819828e-6	M1_vs_M2	HSALNG0130456	anti_sense	Q75	hsa-miR-4258	Blood protein measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement; Apolipoprotein b measurement,-	NCOA5	SMOX
ENSG00000261644	CYLD-AS1	2.07890430054362	1.19952954634048e-17	M1_vs_M2	HSALNG0111361	anti_sense	Q50	hsa-miR-6089,hsa-miR-8485	Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,-	SNX20	PLEKHG2
ENSG00000234869	LINC02925	-2.17057156467618	1.41773550735992e-5	M1_vs_M2	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	JPH4
ENSG00000259065	MIDEAS-AS1	-2.12050431777986	0.00373597661765194	M1_vs_M2	HSALNG0102380	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4323,hsa-miR-3135b,hsa-miR-4472	-	PTGR2	CBX5
ENSG00000286162	ENSG00000286162	2.44889232175627	1.55285747006106e-24	M1_vs_M2	HSALNG0069800	integenic	Q50	NA	NA	PLGRKT	JAK2
ENSG00000205885	C1RL-AS1	4.165506650855	8.60728073925089e-52	M1_vs_M2	HSALNG0088972	anti_sense	Q50	hsa-miR-4418,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6165,hsa-miR-8485	Neuritic plaque measurement,Platelet count,Platelet crit,-	CLSTN3	UPB1
ENSG00000231663	COA6-AS1	-1.83030735550457	0.0324389654817023	M1_vs_M2	HSALNG0011591	anti_sense	Q50	hsa-miR-6763-5p	-	TARBP1	SRRD
ENSG00000225964	NRIR	5.5669447428989	4.28860515380109e-60	M1_vs_M2	HSALNG0012717	integenic	Q75	NA	Depressive symptom measurement,-	CMPK2	GTPBP1
ENSG00000277089	CCL3-AS1	-3.99431089978935	1.46235642243116e-39	M1_vs_M2	HSALNG0116003	anti_sense,sense	Q75	hsa-miR-604,hsa-miR-4726-5p,hsa-miR-6077,hsa-miR-6089,hsa-miR-6743-5p	Blood protein measurement,C-c motif chemokine 3 measurement	CCL18	AP1B1
ENSG00000250041	ENSG00000250041	-2.62481963957521	9.71921881421882e-29	M1_vs_M2	HSALNG0082662	integenic	Q90	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089,hsa-miR-6165	Heel bone mineral density,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,-	ZBED5	MCAT
ENSG00000197989	SNHG12	-1.10825502884116	3.35207803908812e-32	M1_vs_M2	HSALNG0002075	anti_sense	Q50	hsa-miR-363-5p,hsa-miR-324-5p,hsa-miR-3178,hsa-miR-4466,hsa-miR-6089,hsa-miR-6890-3p	-	TAF12	KIAA0930
ENSG00000258602	LINC01629	2.56558222376348	1.6366293383069002e-10	M1_vs_M2	HSALNG0102605	integenic	Q50	hsa-miR-505-5p,hsa-miR-1268b,hsa-miR-6089,hsa-miR-6803-5p,hsa-miR-6823-5p,hsa-miR-6858-5p,hsa-miR-6877-3p	Protein measurement,Atrial fibrillation,Total blood protein measurement; Blood protein measurement,-	LRRC74A	CSF2RB
ENSG00000233621	ZC3H12A-DT	1.50643950165119	7.33361374886267e-32	M1_vs_M2	HSALNG0002623	integenic	Not conserved	NA	NA	MEAF6	PRMT5
ENSG00000268895	A1BG-AS1	1.12901497500241	5.26087343248151e-8	M1_vs_M2	HSALNG0127948	anti_sense	Not conserved	hsa-miR-1204,hsa-miR-4505,hsa-miR-4535,hsa-miR-4695-5p,hsa-miR-4707-5p,hsa-miR-6081	-	ZSCAN22	PSMA3
ENSG00000263120	ENSG00000263120	2.13482812389609	0.026199833898855	M1_vs_M2	HSALNG0117612	sense	Not conserved	NA	-	SCPEP1	RIN3
ENSG00000231131	LNCAROD	3.04831119386521	1.27342881916145e-8	M1_vs_M2	HSALNG0078017	integenic	Not conserved	hsa-miR-6895-5p	Heel bone mineral density,Bone density; Dickkopf‐related protein 1 measurement; Heel bone mineral density,Bone density,Bone density; Heel bone mineral density,Dickkopf‐related protein 1 measurement,Femoral neck bone mineral density; Spine bone mineral density,Bone fracture,Velocity of sound measurement; Bone quantitative ultrasound measurement; Heel bone mineral density,Bone quantitative ultrasound measurement	MBL2	SUSD6
ENSG00000289100	ENSG00000289100	2.90995043073447	7.978821249593831e-9	M1_vs_M2	HSALNG0049520	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7846-3p	NA	PFDN6	ARHGAP5
ENSG00000282164	PEG13	-2.72086067318044	0.026695713640083	M1_vs_M2	HSALNG0150502	sense	Not conserved	NA	NA	TRAPPC9	PFDN4
ENSG00000237976	RFX5-AS1	1.86315000834986	0.039497403757954803	M1_vs_M2	HSALNG0007143	anti_sense	Q90	NA	-	PSMB4	RNMT
ENSG00000273341	ENSG00000273341	-1.62487168548888	4.04107093403082e-11	M1_vs_M2	HSALNG0059115	anti_sense	Q50	hsa-miR-4466,hsa-miR-7703	Body mass index,Gut microbiome measurement,Hba1c measurement,Hemoglobin a1 measurement,-	CCDC146	ANKRD12
ENSG00000229272	LINC03036	-4.18138664068641	9.19475194379016e-12	M1_vs_M2	HSALNG0081008	integenic	Not conserved	NA	NA	EIF3A	PORCN
ENSG00000277287	ENSG00000277287	-1.2414889356275	0.00248569884136043	M1_vs_M2	HSALNG0128242	integenic	Not conserved	NA	-	ITPA	GLA
ENSG00000290718	FAM95B1	-3.15867156051432	5.2296017100315e-4	M1_vs_M2	HSALNG0071261	integenic	Not conserved	NA	-	SPATA31A1	ZNF821
ENSG00000287771	ENSG00000287771	-5.29230745235204	0.0052629581707288	M1_vs_M2	HSALNG0017397	integenic	Q50	NA	Ulcerative colitis; Crohn's disease,Autism spectrum disorder; Ulcerative colitis; Ankylosing spondylitis; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder,-	IL1R1	COTL1
ENSG00000269072	ENSG00000269072	-2.23168286744506	0.0201847401543826	M1_vs_M2	HSALNG0127186	anti_sense	Not conserved	hsa-miR-4463	Sialic acid-binding ig-like lectin 9 measurement,Blood protein measurement; Alkaline phosphatase measurement,Cortical thickness,Blood protein measurement,Granulocyte percentage of myeloid white cells; Blood protein measurement; Cerebrospinal fluid biomarker measurement; Monocyte percentage of leukocytes,Blood protein measurement; Reticulocyte measurement; Cerebrospinal fluid biomarker measurement,C-reactive protein measurement; Body mass index; Protein measurement; Sialic acid-binding ig-like lectin 9 measurement; Blood protein measurement,-	CTU1	ZNF500
ENSG00000230487	PSMG3-AS1	-1.21217814932208	2.3078829123248506e-15	M1_vs_M2	HSALNG0055664	anti_sense	Not conserved	hsa-miR-30b-3p,hsa-miR-762,hsa-miR-1268b,hsa-miR-5589-5p,hsa-miR-6089	-	MAFK	HOMER2
ENSG00000232545	ENSG00000232545	1.49187935835513	0.005908083245194	M1_vs_M2	HSALNG0134472	sense	Q90	hsa-miR-4529-5p,hsa-miR-6132	NA	CABIN1	KCNN4
ENSG00000235531	MSC-AS1	1.94918960530289	5.858119209609519e-43	M1_vs_M2	HSALNG0066120	anti_sense	Not conserved	NA	Lung carcinoma,Gout,Clinical treatment,Attention deficit hyperactivity disorder,Smoking behaviour measurement,Mental development measurement,Diastolic blood pressure,Forced expiratory volume; Response to bronchodilator,-	KCNB2	TYK2
ENSG00000272338	ENSG00000272338	-1.78843466914325	0.0319047545253155	M1_vs_M2	HSALNG0064463	integenic	Not conserved	NA	NA	FUT10	PLA2G4C
ENSG00000253931	LINC02990	-3.98063827630565	1.71992635373319e-11	M1_vs_M2	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	FKBP8
ENSG00000267296	CEBPA-DT	-2.02195353440373	6.021442992527089e-20	M1_vs_M2	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	HIBADH
ENSG00000264290	ENSG00000264290	-1.70615961362516	0.00806100225013098	M1_vs_M2	HSALNG0115587	sense	Q75	hsa-miR-6775-3p	-	TP53I13	CASP2
ENSG00000261618	LINC02605	5.66212836591069	6.06427538806562e-38	M1_vs_M2	HSALNG0150243	integenic	Not conserved	NA	Platelet-to-lymphocyte ratio; Lymphocyte count	ZC2HC1A	EZH2
ENSG00000291006	ENSG00000291006	1.5688935450991	2.3780164262531303e-10	M1_vs_M2	NA	NA	NA	NA	NA	TMEM14A	FSD1L
ENSG00000286646	MAP3K5-AS2	-3.64903382531148	8.69528479351065e-85	M1_vs_M2	HSALNG0053719	anti_sense	Q50	hsa-miR-619-5p	NA	PEX7	TNFSF8
ENSG00000264456	ENSG00000264456	1.20701403227909	2.61147856337093e-5	M1_vs_M2	HSALNG0115675	intronic_sense	Not conserved	hsa-miR-6089	NA	RNF135	KANK1
ENSG00000215458	AATBC	-2.15224296176468	2.8113583045197596e-31	M1_vs_M2	HSALNG0133454	anti_sense	Not conserved	hsa-miR-6089	-	CSTB	RGP1
ENSG00000286067	ENSG00000286067	1.47449698423791	6.35994583541928e-14	M1_vs_M2	HSALNG0094501	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-6791-5p	NA	SIRT4	RIGI
ENSG00000281756	C2-AS1	2.37242400485827	0.00940690601697735	M1_vs_M2	HSALNG0049350	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4492	Age-related macular degeneration,Von willebrand factor measurement,Bmi-adjusted waist circumference; Autism spectrum disorder,Blood protein measurement,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,-	NELFE	RIGI
ENSG00000261625	ENSG00000261625	-2.64125881541299	0.00128518177113904	M1_vs_M2	HSALNG0085289	integenic	Not conserved	NA	NA	MRGPRF	BAG1
ENSG00000277007	ENSG00000277007	-4.0798294962084	3.2832401399095e-4	M1_vs_M2	HSALNG0010635	sense	Q75	NA	Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference,Fev/fec ratio; Heel bone mineral density,Erythrocyte count,Chronic obstructive pulmonary disease,Fev/fec ratio,Gut microbiome measurement,Pulse pressure measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Lean body mass,Hematocrit,-	LYPLAL1	SH3PXD2A
ENSG00000284669	ENSG00000284669	1.89910336773322	0.00509253061603035	M1_vs_M2	HSALNG0025266	anti_sense	Q90	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-1587,hsa-miR-6850-3p	Sex hormone-binding globulin measurement,Memory performance; Paragraph delayed recall measurement,-	TTC21A	CCNY
ENSG00000281005	LINC00921	-1.79926752908387	4.9901769650597e-7	M1_vs_M2	HSALNG0109143	sense	Not conserved	hsa-miR-3925-3p	NA	NA	CCNY
ENSG00000288919	ENSG00000288919	3.34643160144517	0.0176320595114548	M1_vs_M2	HSALNG0126003	integenic	Q75	hsa-miR-1237-5p,hsa-miR-4492,hsa-miR-6803-3p	-	MED29	CBX1
ENSG00000260751	ENSG00000260751	1.97028236392813	0.0225402074983915	M1_vs_M2	HSALNG0110262	sense	Not conserved	hsa-miR-619-5p	NA	UBFD1	GOSR1
ENSG00000216863	LY86-AS1	-2.58689643939191	8.43398910757607e-51	M1_vs_M2	HSALNG0047825	integenic	Not conserved	NA	NA	F13A1	ALDH3A1
ENSG00000225342	LRRK2-DT	2.76152750387288	1.24035261146006e-9	M1_vs_M2	HSALNG0090483	anti_sense	Q50	NA	Serum gamma-glutamyl transferase measurement,Crohn's disease,Mean platelet volume,Cathepsin l1 measurement,Low density lipoprotein cholesterol measurement,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,-	SLC2A13	COL1A1
ENSG00000256508	MRGPRF-AS1	-3.33182513023645	5.55913436572993e-40	M1_vs_M2	HSALNG0085291	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4710,hsa-miR-6735-3p,hsa-miR-6792-5p,hsa-miR-6803-5p,hsa-miR-6808-5p,hsa-miR-7108-3p	Reticulocyte count,Hair colour measurement,Mosquito bite reaction size measurement,-	TPCN2	VAT1
ENSG00000288954	ENSG00000288954	8.70536251232504	2.22209169926124e-22	M1_vs_M2	HSALNG0089060	integenic	Not conserved	hsa-miR-211-3p	Blood protein measurement,-	CLEC4E	FNBP4
ENSG00000233077	LINC01271	2.31995024881144	1.71497655918576e-7	M1_vs_M2	HSALNG0130754	integenic	Q50	hsa-miR-6875-3p	Thyroid stimulating hormone measurement,Monocyte count,-	PEDS1	FOXRED1
ENSG00000226091	LINC00937	4.86060764471627	7.373021264913489e-84	M1_vs_M2	HSALNG0089057	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6735-5p	Viral load,-	FAM90A1	SLC6A12
ENSG00000251179	TMEM92-AS1	5.8740024830309	4.2881390218683e-4	M1_vs_M2	HSALNG0117279	anti_sense	Not conserved	hsa-miR-762,hsa-miR-4505,hsa-miR-6813-5p	NA	COL1A1	CAND1
ENSG00000237372	ENSG00000237372	4.22846986233283	1.09935313838426e-30	M1_vs_M2	HSALNG0072619	integenic	Not conserved	NA	NA	GADD45G	BTN3A3
ENSG00000233360	PDXP-DT	1.80704133215574	0.0252733056234774	M1_vs_M2	HSALNG0135333	anti_sense	Q75	hsa-miR-6749-3p	-	LGALS2	TMEM14C
ENSG00000289365	ENSG00000289365	3.24674063093524	1.08907560907991e-6	M1_vs_M2	HSALNG0139497	integenic	Q50	NA	NA	NXT2	GPLD1
ENSG00000205611	LINC01597	5.04555730852955	0.0274457371280137	M1_vs_M2	HSALNG0129452	integenic	Not conserved	hsa-miR-4433a-3p	-	DEFB116	FIG4
ENSG00000289977	ENSG00000289977	-3.08996543202048	1.31052962999929e-6	M1_vs_M2	HSALNG0114255	integenic	Not conserved	NA	NA	ACADVL	SLC16A10
ENSG00000260188	ENSG00000260188	-4.13355657170619	4.0353873411345e-4	M1_vs_M2	HSALNG0052706	anti_sense	Q50	hsa-miR-2113,hsa-miR-874-3p,hsa-miR-1268b,hsa-miR-4456,hsa-miR-4778-3p,hsa-miR-6089	Hba1c measurement,Heel bone mineral density,Arachidonic acid measurement,Alpha peak frequency measurement; Electroencephalogram measurement; Alpha wave measurement,-	CDC40	ADGRG6
ENSG00000242516	LINC00960	2.72954333040339	3.17613834053647e-7	M1_vs_M2	HSALNG0026938	anti_sense	Not conserved	hsa-miR-619-5p	NA	FRG2C	DUSP22
ENSG00000256746	MADD-AS1	1.98824010416769	1.7031194779679299e-16	M1_vs_M2	HSALNG0084043	intronic_antisense	Q75	hsa-miR-6747-3p	NA	ACP2	HMGCS1
ENSG00000276248	ENSG00000276248	-1.06733406751155	0.0421123888119192	M1_vs_M2	HSALNG0099603	sense	Not conserved	NA	NA	TMCO3	NNT
ENSG00000234572	LINC01800	-3.8185401063597	8.08066143233817e-29	M1_vs_M2	HSALNG0015493	integenic	Q50	hsa-miR-27a-5p,hsa-miR-200c-5p,hsa-miR-7113-3p	Cholesteryl ester 22:6 measurement,Ccl2 measurement,Visceral adipose tissue measurement,Dna methylation,Epithelial cell adhesion molecule measurement,Sex hormone-binding globulin measurement,Obstructive sleep apnea; Sleep apnea measurement,Protein measurement,Monocyte percentage of leukocytes,-	SERTAD2	FAF2
ENSG00000269553	ENSG00000269553	-2.80745136762149	3.25745215414494e-5	M1_vs_M2	HSALNG0125598	intronic_sense	Not conserved	NA	NA	CD22	RNF130
ENSG00000259805	ENSG00000259805	-3.18844281780873	0.0295749637410301	M1_vs_M2	HSALNG0107722	overlap_antisense,overlap_sense,anti_sense	Not conserved	hsa-miR-619-5p	Bmi-adjusted hip circumference,Coronary artery disease,Chronic obstructive pulmonary disease,Mucocutaneous lymph node syndrome,Intelligence,Glomerular filtration rate,Basophil count; Basophil percentage of leukocytes,-	RAMAC	LNPEP
ENSG00000284428	ENSG00000284428	-1.19365434815642	0.0394087618136417	M1_vs_M2	HSALNG0125033	sense	Not conserved	hsa-miR-30b-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-632,hsa-miR-4318,hsa-miR-1268b,hsa-miR-4673,hsa-miR-4722-5p,hsa-miR-6075	Lysophosphatidylcholine 20:3 measurement,Hyperuricemia; Gout,Forced expiratory volume; Smoking status measurement,Pain measurement; Response to non-steroidal anti-inflammatory,-	NA	PCDH12
ENSG00000234389	ENSG00000234389	6.77964541276552	1.09397269249883e-6	M1_vs_M2	HSALNG0017421	sense	Not conserved	hsa-miR-6811-3p	NA	IL18RAP	PPP2CA
ENSG00000233559	LINC00513	-1.75601328915426	0.00124446874967015	M1_vs_M2	HSALNG0061393	integenic	Not conserved	NA	Parental genotype effect measurement; Vitamin d measurement	MKLN1	DPYSL3
ENSG00000255874	PRECSIT	1.37516238215903	5.1442129092665e-4	M1_vs_M2	HSALNG0141617	integenic	Not conserved	NA	Sitting height ratio	ANKRD10	USP4
ENSG00000289053	ENSG00000289053	3.15228436120588	2.1858329033221e-4	M1_vs_M2	HSALNG0056798	integenic	Q50	NA	Interleukin 18 measurement,Gestational age,Monocyte percentage of leukocytes,-	NFE2L3	GORASP1
ENSG00000214922	HLA-F-AS1	1.35426425639349	1.99541393846515e-5	M1_vs_M2	HSALNG0049088	anti_sense	Not conserved	hsa-miR-575,hsa-miR-8485	Age at menopause,Cytokine measurement,Psoriatic arthritis,Bmi-adjusted waist-hip ratio; Hodgkins lymphoma, mixed cellularity,Lung carcinoma,Bmi-adjusted hip circumference,Self reported educational attainment; Cognitive function measurement,Urate measurement,-	ZFP57	ABCC5
ENSG00000233237	LINC00472	4.02372882982437	2.33528885372483e-16	M1_vs_M2	HSALNG0051173	integenic	Q50	NA	NA	B3GAT2	OTOF
ENSG00000258441	LINC00641	1.47198384709243	3.2451709755902003e-16	M1_vs_M2	HSALNG0099873	integenic	Not conserved	NA	Bipolar disorder,-	HNRNPC	TANC1
ENSG00000254419	ENSG00000254419	-1.11629363044275	0.00806942551337204	M1_vs_M2	HSALNG0131276	sense	Not conserved	NA	NA	NPEPL1	SLC30A3
ENSG00000290858	ENSG00000290858	6.34063458267951	7.36563656484142e-5	M1_vs_M2	HSALNG0115677	integenic	Q90	hsa-miR-4478,hsa-miR-6089	Protein measurement,-	TEFM	GALNT3
ENSG00000255050	ENSG00000255050	2.13482439070142	0.0262982300117201	M1_vs_M2	HSALNG0069297	anti_sense	Q50	hsa-miR-4505,hsa-miR-6744-3p	Interleukin 18 measurement	GSDMD	WIPF1
ENSG00000263069	RNF213-AS1	2.00799361330764	1.54245607320188e-16	M1_vs_M2	HSALNG0119191	anti_sense	Q50	NA	-	NPTX1	PLEKHA3
ENSG00000289881	ENSG00000289881	-3.18853472554603	0.0295583041627436	M1_vs_M2	HSALNG0004816	integenic	Not conserved	hsa-miR-4534,hsa-miR-5047,hsa-miR-6830-5p	Survival time; Lung carcinoma,-	SSX2IP	PARD3B
ENSG00000287497	ENSG00000287497	-2.71926644402199	2.4874554652996e-6	M1_vs_M2	HSALNG0047831	integenic	Q75	hsa-miR-151a-5p,hsa-miR-151b,hsa-miR-4710	Serum alanine aminotransferase measurement,Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,Mean reticulocyte volume; Mean corpuscular volume; Erythrocyte count,Mean corpuscular volume,Monocyte count,Pelvic organ prolapse,Bmi-adjusted waist-hip ratio; Bmi-adjusted hip circumference; Urate measurement,-	LY86	ALMS1
ENSG00000291158	LINC00869	2.18185403105867	5.78936633919591e-7	M1_vs_M2	HSALNG0141914	integenic	Not conserved	NA	NA	PPIAL4C	S100PBP
ENSG00000291174	ENSG00000291174	1.76090784060049	7.7227298118239e-4	M1_vs_M2	NA	NA	NA	NA	NA	FRMD8	TRIM62
ENSG00000290054	ENSG00000290054	-5.61530303618979	3.8577206637915e-4	M1_vs_M2	HSALNG0031957	sense	Not conserved	NA	NA	PIGX	IVNS1ABP
ENSG00000274020	LINC01138	1.82293403794582	1.65630458846694e-8	M1_vs_M2	HSALNG0006866	integenic	Not conserved	NA	NA	PPIAL4G	ADPRS
ENSG00000281103	TRG-AS1	1.31278699867537	6.88727999008315e-39	M1_vs_M2	HSALNG0057335	integenic	Not conserved	NA	NA	STARD3NL	SLC2A1
ENSG00000270426	ENSG00000270426	1.00082069419651	0.00871524701050108	M1_vs_M2	HSALNG0039018	sense	Q90	NA	NA	IRF2	IPO13
ENSG00000283633	ENSG00000283633	-1.37876984867785	2.71074727780518e-6	M1_vs_M2	HSALNG0133812	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6784-5p	-	IL17RA	BLZF1
ENSG00000257354	MIRLET7IHG	1.44875942739135	9.48842818247124e-12	M1_vs_M2	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	PRRC2C
ENSG00000257514	ENSG00000257514	-3.53919068592147	0.00560231552021997	M1_vs_M2	HSALNG0093518	anti_sense	Q50	NA	-	SYCP3	CASP8AP2
ENSG00000289725	ENSG00000289725	-3.24683534140067	8.9598992717703e-4	M1_vs_M2	HSALNG0071598	integenic	Not conserved	NA	NA	ZNG1E	MED28
ENSG00000235381	ENSG00000235381	-1.30405478752948	0.015864982529977	M1_vs_M2	HSALNG0054500	anti_sense,sense	Q90	NA	-	TFB1M	ECRG4
ENSG00000232485	RPL37A-DT	-1.44826971785911	2.61921563005643e-5	M1_vs_M2	HSALNG0022128	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4286	-	MARCHF4	ALDH6A1
ENSG00000271926	ENSG00000271926	-2.83123223374952	2.22268242954288e-9	M1_vs_M2	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	NRDE2
ENSG00000259590	LINC02244	-1.22701727933462	7.01408569274904e-39	M1_vs_M2	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	IDE
ENSG00000291049	FAM86B3P	-1.20488712395995	1.6774409702702e-4	M1_vs_M2	NA	NA	NA	NA	NA	ZNF705B	EXOSC8
ENSG00000287265	ENSG00000287265	1.47429087623062	0.00118345560076492	M1_vs_M2	HSALNG0047279	integenic	Not conserved	NA	NA	EXOC2	FAM53C
ENSG00000228022	HCG20	5.41473319857255	0.00981035265373123	M1_vs_M2	HSALNG0049198	integenic	Not conserved	NA	NA	TUBB	ZFP30
ENSG00000253123	ENSG00000253123	-1.3602916186473	4.45364349571316e-53	M1_vs_M2	HSALNG0064558	integenic	Q90	hsa-miR-4483,hsa-miR-6743-3p,hsa-miR-7150,hsa-miR-8485	-	BRF2	TMPO
ENSG00000290427	ENSG00000290427	-1.55572860953343	1.55165294563387e-21	M1_vs_M2	HSALNG0123614	integenic	Not conserved	NA	Susceptibility to chronic sinus infection measurement	MBD3L2B	RDH10
ENSG00000237525	ENSG00000237525	-5.42985520192221	1.68989687754834e-23	M1_vs_M2	HSALNG0022085	integenic	Q50	NA	-	ATIC	RDH10
ENSG00000274265	ENSG00000274265	2.85391952408867	0.00227142924225686	M1_vs_M2	HSALNG0141909	integenic	Not conserved	hsa-miR-885-3p	-	PDE4DIP	SPOP
ENSG00000259673	IQCH-AS1	-1.23488608417023	2.31376131284626e-6	M1_vs_M2	HSALNG0106756	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-615-5p,hsa-miR-4478,hsa-miR-6089,hsa-miR-6762-3p,hsa-miR-6849-3p,hsa-miR-6769b-3p,hsa-miR-7703	Serum gamma-glutamyl transferase measurement,Left ventricular diastolic function measurement,Bmi-adjusted hip circumference,Bmi-adjusted waist circumference,Waist-hip ratio,Bipolar disorder,Bone density,Body mass index,Age at menarche,Erythrocyte count,Body fat percentage,Neuroticism measurement,Response to peginterferon alfa-2a,Risk-taking behaviour,Insomnia measurement,-	AAGAB	PLBD1
ENSG00000266835	GAPLINC	-2.83668395782235	1.4079856347934498e-44	M1_vs_M2	HSALNG0119710	sense	Not conserved	NA	Pr interval,Citrulline measurement,-	TGIF1	PILRB
ENSG00000230107	ENSG00000230107	2.69499131748543	9.60874746431961e-8	M1_vs_M2	HSALNG0135708	integenic	Q90	hsa-miR-3158-5p,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6089,hsa-miR-6132	NA	SERHL2	HNRNPA2B1
ENSG00000171889	MIR31HG	-2.5431142936334	0.00103624015549026	M1_vs_M2	HSALNG0070362	anti_sense,sense	Q50	hsa-miR-4483,hsa-miR-6089,hsa-miR-7151-5p	Aging,High density lipoprotein cholesterol measurement,Coagulation factor v measurement,Susceptibility to shingles measurement,Thyroid preparation use measurement,Hypothyroidism,Autoimmune disease; Hypothyroidism; Thyroid preparation use measurement,Amblyopia,Macula measurement,Autoimmune thyroid disease,-	IFNE	WIPF3
ENSG00000273179	ENSG00000273179	-1.59683002985108	0.00747887000420373	M1_vs_M2	HSALNG0032247	anti_sense	Not conserved	hsa-miR-23a-5p	NA	MAEA	GLIPR2
ENSG00000225434	LINC01504	-1.83126650218779	2.69048371150344e-24	M1_vs_M2	HSALNG0071849	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-4436a,hsa-miR-8485	Serum albumin measurement,Cognitive function measurement,-	GDA	CALD1
ENSG00000237638	LINC02245	-1.7816419709635	1.07122455989808e-22	M1_vs_M2	HSALNG0015516	integenic	Not conserved	NA	NA	RAB1A	RBM19
ENSG00000237989	LINC01679	3.29097125410755	0.00653068690426993	M1_vs_M2	HSALNG0133409	integenic	Not conserved	hsa-miR-6842-5p	Agents acting on the renin-angiotensin system use measurement,Diastolic blood pressure; Systolic blood pressure,Diastolic blood pressure,Phosphatidylcholine 38:2 measurement; Phosphatidylcholine 38:3 measurement,Bmi-adjusted waist circumference,Hair color,Systolic blood pressure,Blood pressure; Cardiovascular disease; Chronic obstructive pulmonary disease,Eye color,Cirrhosis of liver; Non-alcoholic fatty liver disease,High density lipoprotein cholesterol measurement; Metabolic syndrome,-	SIK1	RNF11
ENSG00000254054	ENSG00000254054	-6.09185843154953	1.37741714055706e-16	M1_vs_M2	HSALNG0063689	anti_sense	Q50	hsa-miR-331-3p,hsa-miR-3194-3p,hsa-miR-4257,hsa-miR-2467-3p	NA	PCM1	SNAI1
ENSG00000223901	ENSG00000223901	2.55260014746825	2.14474103961226e-11	M1_vs_M2	HSALNG0133720	anti_sense	Q50	NA	-	YBEY	NEURL2
ENSG00000288928	ENSG00000288928	-2.01411836700054	0.00342921921365799	M1_vs_M2	NA	NA	NA	NA	NA	HIF1A	RIOK1
ENSG00000266709	ENSG00000266709	4.63790422501729	3.57332350899279e-37	M1_vs_M2	HSALNG0114719	intronic_sense	Q50	NA	NA	HS3ST3B1	SYMPK
ENSG00000286504	ENSG00000286504	6.02389354432359	4.4826616362653e-4	M1_vs_M2	HSALNG0089056	integenic	Not conserved	NA	NA	FAM90A1	GZF1
ENSG00000284543	LINC01226	-3.20644524802749	0.038751337019004	M1_vs_M2	HSALNG0002236	sense	Q75	hsa-miR-1231,hsa-miR-1207-5p,hsa-miR-4434	Intelligence,-	TINAGL1	TRAP1
ENSG00000291040	CD99P1	-2.92565395348864	6.23882944230675e-23	M1_vs_M2	HSALNG0136380	integenic	Not conserved	NA	Adolescent idiopathic scoliosis	CD99	UXT
ENSG00000206337	HCP5	1.32692472076267	5.78042891488959e-69	M1_vs_M2	HSALNG0049264	sense	Not conserved	hsa-miR-4257,hsa-miR-4492,hsa-miR-6769b-5p	Trichloroethylene-induced hypersensitivity,Hiv-1 infection,Female reproductive system disease,Blood protein measurement,Heel bone mineral density,Systemic lupus erythematosus,Mhc class i polypeptide-related sequence a measurement,Uveitis,Reticulocyte measurement,Hiv-1 infection; Mhc class i polypeptide-related sequence a measurement; Susceptibility to common cold measurement; Mean platelet volume,Cervical carcinoma,Body height; Bmi-adjusted hip circumference; Basophil percentage of leukocytes,Platelet component distribution width; Eosinophil percentage of leukocytes,Temporal arteritis; Blood protein measurement,Platelet count; Atopic asthma,Platelet-to-lymphocyte ratio; Bmi-adjusted hip circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Chronic hepatitis c virus infection,Psoriatic arthritis,Cervical intraepithelial neoplasia grade 2/3; Mhc class i polypeptide-related sequence a measurement; Bmi-adjusted hip circumference; Cervical carcinoma,Mosquito bite reaction size measurement; Aspirin use measurement; Calcium channel blocker use measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Bmi-adjusted hip circumference,Body weight,Neutrophil percentage of leukocytes,Response to antineoplastic agent,Beta-2 microglobulin measurement,Non-melanoma skin carcinoma,Bmi-adjusted hip circumference; Neutrophil count; Lymphocyte count,Neutrophil count,Bmi-adjusted waist-hip ratio; Red blood cell distribution width,Iritis,17-hydroxyprogesterone measurement,Blood protein measurement; Trefoil factor 3 measurement,Mhc class i polypeptide-related sequence a measurement; Hemoglobin measurement,Platelet-derived growth factor bb measurement,Autism spectrum disorder,Mean platelet volume,Platelet count,Age at diagnosis,Eosinophil count,Platelet aggregation; Prostate carcinoma,Uterine fibroid; Bmi-adjusted waist-hip ratio,Red blood cell distribution width,Keratinocyte carcinoma; Squamous cell carcinoma,Apolipoprotein b measurement,Intelligence,Lung carcinoma,Mhc class i polypeptide-related sequence a measurement; Blood protein measurement,Body height; Stromal cell-derived factor 1 alpha measurement,Granulocyte percentage of myeloid white cells,Susceptibility to mononucleosis measurement,Platelet component distribution width,Hiv-1 infection; Aids; Psoriasis; Drug-induced liver injury,Renal system measurement,Myositis,Polymyositis; Physical activity measurement; Bmi-adjusted waist-hip ratio; Myositis,Eosinophil count; Platelet count,Cytokine measurement; Herpes zoster,Thyroid peroxidase antibody measurement,Squamous cell lung carcinoma; Mmr-related febrile seizures; Bmi-adjusted waist circumference; Lung carcinoma; Eosinophil count,Appendicular lean mass,Glucose measurement,Platelet-to-lymphocyte ratio,Aging,Bmi-adjusted hip circumference; Mhc class i polypeptide-related sequence b measurement; Bmi-adjusted waist-hip ratio,Upper aerodigestive tract neoplasm; Bmi-adjusted hip circumference; Anilide use measurement; Lung carcinoma; Body weight,Parental longevity,Visual perception measurement,Carpal tunnel syndrome,Herpes zoster,Thyrotoxic periodic paralysis,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Susceptibility to cold sores measurement; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Eosinophil percentage of leukocytes,Susceptibility to childhood ear infection measurement,Body height,Lymphocyte count; Basophil count; Myositis; Leukocyte count; Monocyte count,Serum alanine aminotransferase measurement,Bmi-adjusted waist-hip ratio; Mhc class i polypeptide-related sequence b measurement,Angina pectoris,Clinical treatment,Bmi-adjusted waist circumference; Autism spectrum disorder; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to chickenpox measurement,Susceptibility to shingles measurement,Parental genotype effect measurement; Birth weight,Body mass index; Visceral adipose tissue measurement,Response to drug; Drug-induced agranulocytosis,Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,Toxic epidermal necrolysis; Stevens-johnson syndrome,Eczema; Allergic rhinitis,Response to thioamide; Drug-induced agranulocytosis,Prion disease; Psychotic symptoms,Susceptibility to pneumonia measurement,Human papilloma virus infection; Oropharynx cancer,Bmi-adjusted waist circumference; Hypertension; Bmi-adjusted waist-hip ratio	MICB	LRRC61
ENSG00000285966	ENSG00000285966	3.3188428223702	4.35943527512956e-5	M1_vs_M2	HSALNG0102615	integenic	Q50	hsa-miR-1268b,hsa-miR-4463,hsa-miR-4667-3p	-	IRF2BPL	HP1BP3
ENSG00000287809	ENSG00000287809	-2.79295873150337	0.00956626004563806	M1_vs_M2	HSALNG0110117	anti_sense,sense	Not conserved	NA	Velopharyngeal dysfunction,Adolescent idiopathic scoliosis,Empathy measurement,Unipolar depression,Major depressive disorder; Unipolar depression,Balding measurement,Inflammatory biomarker measurement; Ykl40 measurement,Bipolar disorder; Unipolar depression; Disease recurrence,Thrombin activatable fibrinolysis inhibitor activation peptide measurement,-	METTL9	GNG11
ENSG00000282851	BISPR	1.10037479567289	2.9758178113473e-13	M1_vs_M2	HSALNG0124521	sense	Not conserved	hsa-miR-6775-3p	Blood phosphate measurement,-	MVB12A	ZFP36
ENSG00000256967	ENSG00000256967	3.64772158051658	4.03738147661342e-12	M1_vs_M2	HSALNG0088974	anti_sense	Q50	hsa-miR-146b-3p	-	RBP5	ADORA2A
ENSG00000231574	LINC02015	3.97729755492586	8.33759435120891e-9	M1_vs_M2	HSALNG0030884	integenic	Q50	hsa-miR-619-5p,hsa-miR-4433a-3p,hsa-miR-4456,hsa-miR-4508,hsa-miR-6749-5p,hsa-miR-6807-3p,hsa-miR-7703,hsa-miR-4433b-3p,hsa-miR-8485	Systemic lupus erythematosus,Hba1c measurement; Hemoglobin a1 measurement,Hallux valgus,Anxiety disorder,Reaction time measurement,Visual perception measurement,Alcohol drinking,Unipolar depression,Brain volume measurement,Cortical surface area measurement,Chin morphology measurement,Corneal topography,Central corneal thickness,Cortical thickness,Heel bone mineral density,Cortical surface area measurement; Neuroimaging measurement,White matter microstructure measurement,Body height,Calcium measurement,Lobe attachment,Neuropsychological test,Venous thromboembolism,Pathological myopia,Gut microbiome measurement,Adolescent idiopathic scoliosis,Abnormality of the urinary system; Response to radiation,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Ovarian serous carcinoma; Ovarian carcinoma; Progression free survival,Response to cranial radiation therapy; Body mass index,-	KCNMB2	ADORA2A
ENSG00000291097	HLA-L	1.69516564436781	1.78924958926537e-16	M1_vs_M2	HSALNG0049134	integenic	Not conserved	NA	NA	TRIM39	APOL2
ENSG00000270607	NAV2-AS6	1.76176296193765	4.0639396639014e-4	M1_vs_M2	HSALNG0083062	anti_sense	Q75	NA	-	DBX1	APOBEC3A
ENSG00000233384	CNIH3-AS2	-2.03613126915591	1.37583715082884e-10	M1_vs_M2	HSALNG0010968	anti_sense	Q75	hsa-miR-4467,hsa-miR-3960,hsa-miR-7156-3p	-	WDR26	MKLN1
ENSG00000287494	ENSG00000287494	-1.3474263720531101	0.00619835643232761	M1_vs_M2	HSALNG0144545	anti_sense	Q50	hsa-miR-5787	Fev/fec ratio,Platelet component distribution width	PIF1	TTBK2
ENSG00000289127	ENSG00000289127	-4.8120058249423	6.35722896782737e-8	M1_vs_M2	HSALNG0137342	integenic	Q90	NA	NA	MID1IP1	RHBDF2
ENSG00000262468	LINC01569	1.12147871585463	4.45697118508649e-6	M1_vs_M2	HSALNG0109218	integenic	Q50	hsa-miR-1233-5p,hsa-miR-1268b,hsa-miR-5001-3p,hsa-miR-6089,hsa-miR-1273h-5p	Pulse pressure measurement; Central corneal thickness,Electrocardiography; Alkaline phosphatase measurement; Mean corpuscular volume; Mean corpuscular hemoglobin,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Mean corpuscular hemoglobin; Red blood cell density measurement,Red blood cell density measurement; Erythrocyte count,Pulse pressure measurement,Alkaline phosphatase measurement,Mean reticulocyte volume	SRL	PHF10
ENSG00000231528	FAM225A	3.67476131911169	1.81575194651183e-32	M1_vs_M2	HSALNG0073810	integenic	Not conserved	NA	NA	SLC31A2	CDC16
ENSG00000229771	ENSG00000229771	-3.09110636057677	6.59227260618623e-63	M1_vs_M2	HSALNG0130126	integenic	Q90	NA	Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement	MAFB	PGLS
ENSG00000271086	NAMA	-3.22366984721459	0.00245932989683637	M1_vs_M2	HSALNG0073233	integenic	Q75	hsa-miR-892b,hsa-miR-4279,hsa-miR-4638-3p,hsa-miR-5001-3p,hsa-miR-5589-5p,hsa-miR-6504-5p,hsa-miR-6830-5p,hsa-miR-8485	Callous-unemotional behaviour; Body mass index,Mathematical ability,-	ALG2	LSM7
ENSG00000289587	ENSG00000289587	-3.3744846346397	0.0130244226311821	M1_vs_M2	HSALNG0118245	anti_sense	Q50	NA	Post-traumatic stress disorder	APOH	OSBPL2
ENSG00000260256	ENSG00000260256	2.8180325410539	2.93482690979313e-9	M1_vs_M2	HSALNG0133530	integenic	Not conserved	hsa-miR-1178-5p	-	CFAP410	SHFL
ENSG00000279277	ENSG00000279277	1.18478696097295	6.4399431993067e-4	M1_vs_M2	HSALNG0027881	integenic	Q50	hsa-miR-5787	Bipolar disorder,-	CD47	ACSS2
ENSG00000287024	ENSG00000287024	-2.59966700032061	0.012392194525368	M1_vs_M2	HSALNG0140088	integenic	Q75	hsa-miR-3960,hsa-miR-6724-5p,hsa-miR-6773-5p	NA	APLN	ZNF428
ENSG00000232912	RERE-AS1	2.98507111651737	5.10292341977643e-8	M1_vs_M2	HSALNG0000636	anti_sense	Q50	hsa-miR-920,hsa-miR-4447,hsa-miR-4505	Self reported educational attainment,Anorexia nervosa; Autism spectrum disorder; Obsessive-compulsive disorder; Thyroid peroxidase antibody measurement; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome,Diastolic blood pressure; Depressive symptom measurement; Basophil count; Unipolar depression; Smoking status measurement; Eosinophil count; Vitiligo,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Tourette syndrome; Aspartate aminotransferase measurement,Body fat percentage,Cup-to-disc ratio measurement; Systolic blood pressure,Open-angle glaucoma,Autism spectrum disorder,Self reported educational attainment; Intelligence,Wellbeing measurement,-	SLC45A1	ACAP3
ENSG00000245573	BDNF-AS	-1.57996840540137	1.226777694893e-5	M1_vs_M2	HSALNG0083312	integenic	Not conserved	NA	NA	BBOX1	ZNF304
ENSG00000272463	ENSG00000272463	2.54139150380131	5.0294378283873e-4	M1_vs_M2	HSALNG0047304	integenic	Q50	NA	-	EXOC2	UNK
ENSG00000245025	ENSG00000245025	1.45741577727986	8.82172115552963e-6	M1_vs_M2	HSALNG0063952	anti_sense	Not conserved	hsa-miR-6805-5p	Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Renal cell carcinoma,Basal cell carcinoma,-	PEBP4	EIF5A
ENSG00000227531	ENSG00000227531	2.32799157641602	5.9481431085859e-4	M1_vs_M2	HSALNG0073676	integenic	Q50	hsa-miR-23a-5p,hsa-miR-619-5p,hsa-miR-6089,hsa-miR-7107-5p	Bmi-adjusted waist-hip ratio,Monocyte count,Bmi-adjusted hip circumference,Electrocardiography,Leukocyte count,Body height at birth; Birth weight,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Waist-hip ratio; Bmi-adjusted hip circumference; Myeloid white cell count; Bmi-adjusted waist-hip ratio; Monocyte count; Monocyte percentage of leukocytes,Late-onset alzheimers disease,Myeloid white cell count,Leukocyte count; Lymphocyte percentage of leukocytes,Monocyte percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Body height,Neutrophil percentage of leukocytes; Bmi-adjusted waist-hip ratio; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Neutrophil percentage of leukocytes; Birth weight; Basophil count,Eosinophil count,Parental genotype effect measurement; Birth weight,Response to antineoplastic agent; Venous thromboembolism,-	OR2K2	RHBG
ENSG00000232093	DCST1-AS1	-1.78599882702697	0.0226826790226233	M1_vs_M2	HSALNG0007463	anti_sense	Q50	hsa-miR-1207-5p	Calcium measurement; Serum urea measurement; Serum albumin measurement,Hba1c measurement,Dna methylation,Serum gamma-glutamyl transferase measurement; Urate measurement,Forehead morphology measurement,Bmi-adjusted hip circumference,Blood protein measurement; Smoking status measurement,Skin neoplasm,Gait measurement,Eosinophil percentage of leukocytes,Varicose veins; Chin morphology measurement; Cortical surface area measurement; Mosquito bite reaction size measurement; Facial morphology measurement; Serum albumin measurement; Risk-taking behaviour,Attention deficit hyperactivity disorder; Systemic lupus erythematosus; Smoking status measurement; Substance abuse; Risk-taking behaviour; Antisocial behaviour measurement,-	DCST2	TOE1
ENSG00000227392	HPN-AS1	7.36096176411463	2.4608801092219702e-9	M1_vs_M2	HSALNG0125567	anti_sense	Not conserved	NA	NA	LGI4	STARD13
ENSG00000261596	ENSG00000261596	1.20164350164431	2.5786998702596297e-12	M1_vs_M2	HSALNG0110129	sense	Q75	NA	-	METTL9	EPHB2
ENSG00000260997	ENSG00000260997	6.71908908945695	2.4071103547239595e-144	M1_vs_M2	NA	NA	NA	NA	NA	MYO1G	CMPK2
ENSG00000227502	MROCKI	3.57652997558317	3.65258855986046e-25	M1_vs_M2	HSALNG0052921	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505	NA	HDAC2	SOX5
ENSG00000250777	ENSG00000250777	-1.69833480349738	0.00280228134665813	M1_vs_M2	HSALNG0037343	integenic	Q75	hsa-miR-6825-5p	Parental longevity,Energy intake,Systemic lupus erythematosus,Sleep duration; Triglyceride measurement,Triglyceride measurement; High density lipoprotein cholesterol measurement,-	PCDH18	PUM1
ENSG00000280832	GSEC	2.13817921531644	3.34155528383833e-7	M1_vs_M2	HSALNG0088026	anti_sense	Q50	NA	Neutrophil count,Low density lipoprotein cholesterol measurement,-	KIRREL3	SPOCD1
ENSG00000275278	ENSG00000275278	-3.51822307679422	0.010719432682109	M1_vs_M2	HSALNG0090086	anti_sense	Q50	hsa-miR-3960,hsa-miR-6744-3p,hsa-miR-4433b-3p	Fructose measurement; Glucose measurement; Galactose measurement,-	ERGIC2	DMTF1
ENSG00000237943	PRKCQ-AS1	1.36765331918072	0.0120136385773473	M1_vs_M2	HSALNG0075966	integenic	Q50	hsa-miR-30b-3p,hsa-miR-891a-3p,hsa-miR-4632-3p,hsa-miR-6763-5p	Atopic asthma,Eosinophil count,Eczema; Respiratory system disease,Eosinophil percentage of leukocytes,Eczema; Allergic rhinitis,-	PFKFB3	PNPLA8
ENSG00000253522	MIR3142HG	1.71412041837819	7.269581001832279e-118	M1_vs_M2	HSALNG0046249	integenic	Not conserved	NA	NA	PTTG1	STX11
ENSG00000272081	FCHO2-DT	-2.81899639979731	2.08057295324963e-22	M1_vs_M2	HSALNG0042600	anti_sense	Q75	hsa-miR-4466,hsa-miR-3960	Serum urea measurement; Serum albumin measurement; Aspartate aminotransferase measurement,Calcium measurement,Heel bone mineral density,Albumin:globulin ratio measurement; Serum non-albumin protein measurement,Monocyte count,Mean reticulocyte volume; Mean corpuscular volume; Serum albumin measurement,-	ZNF366	TMBIM1
ENSG00000288700	ENSG00000288700	-3.23953402794931	3.8266327017340195e-12	M1_vs_M2	HSALNG0147628	intronic_sense	Q50	NA	NA	CEP63	VILL
ENSG00000260565	ERVK13-1	-1.0271267209771	2.34318260342821e-21	M1_vs_M2	HSALNG0109047	anti_sense	Q75	hsa-miR-4323,hsa-miR-3620-5p,hsa-miR-1587,hsa-miR-6089	Intraocular pressure measurement,Aspartate aminotransferase measurement,-	PRSS27	TBC1D4
ENSG00000234883	MIR155HG	1.73850095576333	2.17820834342424e-27	M1_vs_M2	HSALNG0132382	anti_sense,sense	Q75	hsa-miR-6089,hsa-miR-8485	Neuropsychological test,Intelligence,Response to carboplatin,Nicotine dependence symptom count,Gout,Open-angle glaucoma,Triglyceride measurement,Erythrocyte count,Chronic lymphocytic leukemia,Cerebrospinal fluid biomarker measurement; Alpha synuclein measurement,Duchenne muscular dystrophy; Disease progression measurement,-,Amyloid plaque accumulation rate	JAM2	HUS1
ENSG00000203446	SUGCT-AS1	1.0646355561654	3.0714794135621007e-15	M1_vs_M2	HSALNG0057426	anti_sense	Q90	hsa-miR-6089,hsa-miR-6824-3p	-	MPLKIP	SLC31A1
ENSG00000279278	ENSG00000279278	-2.29596783550881	7.948307825904859e-19	M1_vs_M2	HSALNG0134311	integenic	Not conserved	hsa-miR-198,hsa-miR-210-5p	NA	VPREB1	GMPR
ENSG00000230647	ENSG00000230647	8.02441029569339	3.76357101132589e-14	M1_vs_M2	HSALNG0145008	integenic	Q75	hsa-miR-619-5p	Heel bone mineral density,-	HS3ST3B1	YAP1
ENSG00000188825	LINC00910	-1.16199810073705	0.0015384047774384	M1_vs_M2	HSALNG0116632	integenic	Not conserved	NA	-	CCDC200	ALKBH8
ENSG00000255521	CD44-DT	2.73409993824729	2.65603200629689e-5	M1_vs_M2	HSALNG0083606	anti_sense	Q50	NA	Response to vitamin,-	SLC1A2	FNBP1L
ENSG00000273314	ENSG00000273314	2.73057454313811	2.24679210351891e-6	M1_vs_M2	HSALNG0062087	anti_sense	Q50	hsa-miR-668-5p	NA	EZH2	DNASE2B
ENSG00000284240	LINC02801	-2.58986340599647	0.0206296354702767	M1_vs_M2	HSALNG0004954	integenic	Q90	hsa-miR-619-5p,hsa-miR-5587-3p,hsa-miR-6085	Eosinophil count,Loneliness measurement,Basophil count,Basophil percentage of granulocytes; Basophil count; Basophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Insomnia measurement,-	NA	CEP55
ENSG00000236901	MIR600HG	-1.04448438237367	3.75282845218347e-10	M1_vs_M2	HSALNG0074272	sense	Not conserved	NA	-	STRBP	ENTPD1
ENSG00000232956	SNHG15	1.47077139736677	9.04459429155666e-31	M1_vs_M2	HSALNG0057702	anti_sense,sense	Q50	hsa-miR-4726-3p,hsa-miR-7107-5p	Body height,Diastolic blood pressure,-	MYO1G	ATIC
ENSG00000289564	ENSG00000289564	-2.87345853185558	0.0109404657179266	M1_vs_M2	HSALNG0134258	anti_sense	Not conserved	hsa-miR-619-5p	NA	PPIL2	SMARCAL1
ENSG00000263718	SEPTIN9-DT	-1.55588485431825	0.00140461127705182	M1_vs_M2	HSALNG0118918	anti_sense	Q50	hsa-miR-1227-5p,hsa-miR-8485	Virologic response measurement; Response to abacavir,-	SRSF2	BARD1
ENSG00000273824	ENSG00000273824	6.78982172713371	1.97357411593605e-32	M1_vs_M2	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	CHRNA1
ENSG00000166770	ZNF667-AS1	-1.25000248090973	0.00112071559018928	M1_vs_M2	HSALNG0127764	anti_sense	Not conserved	hsa-miR-6895-5p	Alkaline phosphatase measurement; Low density lipoprotein cholesterol measurement,-	ZNF471	GLCE
ENSG00000258521	ENSG00000258521	2.79289608750939	3.7178112508818694e-25	M1_vs_M2	HSALNG0103731	anti_sense	Not conserved	NA	NA	SLC25A47	MTTP
ENSG00000260528	FAM157C	3.46736940055532	3.6203658004212e-4	M1_vs_M2	HSALNG0113696	integenic	Not conserved	hsa-let-7g-3p	-	GAS8	SHISAL1
ENSG00000274565	ENSG00000274565	-3.00129740784032	2.3508470546985e-4	M1_vs_M2	HSALNG0117970	anti_sense	Q75	NA	-	MARCHF10	ERP27
ENSG00000189238	LINC00943	1.92569636346503	0.00495981111042982	M1_vs_M2	HSALNG0094963	integenic	Q50	hsa-miR-619-5p,hsa-miR-936,hsa-miR-4725-3p	NA	TMEM132B	ETV6
ENSG00000287263	ENSG00000287263	1.99397155992672	2.65746167134446e-60	M1_vs_M2	HSALNG0041483	integenic	Not conserved	hsa-miR-6807-3p	Intelligence,Cytokine measurement	ANXA2R	C1RL
ENSG00000256442	ENSG00000256442	4.89898995418681	0.0456756720615053	M1_vs_M2	HSALNG0089163	integenic	Not conserved	hsa-miR-6515-5p	NA	KLRB1	SMARCC2
ENSG00000290441	ENSG00000290441	5.70674220391236	0.00229247409602103	M1_vs_M2	HSALNG0148215	integenic	Not conserved	hsa-miR-4505,hsa-miR-1587	NA	TLR2	ZNF740
ENSG00000286972	ENSG00000286972	-3.40275033220649	1.4480746986847802e-14	M1_vs_M2	HSALNG0146843	integenic	Q90	NA	Abnormal paneth cell measurement,-	TOP1	JDP2
ENSG00000258689	LINC01269	-3.45769474073674	3.86402065066376e-9	M1_vs_M2	HSALNG0102232	integenic	Q50	hsa-miR-4309,hsa-miR-4478	-	TTC9	SLC24A4
ENSG00000285744	ENSG00000285744	5.7729476355345	4.378455701114769e-141	M1_vs_M2	HSALNG0066417	integenic	Not conserved	NA	NA	ZC2HC1A	WARS1
ENSG00000274536	MIR223HG	-1.87085973656865	5.09186126333957e-5	M1_vs_M2	HSALNG0138297	anti_sense	Q50	hsa-miR-331-3p	Balding measurement,Eosinophil count,Alopecia,Mean platelet volume; Platelet count,Eosinophil percentage of leukocytes	HEPH	LINS1
ENSG00000269220	LINC00528	2.3677398949582	2.52543857856874e-6	M1_vs_M2	HSALNG0133922	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-4257,hsa-miR-6089,hsa-miR-6877-3p	Response to diisocyanate,Adiponectin measurement	BCL2L13	GAS8
ENSG00000290385	ENSG00000290385	2.26254107832025	0.00577411972423867	M1_vs_M2	HSALNG0000017	integenic	Not conserved	NA	NA	OR4F29	TOM1L1
ENSG00000281392	LINC00506	3.36295525192083	0.00371009469240724	M1_vs_M2	HSALNG0027226	integenic	Not conserved	NA	Prostate carcinoma,-	CHMP2B	SGSM2
ENSG00000263345	SGSM2-AS1	-1.05027083029592	0.00879111972858678	M1_vs_M2	HSALNG0113905	anti_sense	Q75	hsa-miR-4313,hsa-miR-6132	Self reported educational attainment; Autism spectrum disorder,Lifestyle measurement,-,Household income	MNT	GNAL
ENSG00000226822	LINC02785	-1.86333321782325	7.33434604218532e-14	M1_vs_M2	HSALNG0005787	anti_sense	Q50	hsa-miR-1224-5p,hsa-miR-4508,hsa-miR-4638-3p,hsa-miR-6089	Bipolar disorder,Neutrophil count,Waist-hip ratio,Heel bone mineral density,Hba1c measurement,Hemoglobin a1 measurement,Mean corpuscular volume,Covid-19,Growth-regulated alpha protein measurement,Herpes zoster,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Forced expiratory volume; Response to bronchodilator,-	NBPF6	SLC39A6
ENSG00000286757	ENSG00000286757	-1.21774834531725	0.0207177351935105	M1_vs_M2	HSALNG0098950	integenic	Q75	hsa-miR-6730-3p	Sleep measurement,-	ZIC5	RPTOR
ENSG00000290727	ALMS1P1	5.95029395697482	6.2775963458624e-4	M1_vs_M2	HSALNG0015975	anti_sense	Not conserved	NA	Serum metabolite measurement; Urinary metabolite measurement,-	ALMS1	CBX4
ENSG00000253671	ENSG00000253671	-1.12412815279094	1.4288142289699e-4	M1_vs_M2	HSALNG0063682	anti_sense	Q50	hsa-miR-1268b,hsa-miR-6089,hsa-miR-6769b-3p,hsa-miR-6867-5p	Body height,Blood protein measurement,Fev change measurement; Response to bronchodilator,-	PCM1	ZCCHC2
ENSG00000269982	ENSG00000269982	-1.21559598030459	4.04629009632231e-6	M1_vs_M2	HSALNG0024078	anti_sense	Q50	NA	Blood protein measurement,-	CRELD1	IFNAR1
ENSG00000255801	ENSG00000255801	6.1592469928485	1.2737722522231e-4	M1_vs_M2	HSALNG0089073	integenic	Not conserved	NA	Takayasu arteritis,Response to radiation	CLEC4E	PTPRF
ENSG00000290095	ENSG00000290095	-2.99561845690641	0.00816811366344404	M1_vs_M2	NA	NA	NA	NA	NA	GALNTL5	IGSF3
ENSG00000237886	NALT1	-1.97845922147168	0.013690318502244	M1_vs_M2	HSALNG0075266	integenic	Q75	hsa-miR-3612,hsa-miR-4674,hsa-miR-5088-3p	Sucrose liking measurement,-	EGFL7	C1orf162
ENSG00000274508	ENSG00000274508	2.31692413479391	8.03363989538772e-5	M1_vs_M2	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	CGN
ENSG00000285632	ENSG00000285632	-1.90343674265198	0.0310532159878643	M1_vs_M2	HSALNG0064623	anti_sense	Not conserved	hsa-miR-619-5p	-	PLPP5	HAX1
ENSG00000246250	ENSG00000246250	1.6523078127262	0.0353626325707549	M1_vs_M2	HSALNG0083840	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-4487	Body mass index,Chronotype measurement,-	ALX4	C1orf35
ENSG00000286872	ENSG00000286872	-2.74274742313372	4.84688198047569e-50	M1_vs_M2	HSALNG0107736	integenic	Not conserved	hsa-miR-4447,hsa-miR-4505	NA	HDGFL3	ETNK2
ENSG00000291114	SIGLEC17P	-1.67153211733524	1.07298314794676e-15	M1_vs_M2	NA	NA	NA	NA	NA	SIGLEC7	RALB
ENSG00000256196	ENSG00000256196	1.7806593129154	0.0468870217649523	M1_vs_M2	HSALNG0084483	anti_sense	Q50	hsa-miR-3155b	Blood protein measurement,-	PRPF19	TAMM41
ENSG00000257127	CLLU1	4.64505272940105	1.67633488421003e-7	M1_vs_M2	HSALNG0093062	anti_sense	Q50	NA	Methionine measurement,Sudden cardiac arrest,-	PLEKHG7	TAMM41
ENSG00000283648	ENSG00000283648	7.01298763194113	2.60871540351766e-7	M1_vs_M2	HSALNG0062073	anti_sense	Q50	hsa-miR-6791-3p	Protein measurement,Parkinson's disease symptom measurement,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Gut microbiome measurement,Crohn's disease,Asparagine measurement,Uterine fibroid measurement,Chronic kidney disease; Diabetic nephropathy,Cardiovascular event measurement; Response to angiotensin-converting enzyme inhibitor; Response to angiotensin receptor blocker,-	EZH2	ITGA9
ENSG00000288961	ENSG00000288961	1.53356453384249	6.57774427146441e-6	M1_vs_M2	HSALNG0116727	integenic	Q50	hsa-miR-619-5p,hsa-miR-1237-5p,hsa-miR-1268b,hsa-miR-4447,hsa-miR-4508,hsa-miR-6816-5p	-	RUNDC3A	GOLGA4
ENSG00000286548	ENSG00000286548	2.36280872256748	1.34946641610779e-10	M1_vs_M2	HSALNG0005059	anti_sense	Q50	NA	Prostate carcinoma,Blood protein measurement,Total blood protein measurement,Mathematical ability,Adolescent idiopathic scoliosis,Bilirubin measurement,-	GBP5	PLA1A
ENSG00000232295	ENSG00000232295	1.0051678774816	0.0333842402329734	M1_vs_M2	HSALNG0051162	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-6803-5p,hsa-miR-6813-5p	Antipsychotic drug related weight gain; Longitudinal bmi measurement,Beta-amyloid 1-42 measurement,Heel bone mineral density,Lung carcinoma,Body height,-	B3GAT2	SPATA9
ENSG00000235823	OLMALINC	1.1276466261429	3.07434550246186e-6	M1_vs_M2	HSALNG0080102	sense	Q50	hsa-miR-378a-5p,hsa-miR-619-5p,hsa-miR-6089	Alkaline phosphatase measurement,-	SCD	GFOD1
ENSG00000236841	ENSG00000236841	-3.3820420291162	0.0145945032832955	M1_vs_M2	HSALNG0020020	overlap_antisense,anti_sense	Q90	NA	Cognitive function measurement; Mathematical ability,-	GCA	TBC1D32
ENSG00000291173	CASP4LP	3.06559486608561	1.37346643041386e-5	M1_vs_M2	NA	NA	NA	NA	NA	CASP12	ATXN7L1
ENSG00000250929	LINC01181	3.02984464227193	9.08435683177548e-60	M1_vs_M2	HSALNG0067501	integenic	Q50	NA	Small vessel stroke,Idiopathic osteonecrosis of the femoral head,Attention deficit hyperactivity disorder,Growth-regulated alpha protein measurement,Pelvic organ prolapse,-	BAALC	TMEM140
ENSG00000291143	ENSG00000291143	2.31602437135974	1.8835970851101e-19	M1_vs_M2	NA	NA	NA	NA	NA	OR2AG2	TLK2
ENSG00000290867	LINC01145	1.79455124176233	1.95120589432101e-5	M1_vs_M2	HSALNG0142314	integenic	Not conserved	NA	-	PPIAL4D	NONO
ENSG00000289844	ENSG00000289844	5.30063147490578	0.0145297093976453	M1_vs_M2	HSALNG0102515	integenic	Q75	hsa-miR-619-5p,hsa-miR-4492,hsa-miR-6089,hsa-miR-6769a-3p	Periodontitis,Basophil count; Basophil percentage of leukocytes,Total blood protein measurement,-	FOS	LPAR4
ENSG00000289092	ENSG00000289092	2.09633364026457	2.5907190088570104e-9	M1_vs_M2	HSALNG0077924	anti_sense	Not conserved	hsa-miR-1273h-5p	Mean corpuscular volume; Mean corpuscular hemoglobin; Mean corpuscular hemoglobin concentration; Erythrocyte count	TIMM23	ZNF185
ENSG00000204832	ST8SIA6-AS1	-5.51885517859961	2.09112916352886e-13	M1_vs_M2	HSALNG0076446	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-6089,hsa-miR-6764-5p	Sleep apnea measurement,Urinary albumin to creatinine ratio; Moderate albuminuria,Blood protein measurement,Aspartate aminotransferase measurement,-	VIM	ST8SIA6
ENSG00000183250	LINC01547	1.26437923354339	6.675680303881271e-9	M1_vs_M2	HSALNG0133586	integenic	Not conserved	hsa-miR-1268b,hsa-miR-1273h-5p	Heel bone mineral density	ITGB2	CAMK2G
ENSG00000290866	OTOAP1	-3.7138703842591	4.9630358592745e-22	M1_vs_M2	NA	NA	NA	NA	NA	NPIPB5	CWC15
ENSG00000249685	ENSG00000249685	1.65000956615451	3.0530395456368e-4	M1_vs_M2	HSALNG0033928	integenic	Q50	NA	Acute lymphoblastic leukemia	KLHL5	PIH1D2
ENSG00000225963	ENSG00000225963	1.62579362592833	2.11154156037837e-5	M1_vs_M2	HSALNG0022854	anti_sense	Q50	hsa-miR-6089,hsa-miR-6763-5p	Subcutaneous adipose tissue measurement,Metabolic rate measurement,Serum non-albumin protein measurement,Obsessive-compulsive disorder; Obsessive-compulsive symptom measurement,-	SP140	TWF1
ENSG00000223949	ROR1-AS1	-2.41416099659307	7.62117143835665e-93	M1_vs_M2	HSALNG0004144	anti_sense	Q90	NA	Intelligence,Blood protein measurement,-	ITGB3BP	DIP2C
ENSG00000219665	ZNF433-AS1	-2.16142262693902	2.3140949707710307e-15	M1_vs_M2	HSALNG0124080	anti_sense,sense	Q75	hsa-miR-619-5p,hsa-miR-4290,hsa-miR-4488,hsa-miR-6735-5p	Corneal endothelial cell measurement,Heel bone mineral density,-	NA	FHIP2A
ENSG00000249502	MED28-DT	2.83907419910359	2.19669501284676e-33	M1_vs_M2	HSALNG0033145	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4771	-	FAM184B	MMAA
ENSG00000249825	THBS4-AS1	-3.45080100312005	1.8578745269404704e-15	M1_vs_M2	HSALNG0042960	anti_sense	Q90	hsa-miR-4447	Corneal topography,Intraocular pressure measurement,-,Thyroid stimulating hormone measurement; Abnormality of refraction	SERINC5	TMEM45B
ENSG00000229400	CNIH3-AS1	4.69991101967242	1.81061831880111e-13	M1_vs_M2	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	WWC2
ENSG00000226004	LINC02528	9.40928492024175	3.89940004583038e-39	M1_vs_M2	HSALNG0053802	integenic	Q50	NA	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,-	PERP	PSTPIP2
ENSG00000230838	LINC01614	-5.20131500608345	1.2524116597376098e-45	M1_vs_M2	HSALNG0022084	integenic	Q50	NA	Kynurenine measurement,Bmi-adjusted waist circumference; Body height,Bmi-adjusted waist circumference,Facial width measurement,Heel bone mineral density,-	TMEM169	PDE3B
ENSG00000226067	LINC00623	2.16183956344584	8.99737124851994e-7	M1_vs_M2	HSALNG0006641	integenic	Not conserved	NA	NA	PPIAL4A	CCDC50
ENSG00000273226	ENSG00000273226	-3.05238759538195	4.65603557326041e-9	M1_vs_M2	HSALNG0070293	anti_sense	Not conserved	NA	NA	DENND4C	PFKM
ENSG00000253217	ENSG00000253217	-1.32483550303147	0.0305980017120502	M1_vs_M2	HSALNG0067281	anti_sense	Q75	NA	Unipolar depression,Lymphocyte count,-	SPAG1	TEX29
ENSG00000278869	ENSG00000278869	1.26014840143157	0.014293653313671	M1_vs_M2	HSALNG0136238	anti_sense	Q90	hsa-miR-874-3p,hsa-miR-4447,hsa-miR-4463,hsa-miR-1343-5p,hsa-miR-5088-3p,hsa-miR-6799-5p,hsa-miR-6877-3p	-	ALG12	CD8A
ENSG00000253154	ENSG00000253154	-2.06178716748557	4.40081258961396e-7	M1_vs_M2	HSALNG0066721	integenic	Q50	hsa-miR-4463,hsa-miR-8485	Chronotype measurement,-	ATP6V0D2	CNKSR3
ENSG00000224397	PELATON	-1.07947629915308	2.0355772706394598e-42	M1_vs_M2	HSALNG0130749	integenic	Q50	hsa-miR-619-5p,hsa-miR-665,hsa-miR-4258,hsa-miR-4284,hsa-miR-4491,hsa-miR-4701-3p,hsa-miR-4733-3p,hsa-miR-6090,hsa-miR-6132,hsa-miR-6748-3p,hsa-miR-6769b-5p,hsa-miR-6887-3p	Hair colour measurement,Monocyte percentage of leukocytes; Mammographic density measurement; Monocyte count,Granulocyte percentage of myeloid white cells; Monocyte count,Gut microbiome measurement,Monocyte percentage of leukocytes,Monocyte count,-	CEBPB	TRIP12
ENSG00000260193	LINC02846	-1.3249910200858	0.00241100602764171	M1_vs_M2	HSALNG0075219	integenic	Q50	hsa-miR-6858-3p	NA	TMEM250	LY96
ENSG00000259321	ENSG00000259321	2.26236129568919	0.00324253487436896	M1_vs_M2	HSALNG0100096	anti_sense,sense	Q90	hsa-miR-619-5p	Serum igg glycosylation measurement,-	PSME1	BTG3
ENSG00000289080	ENSG00000289080	-2.03026587897558	9.3956623723737e-4	M1_vs_M2	HSALNG0110565	integenic	Not conserved	hsa-miR-1228-5p,hsa-miR-4492	Lymphocyte count,-	RABEP2	C21orf91
ENSG00000233175	FMNL1-AS1	2.54746710988466	0.0373240832455968	M1_vs_M2	HSALNG0116843	anti_sense	Q90	hsa-miR-4286	-	SPATA32	USP43
ENSG00000287074	ENSG00000287074	-2.35530735661006	0.0415312098431931	M1_vs_M2	HSALNG0143356	sense	Not conserved	NA	NA	AEBP2	FBXL18
ENSG00000278330	ENSG00000278330	-1.38841544615449	2.9001484679582e-6	M1_vs_M2	HSALNG0122607	anti_sense	Not conserved	NA	-	GALR1	HEATR3
ENSG00000275120	ENSG00000275120	-2.03446258246331	0.0326953459731811	M1_vs_M2	HSALNG0107802	integenic	Not conserved	NA	NA	WDR73	GNAQ
ENSG00000286546	ENSG00000286546	-3.24198169368483	7.29095962911944e-20	M1_vs_M2	HSALNG0128824	anti_sense	Not conserved	NA	Cognitive impairment measurement,High density lipoprotein cholesterol measurement; Response to diuretic,-	KIF16B	DRAM2
ENSG00000274370	ENSG00000274370	-2.37820132952422	9.16042102924572e-6	M1_vs_M2	HSALNG0119502	integenic	Not conserved	hsa-miR-6784-5p	NA	METRNL	HKDC1
ENSG00000233613	DCUN1D2-AS	-2.74329391980536	0.0339551749288532	M1_vs_M2	HSALNG0099596	anti_sense	Not conserved	NA	Neutrophil count; Monocyte percentage of leukocytes,-	TMCO3	NPTN
ENSG00000284882	ENSG00000284882	-1.00087420384626	6.3318960945391e-6	M1_vs_M2	HSALNG0004813	anti_sense	Q50	NA	-	SPATA1	EXOG
ENSG00000289161	ENSG00000289161	1.36092886363139	5.77853940697146e-13	M1_vs_M2	HSALNG0069294	anti_sense	Not conserved	hsa-miR-619-5p	-	MROH6	FCHO2
ENSG00000224186	PITX1-AS1	-1.38680150718476	6.8235621962946e-5	M1_vs_M2	HSALNG0045024	integenic	Not conserved	NA	NA	CATSPER3	NECAP2
ENSG00000271643	PDCD6IP-DT	1.45579239522698	4.52654333132682e-9	M1_vs_M2	HSALNG0025078	anti_sense	Not conserved	NA	-	CLASP2	ST3GAL2
ENSG00000261971	MMP25-AS1	4.04039071334176	3.50515669065837e-59	M1_vs_M2	HSALNG0109107	anti_sense	Q75	hsa-miR-455-3p,hsa-miR-619-5p,hsa-miR-3178,hsa-miR-4286,hsa-miR-4472,hsa-miR-4498,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6132,hsa-miR-6767-5p,hsa-miR-6779-5p,hsa-miR-6803-5p,hsa-miR-6836-5p,hsa-miR-6860,hsa-miR-8072	-	BICDL2	KCNJ15
ENSG00000287415	ENSG00000287415	-4.59769449386528	8.94789510886781e-16	M1_vs_M2	HSALNG0025355	integenic	Q50	hsa-miR-8485	Polyp of colon,Colorectal cancer; Colorectal adenoma,Colorectal cancer,Heel bone mineral density,Hip bone mineral density,Testosterone measurement; Systolic blood pressure,Testosterone measurement,Hypermetropia; Bone density; Myopia,Bone density,Femoral neck bone mineral density; Bone fracture,Bone density; Heel bone mineral density,Drugs affecting bone structure and mineralization use measurement,Femoral neck bone mineral density; Spine bone mineral density,Osteoporosis,Lean body mass; Bone density,Adolescent idiopathic scoliosis,Systolic blood pressure,Myopia,Mean arterial pressure,Forced expiratory volume; Fev/fec ratio; Response to bronchodilator,Response to amisulpride; Longitudinal bmi measurement,Refractive error,-	ZNF621	LCA5L
ENSG00000234456	MAGI2-AS3	2.79351861670236	1.10329066115576e-48	M1_vs_M2	HSALNG0059170	anti_sense	Q75	hsa-miR-339-5p,hsa-miR-4447,hsa-miR-3960,hsa-miR-5001-3p,hsa-miR-6749-3p,hsa-miR-6786-5p,hsa-miR-8485	-	GNAI1	C2CD2
ENSG00000273472	ENSG00000273472	2.54099642744547	4.61554294407625e-39	M1_vs_M2	HSALNG0148201	integenic	Q50	NA	NA	ELMOD2	ACAN
ENSG00000226328	NUP50-DT	1.06439059832731	2.57202831233483e-16	M1_vs_M2	HSALNG0135916	integenic	Q50	hsa-miR-4492,hsa-miR-6763-5p	Mean corpuscular hemoglobin concentration,-	KIAA0930	SPATA2
ENSG00000226441	PLCL2-AS1	-3.55902476914281	0.0080252473344214	M1_vs_M2	HSALNG0024502	anti_sense	Q75	NA	NA	TBC1D5	ZC3H18
ENSG00000260260	SNHG19	-1.11006110460573	0.0213678741904875	M1_vs_M2	HSALNG0108990	anti_sense	Q50	NA	-	PKD1	SON
ENSG00000125462	MIR9-1HG	5.57808509944763	2.51808986980856e-16	M1_vs_M2	HSALNG0007588	sense	Not conserved	NA	NA	MEF2D	CLIC6
ENSG00000267026	ENSG00000267026	-2.01411444144708	0.00369823699661779	M1_vs_M2	HSALNG0073203	anti_sense	Not conserved	hsa-miR-6729-3p	NA	ANKS6	MED8
ENSG00000272172	ENSG00000272172	-2.77443691591747	0.0452400943535957	M1_vs_M2	HSALNG0069270	anti_sense	Not conserved	hsa-miR-3960	Body height,-	TOP1MT	ACE
ENSG00000272129	ENSG00000272129	-2.67282943122672	0.0197164606347245	M1_vs_M2	HSALNG0051481	integenic	Q50	NA	NA	BCKDHB	SPON2
ENSG00000246528	SLCO5A1-AS1	5.61548433446854	0.00432588684255482	M1_vs_M2	HSALNG0066029	anti_sense	Q50	NA	Leukocyte count; Neutrophil count,Diverticular disease,Response to cetuximab; Skin disease,-	SULF1	CTBP1
ENSG00000243089	ENSG00000243089	3.92588257581493	2.43447767430291e-8	M1_vs_M2	HSALNG0027523	integenic	Q50	NA	Bmi-adjusted waist circumference; Optic cup area measurement,Serum alanine aminotransferase measurement,Precuneus cortex volume measurement,Optic cup area measurement; Optic disc size measurement,Cup-to-disc ratio measurement,Rr interval,Optic disc area measurement,Liver fibrosis measurement,Susceptibility to childhood ear infection measurement,Bmi-adjusted waist circumference,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Chronic kidney disease,Body height,Atrophic macular degeneration; Age-related macular degeneration; Wet macular degeneration,Cup-to-disc ratio measurement; Optic cup area measurement,-	FILIP1L	NDUFV3
ENSG00000230555	LINC02916	-1.08256041941504	0.0154364508380893	M1_vs_M2	HSALNG0077549	integenic	Q50	hsa-miR-619-5p	NA	ZNF487	VAV2
ENSG00000272669	ENSG00000272669	1.5160199407918	3.677822663078e-4	M1_vs_M2	HSALNG0135442	anti_sense	Not conserved	hsa-miR-210-5p,hsa-miR-6763-3p	NA	GTPBP1	CD3G
ENSG00000286129	ENSG00000286129	-1.32268906554446	0.00553280959092905	M1_vs_M2	HSALNG0134321	integenic	Not conserved	NA	-	VPREB1	IL6R
ENSG00000273032	DGCR5	-5.77038123494958	1.0224309441966301e-15	M1_vs_M2	HSALNG0133984	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-764	NA	FAM246C	SH2B2
ENSG00000234147	ENSG00000234147	-3.5814761202902	2.93320424039604e-8	M1_vs_M2	HSALNG0053918	integenic	Q75	hsa-miR-4281,hsa-miR-6776-5p,hsa-miR-8485	3-hydroxypropylmercapturic acid measurement,Susceptibility to bacterial meningitis measurement,Sleep quality,Facial emotion recognition measurement,Response to diisocyanate,Acute lymphoblastic leukemia,Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio,Reaction time measurement,-	NMBR	SYVN1
ENSG00000272335	ENSG00000272335	-1.17167667723051	1.02429503341022e-6	M1_vs_M2	HSALNG0041565	integenic	Not conserved	NA	-	MRPS30	SLC45A1
ENSG00000289589	ENSG00000289589	6.28288201729241	6.70521374625746e-5	M1_vs_M2	HSALNG0008846	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-7108-5p	Eosinophil count; Eosinophil percentage of leukocytes,Eosinophil count,Neuroimaging measurement; Cortical thickness; Brain measurement,-	STX6	DHRS3
ENSG00000272449	ENSG00000272449	1.10878006988243	3.3578332248918694e-11	M1_vs_M2	HSALNG0000274	integenic	Not conserved	hsa-miR-8485	NA	TNFRSF14	PEA15
ENSG00000267712	LINC01539	6.77892104400837	7.15081264085834e-6	M1_vs_M2	HSALNG0121712	integenic	Q75	hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-7108-3p	Risk-taking behaviour,Risky sexual behaviour measurement,Smoking status measurement,Smoking initiation,Smoking behavior; Smoking status measurement,Diabetic retinopathy,Self reported educational attainment; Mathematical ability,Diverticular disease,Unipolar depression,Hiv-1 infection,Attention deficit hyperactivity disorder; Antisocial behaviour measurement; Substance abuse,Systolic blood pressure; Smoking behaviour measurement,-	TCF4	FCAMR
ENSG00000258768	ENSG00000258768	-2.1990589832145	0.00189754082984904	M1_vs_M2	HSALNG0099772	overlap_antisense,anti_sense,sense	Q50	hsa-miR-6809-3p	Cervical carcinoma,Alzheimer's disease biomarker measurement,-	TTC5	FBXO41
ENSG00000258018	LINC02457	-1.68601462244132	5.01254202151461e-10	M1_vs_M2	HSALNG0094325	integenic	Not conserved	NA	NA	MAP1LC3B2	SLC22A15
ENSG00000255363	LINC02757	2.40353327081659	2.48527911411557e-5	M1_vs_M2	HSALNG0085868	integenic	Not conserved	hsa-miR-4710	NA	LRRC32	CCT3
ENSG00000272555	ENSG00000272555	-1.06301752076911	0.0143975435719054	M1_vs_M2	HSALNG0022299	integenic	Not conserved	NA	NA	CYP27A1	CWC22
ENSG00000287691	ENSG00000287691	2.48548059479035	7.1985517548153e-5	M1_vs_M2	HSALNG0002358	anti_sense	Q50	hsa-miR-4448	Mosaic loss of chromosome y measurement,-	HPCA	PYHIN1
ENSG00000224995	LINC01526	-2.40776251826468	4.60991807510233e-6	M1_vs_M2	HSALNG0051540	integenic	Q75	hsa-miR-761,hsa-miR-3619-5p,hsa-miR-6132	Loneliness measurement,Basophil count; Basophil percentage of leukocytes; Monocyte percentage of leukocytes,Coronary artery disease,Bmi-adjusted waist circumference,Cognitive function measurement,Body height,Myocardial infarction,Central corneal thickness,Intraocular pressure measurement,Adolescent idiopathic scoliosis,Bell's palsy,Bone density; Heel bone mineral density,Basophil count; Basophil percentage of leukocytes,Monocyte percentage of leukocytes,Central corneal thickness; Intraocular pressure measurement,Corneal resistance factor; Intraocular pressure measurement,Central corneal thickness; Corneal topography,Obsessive-compulsive disorder; Sex interaction measurement,Heel bone mineral density,-	TENT5A	RPL22L1
ENSG00000231808	LINC01388	1.48456205220374	6.167763400109e-4	M1_vs_M2	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	RYBP
ENSG00000267272	LINC01140	-1.0875511851288	0.0261831754411126	M1_vs_M2	HSALNG0004949	sense	Q90	NA	Smoking behavior,Cortical surface area measurement,-	NA	CRELD1
ENSG00000272145	NFYC-AS1	1.64367576664684	0.0169294939914521	M1_vs_M2	HSALNG0002891	anti_sense	Q90	hsa-miR-661,hsa-miR-4447,hsa-miR-4761-3p,hsa-miR-8072	Body height,-	RIMS3	POLR2H
ENSG00000231672	DIRC3	-1.80773597046978	4.4856307579359e-6	M1_vs_M2	HSALNG0022200	integenic	Not conserved	NA	NA	TNS1	ANAPC10
ENSG00000261036	ENSG00000261036	-2.18336225341347	0.00253913061159499	M1_vs_M2	HSALNG0044432	integenic	Not conserved	NA	NA	DTWD2	ADGRV1
ENSG00000286174	ENSG00000286174	5.08934777493499	1.13687486888492e-28	M1_vs_M2	HSALNG0010970	anti_sense	Q50	NA	Mortality,White matter microstructure measurement,-	WDR26	ANKRD33B
ENSG00000273002	ARHGEF2-AS2	1.52495442684131	3.5063595384934203e-9	M1_vs_M2	HSALNG0007540	anti_sense	Q75	NA	Comparative body size at age 10, self-reported,-	RXFP4	CSF2
ENSG00000254338	MAFA-AS1	-4.63290562651719	6.31530054731041e-10	M1_vs_M2	HSALNG0069286	anti_sense	Q75	hsa-miR-6803-5p,hsa-miR-6769b-5p	Apolipoprotein a 1 measurement; High density lipoprotein cholesterol measurement,-	RHPN1	CREBRF
ENSG00000235257	ITGA9-AS1	-3.44354455838139	4.38677553193818e-5	M1_vs_M2	HSALNG0025195	anti_sense	Not conserved	NA	NA	PLCD1	DAGLB
ENSG00000287839	ENSG00000287839	2.0669868640336	2.35653552321868e-19	M1_vs_M2	HSALNG0007520	integenic	Not conserved	NA	Neutrophil count	YY1AP1	COG5
ENSG00000250274	ENSG00000250274	4.28203644884947	1.71590262300254e-14	M1_vs_M2	NA	NA	NA	NA	NA	LCP2	ALDH7A1
ENSG00000289070	ENSG00000289070	-4.30151670312603	5.53549332261465e-31	M1_vs_M2	HSALNG0118660	anti_sense	Q50	hsa-miR-619-5p	Blood protein measurement,-	CD300A	CYBB
ENSG00000214401	KANSL1-AS1	-1.02155030200698	5.49487732400982e-8	M1_vs_M2	HSALNG0116913	anti_sense	Q75	hsa-miR-4665-3p,hsa-miR-9899	-	LRRC37A	ARHGAP12
ENSG00000243491	ENSG00000243491	-3.79146413225584	8.99266348005315e-6	M1_vs_M2	HSALNG0012921	integenic	Not conserved	hsa-miR-665,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-4650-5p,hsa-miR-4691-5p,hsa-miR-6829-5p	NA	YWHAQ	DDIAS
ENSG00000250519	ENSG00000250519	2.67434832271061	2.00715706223436e-6	M1_vs_M2	HSALNG0086510	integenic	Q50	NA	Serum alanine aminotransferase measurement,-	PANX1	PRPF18
ENSG00000291178	ENSG00000291178	1.32158742760685	0.0373166927831601	M1_vs_M2	HSALNG0059995	anti_sense	Not conserved	hsa-miR-619-5p	Hemoglobin measurement,Family history of alzheimer’s disease; Late-onset alzheimers disease; Red blood cell distribution width,Platelet count; Platelet crit,-	ZCWPW1	ARHGEF40
ENSG00000260807	CEROX1	-1.71844902330248	1.17320366142456e-13	M1_vs_M2	HSALNG0108830	sense	Q50	hsa-miR-505-5p,hsa-miR-615-5p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-7106-3p,hsa-miR-7160-3p	Body height,-	LMF1	METTL3
ENSG00000185433	LINC00158	6.4805151907273	1.06025942102881e-29	M1_vs_M2	HSALNG0132374	integenic	Not conserved	NA	NA	MRPL39	ABTB2
ENSG00000231858	STAT4-AS1	6.77997665335884	5.42928644611558e-7	M1_vs_M2	HSALNG0021145	anti_sense	Q75	hsa-miR-3666	-	GLS	NUDT13
ENSG00000260877	ENSG00000260877	3.10195228065677	9.05450681440509e-16	M1_vs_M2	HSALNG0085333	integenic	Not conserved	hsa-miR-4308,hsa-miR-4447,hsa-miR-4492	NA	MYEOV	PPFIBP2
ENSG00000258791	LINC00520	-1.65270025191995	8.930572331549059e-19	M1_vs_M2	HSALNG0101489	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6165	Parental longevity,-	TBPL2	TMED3
ENSG00000258810	ENSG00000258810	-2.26004424566629	5.84465414667684e-5	M1_vs_M2	HSALNG0099831	integenic	Not conserved	hsa-miR-4732-3p	NA	RNASE6	NDEL1
ENSG00000259342	ENSG00000259342	3.23757097021962	1.38238680677881e-13	M1_vs_M2	HSALNG0105649	anti_sense	Q75	hsa-miR-4505	-	GATM	MMP10
ENSG00000260803	ENSG00000260803	-2.4294509285981	8.7927188235597e-4	M1_vs_M2	HSALNG0144829	integenic	Q75	hsa-miR-4650-5p	-	POLR3K	STX3
ENSG00000178803	ADORA2A-AS1	7.83531531061783	2.6044087569524e-14	M1_vs_M2	HSALNG0134495	anti_sense	Q50	hsa-miR-370-3p,hsa-miR-6807-3p	Alcohol consumption measurement,Acne,Sodium measurement,Glucagon measurement,Coffee consumption measurement,Supramarginal gyrus volume measurement,Tea consumption measurement,Cups of coffee per day measurement,Serum gamma-glutamyl transferase measurement,Coffee consumption measurement; Tea consumption measurement,Alcohol use disorder measurement; Alcohol consumption measurement,-	GUCD1	C15orf48
ENSG00000255921	ENSG00000255921	1.78448408907427	5.52722749419267e-7	M1_vs_M2	HSALNG0089886	anti_sense	Not conserved	hsa-miR-6763-5p,hsa-miR-7847-3p	-	IRAG2	SP2
ENSG00000226950	DANCR	-1.03686282943394	5.80894605802474e-6	M1_vs_M2	HSALNG0148096	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-7108-3p	Response to citalopram; Mood disorder; Response to escitalopram; Unipolar depression,-	RASL11B	VKORC1
ENSG00000242048	PRKAG2-AS2	2.77198375420193	1.27343706746667e-67	M1_vs_M2	HSALNG0149841	anti_sense	Not conserved	NA	NA	GALNTL5	MFSD3
ENSG00000272008	ENSG00000272008	5.87400747694536	8.69689129355e-4	M1_vs_M2	HSALNG0149464	anti_sense	Q75	NA	-	CGA	CD300C
ENSG00000229140	CCDC26	-5.50081815327776	1.2239643927440799e-62	M1_vs_M2	HSALNG0068551	integenic	Q50	hsa-miR-575,hsa-miR-619-5p,hsa-miR-885-3p,hsa-miR-4287,hsa-miR-4328,hsa-miR-3677-3p,hsa-miR-6809-3p,hsa-miR-6873-3p,hsa-miR-6892-3p,hsa-miR-8485	Dna methylation,Eczema,Balding measurement,Heel bone mineral density,Lip morphology measurement,Facial morphology measurement,Unipolar depression,Creatinine measurement,Cleft lip; Oral cleft; Cleft palate,Myeloid white cell count,Cleft lip; Progranulin measurement,Cortical surface area measurement; Cortical thickness,Alkaline phosphatase measurement,Cleft lip; Neuroimaging measurement; Heel bone mineral density; Blood phosphate measurement; Cleft palate; Brain measurement,Cleft lip; Oral cleft,Lung adenocarcinoma,Leukocyte count,Neutrophil count,Cleft lip,Eosinophil count,Vital capacity,Self reported educational attainment,Forced expiratory volume,Mathematical ability,Fev/fec ratio,Acute lymphoblastic leukemia,Body height,Monocyte count,Monocyte percentage of leukocytes,B-cell acute lymphoblastic leukemia,Gut microbiome measurement,Creatinine measurement; Glomerular filtration rate,Nicotine dependence,Glioma,Central nervous system cancer,Hypospadias,Urate measurement,Lateral occipital cortex volume measurement,Uterine fibroid,Platelet count; Platelet crit,Indole-3-propionate measurement,Bullous pemphigoid,Cortical surface area measurement,Mitochondrial dna measurement,Inflammatory bowel disease; Mean corpuscular hemoglobin concentration; Mean corpuscular hemoglobin; Monocyte count; Mean corpuscular volume,Leukocyte count; Monocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Erythrocyte count,Eosinophil count; Monocyte count; Basophil count; Eosinophil percentage of leukocytes,Eosinophil count; Eosinophil percentage of granulocytes; Eosinophil percentage of leukocytes,Neutrophil-to-lymphocyte ratio,Cortical thickness,Leukocyte count; Neutrophil count; Myeloid white cell count,Neutrophil percentage of leukocytes; Mean corpuscular hemoglobin,Mosaic loss of chromosome y measurement,Resistin measurement; Myeloperoxidase measurement,Lymphocyte percentage of leukocytes; Neutrophil count,Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Leukocyte count; Neutrophil count; Monocyte count,Neutrophil percentage of granulocytes; Neutrophil percentage of leukocytes,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes,Inflammatory bowel disease; Ulcerative colitis; Monocyte count; Monocyte:lymphocyte ratio; Mean corpuscular volume; Red blood cell density measurement; Erythrocyte count,Adolescent idiopathic scoliosis,Monocyte count; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil count; Basophil count; Leukocyte count; Eosinophil count; Granulocyte count,Mean corpuscular volume; Mean corpuscular hemoglobin; Monocyte count,Erythrocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Neutrophil count; Myeloid white cell count,Red blood cell density measurement,Mean reticulocyte volume,Neutrophil percentage of leukocytes,Basophil percentage of granulocytes; Educational attainment; Basophil count; Basophil percentage of leukocytes,Granulocyte percentage of myeloid white cells,Eye color,Monocyte percentage of leukocytes; Monocyte count,Neuroimaging measurement; Glioblastoma multiforme; Glioma; White matter microstructure measurement; Brain volume measurement; Age at onset; Central nervous system cancer,Platelet count,Basophil count,Retinopathy,Granulocyte percentage of myeloid white cells; Monocyte percentage of leukocytes; Monocyte count,Leukocyte count; Lymphocyte percentage of leukocytes; Myeloid white cell count,Basophil count; Eosinophil percentage of leukocytes,Platelet crit,Eosinophil count; Eosinophil percentage of leukocytes,Response to methotrexate; Juvenile idiopathic arthritis,Cleft lip; Cleft palate,Unipolar depression; Endometriosis,Brain volume measurement; Neuroimaging measurement; Brain measurement,-	GSDMC	CD300A
ENSG00000269970	ENSG00000269970	-1.76280857487155	7.0957033241453e-4	M1_vs_M2	HSALNG0074238	sense	Not conserved	NA	NA	PTGS1	GHDC
ENSG00000291236	ENSG00000291236	3.29128624542851	0.00663101028907738	M1_vs_M2	NA	NA	NA	NA	NA	TNS1	FAM107A
ENSG00000285863	ENSG00000285863	1.16522679083049	0.0113000296608502	M1_vs_M2	HSALNG0144382	anti_sense	Not conserved	NA	Fev/fec ratio,-	C2CD4A	STX18
ENSG00000255422	ENSG00000255422	-2.36195433029836	6.43684663054915e-16	M1_vs_M2	HSALNG0087571	anti_sense	Q90	NA	-	PHLDB1	RNF181
ENSG00000241886	ENSG00000241886	1.50605943950326	3.87830213038856e-6	M1_vs_M2	HSALNG0137207	sense	Q90	NA	-	GK	LRRC28
ENSG00000285551	LINC02929	-4.674794096298	4.22884123944733e-7	M1_vs_M2	HSALNG0078329	sense	Q75	hsa-miR-4505,hsa-miR-1587,hsa-miR-5703	NA	NA	ENHO
ENSG00000231856	ENSG00000231856	2.19996801377813	0.0347094314539724	M1_vs_M2	HSALNG0097204	anti_sense	Not conserved	hsa-miR-4530,hsa-miR-5089-5p	-	WDFY2	SLC35G2
ENSG00000266718	ENSG00000266718	-2.6986846089255	0.0450292011988564	M1_vs_M2	HSALNG0115789	anti_sense	Not conserved	NA	Nicotine dependence symptom count	CDK5R1	RAB3B
ENSG00000228863	ENSG00000228863	3.05562696477489	2.0224788673314094e-11	M1_vs_M2	HSALNG0007856	anti_sense	Not conserved	hsa-miR-4776-3p	Moderate albuminuria,-	SLAMF7	CLIC4
ENSG00000276148	ENSG00000276148	-1.92443454698383	0.0460163945401343	M1_vs_M2	HSALNG0090284	anti_sense	Q75	NA	NA	YARS2	TAPT1
ENSG00000263050	DPH1-AS1	2.31522519109263	0.0103117896759867	M1_vs_M2	HSALNG0113878	anti_sense	Q75	hsa-miR-3178,hsa-miR-4640-3p,hsa-miR-4747-5p,hsa-miR-8485	Hepatocyte growth factor measurement,-	SMG6	HNRNPF
ENSG00000258733	LINC02328	2.05933262974807	2.22019165308157e-8	M1_vs_M2	HSALNG0102968	integenic	Not conserved	NA	NA	FLRT2	PUSL1
ENSG00000185168	LINC00482	-2.83168460992159	0.00167099241606266	M1_vs_M2	HSALNG0145393	integenic	Not conserved	hsa-miR-6852-5p	-	SLC38A10	FAXDC2
ENSG00000235478	LINC01664	-4.30780370783533	2.0350211797302e-4	M1_vs_M2	HSALNG0133870	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4279,hsa-miR-6132	Aging,Emotional symptom measurement,-	IL17RA	TMED10
ENSG00000265678	ENSG00000265678	2.51140290524984	0.00360549036702558	M1_vs_M2	HSALNG0119378	anti_sense	Q50	NA	NA	SLC16A3	KRT8
ENSG00000235215	ENSG00000235215	3.12893633928429	0.0148181498965757	M1_vs_M2	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	METTL7B
ENSG00000234807	LINC01135	-3.67078943922952	5.413481912484979e-136	M1_vs_M2	HSALNG0003956	anti_sense	Q50	hsa-miR-497-5p,hsa-miR-504-3p,hsa-miR-922,hsa-miR-3197,hsa-miR-5587-3p,hsa-miR-5787,hsa-miR-6722-3p,hsa-miR-6728-3p,hsa-miR-6829-3p,hsa-miR-6873-3p,hsa-miR-7108-3p	Aminoadipic acid measurement,Neuropsychological test,Empathy measurement,Sleep duration,-	FGGY	HOPX
ENSG00000174370	KCNJ5-AS1	-2.41448915904432	1.27845923515559e-192	M1_vs_M2	NA	NA	NA	NA	NA	TP53AIP1	PWWP2B
ENSG00000228742	LINC02577	-1.87328956753282	8.009177750983e-4	M1_vs_M2	HSALNG0060386	integenic	Not conserved	hsa-miR-4281,hsa-miR-4710	Eosinophil count,Agents acting on the renin-angiotensin system use measurement,Systolic blood pressure; Common carotid intimal medial thickness; Alcohol drinking,Diuretic use measurement,Systolic blood pressure; Mean arterial pressure,Eosinophil percentage of leukocytes,Cognitive inhibition measurement,-	PIK3CG	MAL
ENSG00000230438	SERPINB9P1	1.85276957055801	1.7411308053976198e-50	M1_vs_M2	HSALNG0047525	integenic	Not conserved	NA	NA	SERPINB9	SLFN12
ENSG00000238045	MVP-DT	2.74144729455202	6.653156800700739e-34	M1_vs_M2	HSALNG0144898	anti_sense	Q90	hsa-miR-4745-3p	NA	CDIPT	CEBPB
ENSG00000239445	ST3GAL6-AS1	-1.78979336628622	1.76093786854832e-35	M1_vs_M2	HSALNG0027499	anti_sense	Q50	hsa-miR-937-5p	Leukocyte count; Monocyte count,Vascular endothelial growth factor receptor 3 measurement,Monocyte percentage of leukocytes,Eosinophil count,Keratinocyte carcinoma; Basal cell carcinoma,Leukocyte count,Eosinophil count; Skin neoplasm,Eosinophil count; Eosinophil percentage of leukocytes,Unipolar depression,Non-melanoma skin carcinoma,-	DCBLD2	AZU1
ENSG00000238164	TNFRSF14-AS1	-1.2929990746306	9.191582330584767e-40	M1_vs_M2	HSALNG0000275	anti_sense	Q75	hsa-miR-505-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4481,hsa-miR-1343-3p,hsa-miR-5589-5p,hsa-miR-6751-3p,hsa-miR-6769a-3p,hsa-miR-6813-5p,hsa-miR-6852-5p	Eosinophil count,Rheumatoid arthritis,Eosinophil count; Eosinophil percentage of leukocytes,-	HES5	AZU1
ENSG00000162888	C1orf147	2.65217567078184	1.36132360749397e-10	M1_vs_M2	NA	NA	NA	NA	NA	EIF2D	NIPAL4
ENSG00000233975	LINC02574	5.94992456303275	9.4849573644168e-4	M1_vs_M2	HSALNG0002009	integenic	Q50	hsa-miR-619-5p	Body weight,Systolic blood pressure; Pulse pressure measurement; Mean arterial pressure,Body mass index,-	IFI6	MUCL1
ENSG00000236700	LINC01010	-1.49154966904276	4.3077500647789897e-70	M1_vs_M2	HSALNG0053623	integenic	Q50	hsa-miR-619-5p,hsa-miR-4267,hsa-miR-4430,hsa-miR-6089	Dental caries,-	TBPL1	RASGRP1
ENSG00000254554	ADM-DT	3.88999492150208	1.0150919741088e-4	M1_vs_M2	HSALNG0082648	integenic	Q50	hsa-miR-6132	Waist-hip ratio; Bmi-adjusted waist-hip ratio,Appendicular lean mass,Total cholesterol measurement,Breast carcinoma,-	SBF2	WASHC2C
ENSG00000233901	LINC01503	-2.03186721929662	7.1826136520702e-19	M1_vs_M2	HSALNG0074718	integenic	Q75	hsa-miR-185-3p,hsa-miR-762,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4530,hsa-miR-1587,hsa-miR-6089,hsa-miR-6732-5p,hsa-miR-6791-5p,hsa-miR-8485	Atopic eczema,Protein measurement,Caudate nucleus measurement; Functional brain measurement; Response to reward,-	NA	NOC3L
ENSG00000286481	ENSG00000286481	-3.82114883498138	9.15236625502166e-13	M1_vs_M2	HSALNG0018495	integenic	Not conserved	NA	NA	TSN	ABLIM3
ENSG00000287733	ENSG00000287733	1.00676574371175	3.48347524572419e-6	M1_vs_M2	HSALNG0061536	integenic	Not conserved	hsa-miR-4761-3p	Monocyte count	TMEM140	MFSD4B
ENSG00000258875	ENSG00000258875	2.57607066958761	2.2727639557708e-5	M1_vs_M2	HSALNG0103182	anti_sense	Q50	hsa-miR-7155-5p	NA	DGLUCY	TRIB1
ENSG00000230061	TRPM2-AS	1.85976797364154	0.0166044922121211	M1_vs_M2	HSALNG0133533	anti_sense	Q50	hsa-miR-4486,hsa-miR-6888-5p,hsa-miR-7110-5p	-	TSPEAR	NABP1
ENSG00000288767	ENSG00000288767	4.18719267842134	7.405976157212111e-10	M1_vs_M2	HSALNG0096284	integenic	Not conserved	NA	NA	RFC3	ZNF791
ENSG00000253549	CA3-AS1	-1.54780763912324	1.4647955409396e-4	M1_vs_M2	HSALNG0066709	anti_sense	Q50	hsa-miR-491-5p,hsa-miR-4482-5p,hsa-miR-4707-5p,hsa-miR-6810-5p	Glomerular filtration rate,-	CA1	GNG5
ENSG00000227066	ENSG00000227066	2.69488254878107	6.005868187098e-4	M1_vs_M2	HSALNG0001417	integenic	Not conserved	NA	NA	PLA2G2F	GTF2IRD2B
ENSG00000290394	ENSG00000290394	2.55216148851034	0.01431627612503	M1_vs_M2	HSALNG0109791	anti_sense	Not conserved	hsa-miR-6837-5p	-	RRN3	MFSD4A
ENSG00000225886	ENSG00000225886	5.26076013859043	8.367555236741918e-22	M1_vs_M2	HSALNG0002013	integenic	Not conserved	NA	NA	FAM76A	PELI3
ENSG00000251230	MIR3945HG	5.95444878524423	4.64322972561525e-177	M1_vs_M2	HSALNG0039050	integenic	Not conserved	hsa-miR-619-5p	Mean platelet volume,Mean reticulocyte volume,-	ACSL1	ADGRE1
ENSG00000253773	CFAP418-AS1	-3.60347148933719	1.3577154588728298e-23	M1_vs_M2	HSALNG0150259	integenic	Q50	hsa-miR-3960,hsa-miR-6089,hsa-miR-8072	NA	PLEKHF2	GK5
ENSG00000205837	LINC00487	5.68128956443739	2.64429135234271e-17	M1_vs_M2	HSALNG0012718	integenic	Q50	hsa-miR-4430	NA	CMPK2	RMI2
ENSG00000229931	ATXN1-AS1	-1.99253475295346	4.70409572210934e-9	M1_vs_M2	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	TOMM5
ENSG00000253939	ENSG00000253939	5.30135316237006	0.00760408907700478	M1_vs_M2	HSALNG0064732	anti_sense	Q50	NA	Blood metabolite measurement	ADAM2	PLEKHD1
ENSG00000286707	ENSG00000286707	-3.24205402391943	0.00108058539748973	M1_vs_M2	HSALNG0013717	anti_sense,sense	Q90	NA	Non-small cell lung carcinoma,-	SELENOI	ZNF135
ENSG00000232453	LINC02777	-1.04737151161237	1.88394021928482e-10	M1_vs_M2	HSALNG0003962	integenic	Not conserved	NA	Bmi-adjusted hip circumference,-	JUN	SPRYD4
ENSG00000225177	NHSL1-AS1	-2.9185785020177	2.98662857396733e-32	M1_vs_M2	HSALNG0053831	anti_sense	Q75	hsa-miR-345-5p,hsa-miR-1228-5p,hsa-miR-4534,hsa-miR-6816-5p	-	CCDC28A	METRNL
ENSG00000289618	ENSG00000289618	-2.35485503743142	0.0201847401543826	M1_vs_M2	HSALNG0112251	anti_sense,sense	Not conserved	NA	Eosinophil count,High density lipoprotein cholesterol measurement,-	DUS2	C19orf18
ENSG00000289691	ENSG00000289691	1.02330197308291	0.0496664643824237	M1_vs_M2	HSALNG0060000	sense	Q75	hsa-miR-619-5p	-	PILRA	C19orf18
ENSG00000291086	LGALS17A	5.96344174789393	8.052819254003938e-22	M1_vs_M2	HSALNG0126029	integenic	Not conserved	NA	NA	LGALS14	SAMD9L
ENSG00000272734	ADIRF-AS1	-1.35216984917083	7.163110340781739e-12	M1_vs_M2	HSALNG0079425	anti_sense,sense	Q75	hsa-miR-3620-5p,hsa-miR-4447,hsa-miR-4505,hsa-miR-1587	-	MMRN2	TGIF1
ENSG00000254859	ENSG00000254859	1.40763524425017	0.0056052549221352	M1_vs_M2	HSALNG0150508	integenic	Not conserved	NA	Leukocyte count	ZC3H3	ZNF491
ENSG00000260711	ENSG00000260711	2.94656300990357	0.0448887492637289	M1_vs_M2	HSALNG0103215	sense	Not conserved	NA	NA	CATSPERB	NDUFV2
ENSG00000224307	LINC02975	-3.37771867684195	1.0010592766373098e-131	M1_vs_M2	HSALNG0074715	integenic	Not conserved	hsa-miR-520a-5p,hsa-miR-4492,hsa-miR-4684-3p,hsa-miR-4748,hsa-miR-5693	NA	NA	MAF
ENSG00000261211	ENSG00000261211	-2.08231734001233	7.04462287905278e-10	M1_vs_M2	HSALNG0047833	integenic	Q75	hsa-miR-6833-3p	Reticulocyte count; Reticulocyte measurement,Bmi-adjusted hip circumference,-	F13A1	ZNF713
ENSG00000249207	ENSG00000249207	2.61611258715043	0.00996172678301521	M1_vs_M2	HSALNG0033933	integenic	Not conserved	hsa-miR-6090,hsa-miR-1273h-5p	NA	TMEM156	GLULP4
ENSG00000231346	LINC01160	-3.27769632572962	6.0325567488987e-50	M1_vs_M2	HSALNG0006063	anti_sense	Q75	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-4787-5p,hsa-miR-6089	Leukocyte count,Lymphocyte count,-	TMIGD3	THBD
ENSG00000271032	ENSG00000271032	3.41816081136608	3.83554002609118e-21	M1_vs_M2	HSALNG0125561	anti_sense	Not conserved	NA	Calcium measurement; Serum albumin measurement,Serum albumin measurement,-	ZNF792	EXOC3L1
ENSG00000233818	CLDN14-AS1	-2.76624715294755	6.46402449241604e-8	M1_vs_M2	HSALNG0132951	integenic	Not conserved	NA	NA	CHAF1B	SAMD4B
ENSG00000274461	LINC02930	-4.59090636833608	3.0551994296106e-39	M1_vs_M2	HSALNG0081109	integenic	Not conserved	NA	Adolescent idiopathic scoliosis,Left inferior lateral ventricle volume measurement; T-tau measurement; Cerebrospinal fluid biomarker measurement,-	PLPP4	PCARE
ENSG00000227917	ENSG00000227917	2.48061143191816	0.0202215127824272	M1_vs_M2	HSALNG0069521	integenic	Not conserved	hsa-miR-4722-5p	-	FOXD4	PDXDC1
ENSG00000260077	ENSG00000260077	1.17551594457274	1.15636118134649e-5	M1_vs_M2	HSALNG0012948	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3183	Neuroticism measurement; Worry measurement,Mean corpuscular volume,Body height	CYS1	ZNF771
ENSG00000204261	PSMB8-AS1	1.10777987970877	1.1969351791194e-4	M1_vs_M2	HSALNG0049455	anti_sense,sense	Q75	NA	Systemic lupus erythematosus,Iga glomerulonephritis,Kidney disease,-,Platelet-to-lymphocyte ratio,Autoimmune disease	PSMB9	FUT7
ENSG00000225783	MIAT	2.37231740469922	6.661121326315459e-25	M1_vs_M2	HSALNG0134655	integenic	Q50	hsa-miR-216a-3p,hsa-miR-619-5p,hsa-miR-1285-5p,hsa-miR-4496,hsa-miR-4505,hsa-miR-4690-3p,hsa-miR-4726-3p,hsa-miR-5007-5p,hsa-miR-6089,hsa-miR-6754-5p,hsa-miR-6777-3p,hsa-miR-8485	Serum igg glycosylation measurement,Rr interval,Non-hodgkins lymphoma,Grey matter density measurement,Diet measurement,Gastroesophageal reflux disease,Self reported educational attainment; Cognitive function measurement,Cognitive function measurement; Mathematical ability,Intelligence,Lysophosphatidylethanolamine 18:1 measurement,Cognition,Electroencephalogram measurement; Theta wave measurement,Parental genotype effect measurement; Peanut allergy measurement,Covid-19; Pneumonia,Hypermetropia; Myopia,-	CRYBA4	PRF1
ENSG00000288754	ENSG00000288754	-1.90053641846202	2.02340979312424e-7	M1_vs_M2	HSALNG0136023	integenic	Q50	hsa-miR-3620-5p,hsa-miR-1268b,hsa-miR-4437,hsa-miR-4505,hsa-miR-1587,hsa-miR-6131	Ocular sarcoidosis,Adolescent idiopathic scoliosis,-	GRAMD4	YOD1
ENSG00000289942	ENSG00000289942	5.17910803371647	0.0117904383405961	M1_vs_M2	NA	NA	NA	NA	NA	TMPRSS11E	OR52N4
ENSG00000276476	LINC00540	4.72624536009313	5.486963892804451e-9	M1_vs_M2	HSALNG0143794	integenic	Q50	NA	NA	FGF9	PHLDA2
ENSG00000182376	ENSG00000182376	-2.87038440827658	0.0109632817005581	M1_vs_M2	NA	NA	NA	NA	NA	CTU2	ENSG00000182376
ENSG00000230303	ENSG00000230303	-2.53330102988971	0.0341296737849873	M1_vs_M2	HSALNG0072359	integenic	Not conserved	NA	Viral load,-	AGTPBP1	TTC3
ENSG00000272894	MIOS-DT	1.85715836779396	0.00705090600527937	M1_vs_M2	HSALNG0056056	anti_sense	Not conserved	hsa-miR-5571-3p	NA	COL28A1	HMGN4
ENSG00000229337	ENSG00000229337	1.70609011982265	0.0053013631751882	M1_vs_M2	HSALNG0146662	integenic	Not conserved	NA	NA	NFE2L2	SPATA13
ENSG00000289351	ENSG00000289351	-2.39956527498939	1.3069874990606e-4	M1_vs_M2	HSALNG0028867	integenic	Not conserved	NA	NA	COPG1	SPATA13
ENSG00000271880	ENSG00000271880	-1.6669454987559	0.00129237281344036	M1_vs_M2	NA	NA	NA	NA	NA	ADIRF	NPIPA5
ENSG00000241042	ENSG00000241042	5.1793030408237	0.0261922095794106	M1_vs_M2	HSALNG0003965	integenic	Not conserved	NA	Excessive daytime sleepiness measurement,Self reported educational attainment; Intelligence; Cognitive function measurement; Mathematical ability,Protein measurement,Intelligence; Verbal-numerical reasoning measurement,Mathematical ability,Fat body mass,Platinum measurement; Response to cisplatin,-	JUN	ARSI
ENSG00000235513	L3MBTL2-AS1	3.34212663759061	7.55000209899218e-31	M1_vs_M2	HSALNG0135617	anti_sense	Q75	hsa-miR-6731-5p	Anorexia nervosa; Autism spectrum disorder; Depressive symptom measurement; Obsessive-compulsive disorder; Attention deficit hyperactivity disorder; Unipolar depression; Bipolar disorder; Tourette syndrome; Neuroticism measurement,Neuroticism measurement,Breast carcinoma,Red blood cell distribution width,Mood instability measurement,Anxiety measurement; Neuroticism measurement,Depressive symptom measurement; Unipolar depression; Wellbeing measurement; Bipolar disorder; Neuroticism measurement,-	CHADL	C22orf46P
ENSG00000245248	USP2-AS1	-2.63584765384981	3.5621089047922604e-21	M1_vs_M2	HSALNG0143088	integenic	Not conserved	NA	-	RNF26	SEPTIN9
ENSG00000223969	ENSG00000223969	1.3268623090056	0.00125830849696744	M1_vs_M2	HSALNG0059467	anti_sense	Q75	NA	-	FAM237B	IMMP2L
ENSG00000253837	ENSG00000253837	2.40782261275485	0.0288013345227331	M1_vs_M2	HSALNG0063981	anti_sense	Q50	hsa-miR-4534	-	R3HCC1	DGAT1
ENSG00000243055	GK-AS1	1.98568852222339	4.67621209778507e-15	M1_vs_M2	HSALNG0151186	anti_sense	Q50	hsa-miR-619-5p	-	TAB3	SEMA4B
ENSG00000251323	LINC02728	3.15869440730802	1.18744106622656e-7	M1_vs_M2	HSALNG0085981	integenic	Q75	hsa-miR-4530	Creatinine measurement; Body height,Total blood protein measurement	GAB2	FAF1
ENSG00000197536	IRF1-AS1	3.85180091582228	6.64751659540911e-102	M1_vs_M2	HSALNG0044848	anti_sense,sense	Q50	hsa-miR-33b-5p,hsa-miR-4257,hsa-miR-4463,hsa-miR-6748-3p,hsa-miR-6803-5p	Fibrinogen measurement,Chronic obstructive pulmonary disease,Metabolite measurement,Apolipoprotein b measurement,Glycine measurement,Red blood cell distribution width,Neutrophil percentage of leukocytes,Ulcerative colitis; Diastolic blood pressure; Inflammatory bowel disease; Crohn's disease,Psoriasis; Inflammatory bowel disease; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Adult onset asthma; Sclerosing cholangitis,Fibrinogen measurement; Sex hormone-binding globulin measurement,Urinary albumin to creatinine ratio,Diastolic blood pressure; Crohn's disease,Atopic asthma,Eosinophil count; Eosinophil percentage of leukocytes,Mean corpuscular hemoglobin,Nasal cavity polyp; Perceived unattractiveness to mosquitos measurement; Adult onset asthma,Serum metabolite measurement; Low density lipoprotein cholesterol measurement; Crohn's disease; Eczema; Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis; Rheumatoid arthritis; Aspartate aminotransferase measurement,Respiratory system disease; Adult onset asthma,Carotid plaque build,Low density lipoprotein cholesterol measurement,Chronic obstructive pulmonary disease; Smoking status measurement,Neutrophil count,Fibrinogen measurement; Lymphocyte count,Polycystic ovary syndrome,Fibrinogen measurement; Sex hormone-binding globulin measurement; Balding measurement,Neutrophil percentage of granulocytes; Eosinophil percentage of granulocytes; Mosquito bite reaction itch intensity measurement; Basophil count; Mosquito bite reaction size measurement; Eosinophil percentage of leukocytes; Eosinophil count,Mitochondrial dna measurement,Estrogen-receptor positive breast cancer; Breast carcinoma,Inhalant adrenergic use measurement,Cardiovascular disease,Eosinophil count,Diastolic blood pressure,Lymphocyte percentage of leukocytes,Total cholesterol measurement; Low density lipoprotein cholesterol measurement,Platelet count,Platelet crit,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Eczema; Allergic rhinitis,Fev/fec ratio,Autoimmune thyroid disease; Psoriasis; Common variable immunodeficiency; Mosquito bite reaction itch intensity measurement; Ulcerative colitis; Ankylosing spondylitis; Basophil count; Systemic lupus erythematosus; Crohn's disease; Mosquito bite reaction size measurement; Celiac disease; Autoimmune disease; Juvenile idiopathic arthritis,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Leukocyte count; Crohn's disease; Eosinophil percentage of leukocytes; Eosinophil count; Sclerosing cholangitis; Aspartate aminotransferase measurement,Hemoglobin a1 measurement,Reticulocyte count; Reticulocyte measurement,-	NA	GP1BA
ENSG00000262151	ENSG00000262151	-4.81699027099126	7.49011671878507e-8	M1_vs_M2	HSALNG0109562	anti_sense	Q50	hsa-miR-149-5p,hsa-miR-619-5p,hsa-miR-4463,hsa-miR-4774-5p,hsa-miR-6728-3p	Red blood cell density measurement; Erythrocyte count,Susceptibility to chronic sinus infection measurement,Nasopharyngeal neoplasm; Bmi-adjusted waist-hip ratio; Celiac disease,Ulcerative colitis,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Monocyte count,Monocyte count,Monocyte percentage of leukocytes; Monocyte count,Serum albumin measurement,-	DEXI	FAM174B
ENSG00000260219	CD2BP2-DT	-1.37383564169912	3.73347346196712e-30	M1_vs_M2	HSALNG0110725	anti_sense	Q50	hsa-miR-4534,hsa-miR-6775-3p	-	MYL11	ROR1
ENSG00000254233	LINC02365	-1.33612599746861	0.011338018451602	M1_vs_M2	HSALNG0039030	integenic	Not conserved	NA	NA	CASP3	OLFML2A
ENSG00000287543	ENSG00000287543	3.81830226348757	1.87030993436181e-17	M1_vs_M2	HSALNG0144564	anti_sense	Q50	NA	Bmi-adjusted hip circumference,-	GOLGA6A	IKZF1
ENSG00000117242	PINK1-AS	-1.31376175622198	8.8261282062431e-6	M1_vs_M2	HSALNG0001460	intronic_antisense	Not conserved	NA	-	DDOST	LRCH3
ENSG00000237927	ENSG00000237927	3.98743681751674	4.12317163208011e-5	M1_vs_M2	HSALNG0054755	integenic	Not conserved	hsa-miR-183-5p,hsa-miR-5585-3p,hsa-miR-6089	Lipoprotein a measurement,Atrophic macular degeneration,-	SOD2	LRCH3
ENSG00000250033	SLC7A11-AS1	4.36992667627818	1.75935723483e-4	M1_vs_M2	HSALNG0037355	anti_sense	Q75	hsa-miR-6089	Body height,Neuroticism measurement,Neurotic disorder,Wellbeing measurement; Neuroticism measurement,Eosinophil count; Serum metabolite measurement; Depressive symptom measurement; Eosinophil percentage of leukocytes,Eosinophil count,Ccl2 measurement,Wellbeing measurement; Smoking behaviour measurement,-	NOCT	ZNF17
ENSG00000273972	ENSG00000273972	2.12648279523623	0.00871274053365107	M1_vs_M2	HSALNG0105662	integenic	Not conserved	NA	-	SQOR	ZFP91
ENSG00000264707	L3MBTL4-AS1	-1.28095762399683	3.57136292741685e-5	M1_vs_M2	HSALNG0119795	anti_sense	Q50	NA	NA	ARHGAP28	EPOR
ENSG00000214870	LINC02981	-1.74206823797013	1.13229035078765e-8	M1_vs_M2	HSALNG0056819	integenic	Not conserved	NA	NA	SNX10	TLR5
ENSG00000290928	ENSG00000290928	-1.16016643312919	0.00388313451081043	M1_vs_M2	HSALNG0115658	integenic	Not conserved	NA	NA	ATAD5	B3GLCT
ENSG00000262097	LINC02185	-4.39283439678615	4.7453906726086097e-57	M1_vs_M2	HSALNG0109713	integenic	Q50	hsa-miR-645,hsa-miR-4330,hsa-miR-4453	-	PARN	SRGAP3
ENSG00000226281	ENSG00000226281	-2.54381557689593	3.7302224209439096e-100	M1_vs_M2	HSALNG0047836	integenic	Not conserved	hsa-miR-762,hsa-miR-5787	NA	F13A1	EVL
ENSG00000255443	CD44-AS1	2.25910793252306	1.9100075007998e-4	M1_vs_M2	HSALNG0083610	anti_sense	Q50	NA	-	SLC1A2	HSH2D
ENSG00000266402	SNHG25	-2.41239204831646	0.0023832846813315	M1_vs_M2	HSALNG0118080	anti_sense	Q75	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-6716-5p	-	PRR29	ARHGEF12
ENSG00000260943	LINC02555	2.40784533696434	0.0288670590052072	M1_vs_M2	HSALNG0090479	integenic	Q50	NA	Inflammatory bowel disease,Low density lipoprotein cholesterol measurement,Mean platelet volume; Platelet count,Bacteriemia,-	SLC2A13	AP2A1
ENSG00000226777	FAM30A	-1.07110620289237	0.0169781398038436	M1_vs_M2	HSALNG0104257	integenic	Not conserved	NA	NA	TMEM121	WDR45
ENSG00000274515	ENSG00000274515	5.41396901359988	0.00459457206934618	M1_vs_M2	HSALNG0107305	intronic_antisense	Q50	hsa-miR-6787-3p	NA	SNX33	ZMYM1
ENSG00000234142	LINC01675	5.87400371419394	5.0153572228019e-4	M1_vs_M2	HSALNG0008185	integenic	Q75	NA	-	FAM78B	SLC25A29
ENSG00000256262	USP30-AS1	2.82543963849468	1.82843207425777e-50	M1_vs_M2	HSALNG0093872	anti_sense	Not conserved	hsa-miR-4467,hsa-miR-3960	Platelet-to-lymphocyte ratio; Platelet count; Platelet crit,-	SVOP	CR1L
ENSG00000291223	FAM86DP	-1.49749564178831	1.1070522865324e-11	M1_vs_M2	HSALNG0026916	integenic	Not conserved	hsa-miR-485-5p	NA	ZNF717	H4C16
ENSG00000254703	SENCR	-1.8941409233913	8.53819340193029e-7	M1_vs_M2	HSALNG0088110	intronic_antisense	Q90	hsa-miR-4472,hsa-miR-6803-5p	Platelet count; Platelet crit,Basophil count,-	ETS1	ZNF71
ENSG00000181577	LINC03040	2.79140423011584	2.6884371378971302e-9	M1_vs_M2	NA	NA	NA	NA	NA	TMEM63B	MT1F
ENSG00000272666	KLHDC7B-DT	4.87236291201858	1.06153467571022e-14	M1_vs_M2	HSALNG0136305	integenic	Q50	hsa-miR-5589-5p	Erythrocyte count,Monocyte count	SYCE3	MT1F
ENSG00000231233	CFAP58-DT	1.26239990961315	6.734433673956e-4	M1_vs_M2	HSALNG0080427	integenic	Q50	NA	NA	ITPRIP	F5
ENSG00000249249	TICAM2-AS1	3.47132692430697	9.54339553019319e-6	M1_vs_M2	HSALNG0044270	anti_sense	Q90	NA	-	AP3S1	L3MBTL3
ENSG00000269889	ENSG00000269889	5.17810090706978	0.0237948868222928	M1_vs_M2	HSALNG0030592	anti_sense	Q50	hsa-miR-941,hsa-miR-6816-5p	Sex hormone-binding globulin measurement; Mean corpuscular hemoglobin concentration; Erythrocyte count,Neutrophil percentage of granulocytes; Eosinophil count; Basophil count,Eosinophil count; Eosinophil percentage of leukocytes,Lung adenocarcinoma,Neutrophil percentage of leukocytes,Mean corpuscular hemoglobin concentration; Mean corpuscular volume; Platelet count; Erythrocyte count,-	MYNN	RNU6-1099P
ENSG00000290999	ENSG00000290999	3.36079883617701	4.0025010060003e-5	M1_vs_M2	NA	NA	NA	NA	NA	SEC22B	TATDN3
ENSG00000291135	FCGR1BP	3.56425488785614	4.20676730142715e-13	M1_vs_M2	NA	NA	NA	NA	NA	SRGAP2C	MIR29B2CHG
ENSG00000205057	CLLU1-AS1	2.87588462337032	4.18712959555247e-26	M1_vs_M2	NA	NA	NA	NA	NA	BTG1	LINC00963
ENSG00000248187	ENSG00000248187	-4.24355628199891	1.2770285734223198e-200	M1_vs_M2	HSALNG0037074	integenic	Q50	hsa-miR-6855-5p,hsa-miR-6769b-5p	NA	PGRMC2	TMEM273
ENSG00000267745	ENSG00000267745	2.95668527224864	0.00354786989817799	M1_vs_M2	HSALNG0115943	integenic	Not conserved	NA	-	SLFN12	SYT15
ENSG00000254254	PENK-AS1	5.30107990926107	0.0105541327913863	M1_vs_M2	HSALNG0065478	integenic	Q75	hsa-miR-4296	NA	CHCHD7	NBDY
ENSG00000276462	LINC03025	7.83634475081874	2.2686662773750303e-74	M1_vs_M2	HSALNG0071581	integenic	Not conserved	NA	NA	FOXD4L6	TMEM51-AS2
ENSG00000235703	EOLA2-DT	-1.1308026148855	3.00737831501195e-6	M1_vs_M2	HSALNG0140629	integenic	Q50	hsa-miR-4640-3p	NA	HSFX4	AIF1
ENSG00000261888	ENSG00000261888	-3.95643665452832	4.37926622532973e-26	M1_vs_M2	HSALNG0145190	integenic	Not conserved	NA	Hematocrit	METRNL	TRIM27
ENSG00000284734	ENSG00000284734	5.18004648471794	0.0230382701550666	M1_vs_M2	HSALNG0005052	anti_sense	Not conserved	NA	NA	GBP6	SCGB2B2
ENSG00000281920	ENSG00000281920	-6.17664110799237	1.3804160689891e-4	M1_vs_M2	HSALNG0015543	integenic	Q90	hsa-miR-128-2-5p,hsa-miR-194-3p,hsa-miR-619-5p,hsa-miR-3190-5p,hsa-miR-4258,hsa-miR-4447,hsa-miR-4685-3p,hsa-miR-4763-3p,hsa-miR-6130,hsa-miR-6132,hsa-miR-6730-5p,hsa-miR-6752-3p,hsa-miR-6858-5p	Systemic lupus erythematosus,Neutrophil percentage of leukocytes,Crohn's disease; Inflammatory bowel disease,Lymphocyte percentage of leukocytes; Myeloid white cell count; Granulocyte count,Monocyte percentage of leukocytes; Monocyte count,Bell's palsy,Body height; Bipolar disorder,Bipolar disorder,Body height,Pulse pressure measurement,Systolic blood pressure,Waist-hip ratio,Protein measurement,Iron biomarker measurement,Nicotine dependence symptom count,Cognitive decline measurement,Neuroimaging measurement,Fev/fec ratio,Brain volume measurement,Isthmus cingulate cortex volume measurement,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Cortical surface area measurement,Cortical surface area measurement; Cortical thickness,Facial morphology measurement; Gut microbiome measurement,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Serum gamma-glutamyl transferase measurement; Vital capacity,White matter microstructure measurement,Bmi-adjusted waist-hip ratio,Waist-hip ratio; Smoking behavior; Bmi-adjusted waist-hip ratio,Calcium measurement,Sex hormone-binding globulin measurement,Susceptibility to chickenpox measurement,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Myocardial infarction,Heel bone mineral density,Psoriasis; Ulcerative colitis; Ankylosing spondylitis; Crohn's disease; Sclerosing cholangitis,Electroencephalogram measurement; Theta wave measurement,Squamous cell lung carcinoma; Family history of lung cancer,Covid-19; Mortality,Forced expiratory volume; Response to bronchodilator,Post-operative delirium; Response to surgery,Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement; Brain measurement,Cortical surface area measurement; Neuroimaging measurement,Bipolar disorder; Body mass index,Response to ketamine; Dissociation measurement,-	ACTR2	SMG1P2
ENSG00000290399	ENSG00000290399	3.6050045203913	5.69829264847973e-6	M1_vs_M2	HSALNG0104477	integenic	Not conserved	NA	NA	NIPA1	C22orf42
ENSG00000290710	HLA-V	2.6704481292194	5.57281402209978e-5	M1_vs_M2	NA	NA	NA	NA	NA	HLA-G	HLA-A
ENSG00000272341	ENSG00000272341	-2.19571997288599	9.02868076125943e-16	M1_vs_M2	HSALNG0048332	anti_sense	Q75	hsa-miR-6799-5p	-	STMND1	TRIM71
ENSG00000269293	ZSCAN16-AS1	-1.07379371792872	2.92859904487548e-8	M1_vs_M2	HSALNG0048933	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-1587,hsa-miR-3972,hsa-miR-7150	NA	OR2B8P	TRBJ2-3
ENSG00000259668	ENSG00000259668	1.0920173987565	6.07247211425073e-8	M1_vs_M2	HSALNG0105911	anti_sense	Q75	hsa-miR-4443	C-reactive protein measurement,Body mass index,Self reported educational attainment,-,Waist-hip ratio; Smoking behavior; Body mass index,Body fat percentage	GLDN	RPL18AP3
ENSG00000289298	ENSG00000289298	-1.48272473777426	1.6721935425273e-4	M1_vs_M2	HSALNG0126206	integenic	Not conserved	NA	NA	CEACAM4	PIGCP1
ENSG00000289071	ENSG00000289071	2.95153765590525	0.0319402625381024	M1_vs_M2	NA	NA	NA	NA	NA	CD46	EML6
ENSG00000267288	ENSG00000267288	5.17784469538494	0.0320272974857407	M1_vs_M2	HSALNG0116825	anti_sense	Q90	hsa-miR-939-3p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-6802-5p	Balding measurement,-	PLCD3	ENSG00000216285
ENSG00000273855	ENSG00000273855	-1.30171712965195	1.9505549735236e-4	M1_vs_M2	HSALNG0105214	sense	Q75	hsa-miR-4293,hsa-miR-5088-3p	NA	PLCB2	FNIP1
ENSG00000237310	LINC03011	-1.01750415493466	0.0172998484279394	M1_vs_M2	HSALNG0058603	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-6782-5p,hsa-miR-6803-5p,hsa-miR-6833-3p	-	TPST1	MIR1286
ENSG00000285907	ENSG00000285907	4.52055675801839	1.20998234924865e-7	M1_vs_M2	HSALNG0072614	integenic	Q50	hsa-miR-619-5p,hsa-miR-4455,hsa-miR-6826-3p	Body mass index; Metabolic syndrome,Risk-taking behaviour,Triglyceride measurement,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Grip strength measurement; Body mass index,Visceral adipose tissue measurement,Body mass index,Chronotype measurement,Fibrinogen measurement; Cortical thickness,Cleft lip; Cleft palate,Serum alanine aminotransferase measurement; Response to combination chemotherapy,Triglyceride measurement; Chronotype measurement,Neuroimaging measurement; Brain measurement,Age at menarche,Cortical surface area measurement; Hemoglobin measurement; Hematocrit; Mathematical ability,Hematocrit,Cognitive function measurement,Mathematical ability,-	SEMA4D	FADS3
ENSG00000222042	ENSG00000222042	6.22197011629992	2.6054609961129e-4	M1_vs_M2	HSALNG0132366	integenic	Not conserved	NA	NA	MRPL39	ENSG00000222042
ENSG00000267481	ENSG00000267481	-1.38545253982185	0.0161351232342343	M1_vs_M2	HSALNG0124757	sense	Not conserved	hsa-miR-619-5p	-	ZNF506	ENSG00000223343
ENSG00000230825	LINC03016	4.73450452747326	0.0485727316616086	M1_vs_M2	HSALNG0056038	integenic	Q50	hsa-miR-619-5p,hsa-miR-4290	Smooth surface dental caries,Daytime rest measurement,Body mass index; Visceral adipose tissue measurement	C1GALT1	LINC02068
ENSG00000227155	DOCK8-AS2	1.13461428505911	0.011888902815761	M1_vs_M2	HSALNG0069538	anti_sense	Q90	hsa-miR-4268,hsa-miR-4743-3p	Bilirubin measurement,Hair morphology measurement,-	ZNG1A	MIR503HG
ENSG00000235545	DOCK7-DT	-4.0625968052284	1.5555724389037e-4	M1_vs_M2	HSALNG0004080	anti_sense	Q50	NA	Serum metabolite measurement,High density lipoprotein cholesterol measurement,Platelet count,Triglyceride measurement,Mean corpuscular volume,Bilirubin measurement; Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Blood metabolite measurement,Apolipoprotein a 1 measurement; Total cholesterol measurement; Apolipoprotein b measurement; Low density lipoprotein cholesterol measurement; Triglyceride measurement,Bilirubin measurement,-	ATG4C	NQO2-AS1
ENSG00000258404	LINC02320	-2.43659615477613	3.082032801072e-4	M1_vs_M2	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	SLC9A3-AS1
ENSG00000285190	ENSG00000285190	-6.14714925476891	3.92421582313876e-5	M1_vs_M2	HSALNG0043300	anti_sense	Q50	hsa-miR-7703	Body mass index,Body height,-	RASA1	ARL6IP1P2
ENSG00000271474	UNC5C-AS1	6.02389993265775	4.5899284566034e-4	M1_vs_M2	HSALNG0035909	anti_sense	Q50	NA	-	PDHA2	CYP4A22-AS1
ENSG00000229953	BCAN-AS2	-1.23034901163057	0.0152434908435242	M1_vs_M2	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	ENSG00000225963
ENSG00000242258	LINC00996	8.61396050314265	2.50368991648785e-21	M1_vs_M2	HSALNG0062275	sense	Not conserved	NA	Electroencephalogram measurement	GIMAP8	HAR1A
ENSG00000248809	LINC01095	5.30047445371739	0.0186717025605589	M1_vs_M2	HSALNG0037693	integenic	Q50	hsa-miR-1227-5p,hsa-miR-6802-5p,hsa-miR-6819-5p,hsa-miR-1273h-5p	Systolic blood pressure change measurement; Response to hydrochlorothiazide,Fev/fec ratio; Response to bronchodilator,-	SLC10A7	PSMC1P12
ENSG00000229664	ENSG00000229664	5.61527045681584	0.00391894905667527	M1_vs_M2	HSALNG0075911	anti_sense	Not conserved	hsa-miR-4722-5p,hsa-miR-6089,hsa-miR-6873-3p	Liver fibrosis measurement; Epstein barr virus nuclear antigen 1 igg measurement,Response to diisocyanate,Interleukin 2 receptor antagonist measurement,Crohn's disease; Inflammatory bowel disease,Hypothyroidism; Thyroid preparation use measurement,Eosinophil count; Respiratory system disease; Eosinophil percentage of leukocytes,Tonsillectomy risk measurement,Ovarian serous carcinoma; Response to carboplatin; Response to paclitaxel; Progression free survival,-	RBM17	PSMC1P12
ENSG00000250802	ZBED3-AS1	-2.72716746921823	2.57998572456739e-28	M1_vs_M2	HSALNG0042820	anti_sense,sense	Q50	hsa-miR-619-5p,hsa-miR-877-3p,hsa-miR-4505,hsa-miR-4722-5p,hsa-miR-6803-5p,hsa-miR-6892-3p	Self-injurious behavior,Fasting blood glucose measurement,Autism,Glucose measurement; Fasting blood glucose measurement,Hemoglobin a1 measurement; Bmi-adjusted waist-hip ratio,Body mass index,Glucose measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Hba1c measurement,Glucose measurement; Hba1c measurement,Hba1c measurement; Bmi-adjusted waist-hip ratio,Dental caries,Testosterone measurement,Hematocrit; Hemoglobin measurement,Hematocrit; Hemoglobin measurement; Red blood cell density measurement; Erythrocyte count,Thyroid stimulating hormone measurement; Erythrocyte count,Hematocrit; Hemoglobin measurement; Red blood cell density measurement,Hemoglobin measurement,Bmi-adjusted waist-hip ratio,-	NA	FTLP3
ENSG00000233610	LINC00462	5.17878567027088	0.0151976513326478	M1_vs_M2	HSALNG0097004	anti_sense	Not conserved	NA	NA	RCBTB2	MAGOH-DT
ENSG00000223749	MIR503HG	1.95094888586659	9.14039991272519e-6	M1_vs_M2	HSALNG0140233	integenic	Q90	hsa-miR-4292	Body height; Testosterone measurement,Testosterone measurement	PLAC1	DOCK8-AS2
ENSG00000283213	ENSG00000283213	-1.62314725693929	7.1195552323259e-4	M1_vs_M2	HSALNG0110217	anti_sense	Q90	NA	-	USP31	SUB1P1
ENSG00000260351	ENSG00000260351	-2.46186817359932	3.50734895085851e-5	M1_vs_M2	HSALNG0144425	integenic	Q75	NA	NA	TM6SF1	WASH7P
ENSG00000260898	ADPGK-AS1	-1.38461141033057	7.34884326722285e-11	M1_vs_M2	HSALNG0107094	anti_sense	Q75	hsa-miR-484,hsa-miR-6089,hsa-miR-6848-5p,hsa-miR-8485	Urate measurement,Grip strength measurement,Body weight,Vital capacity,Body mass index,Body mass index; Visceral adipose tissue measurement,Triglyceride measurement; Body mass index,-	BBS4	KLLN
ENSG00000224652	LINC00885	-2.18823383150513	6.0510033427656414e-9	M1_vs_M2	HSALNG0031897	integenic	Not conserved	hsa-miR-920,hsa-miR-3169,hsa-miR-6133	Hba1c measurement,Mean corpuscular volume; Erythrocyte count,-	SLC51A	RPL11P1
ENSG00000227544	LINC03013	-3.53921236291368	0.00559098005178492	M1_vs_M2	HSALNG0057229	integenic	Q90	hsa-miR-619-5p,hsa-miR-5006-3p	-	SEPTIN7	LINC03013
ENSG00000269667	ENSG00000269667	5.04555505985652	0.0225447768906235	M1_vs_M2	HSALNG0144810	integenic	Not conserved	hsa-miR-4516	Monocyte count,Leukocyte count; Rheumatoid arthritis; Monocyte percentage of leukocytes,Neutrophil count; Granulocyte percentage of myeloid white cells; Myeloid white cell count; Leukocyte count; Monocyte count; Monocyte percentage of leukocytes,Oral ulcer,Eosinophil count,Leukocyte count; Lymphocyte count	IRF8	ST13P21
ENSG00000222017	ENSG00000222017	5.04555456703525	0.0216765275188083	M1_vs_M2	HSALNG0021397	anti_sense,sense	Not conserved	hsa-miR-4268	Monocyte count,Red blood cell distribution width,Circadian rhythm,Chronotype measurement,Rheumatoid arthritis,Platelet count,Brain aneurysm,Body mass index,-	MARS2	ST13P21
ENSG00000289197	ENSG00000289197	4.73450443901635	0.0483153753207479	M1_vs_M2	HSALNG0039059	integenic	Not conserved	NA	Mosquito bite reaction size measurement; Mosquito bite reaction itch intensity measurement,-	HELT	ST13P21
ENSG00000228923	ENSG00000228923	5.87400256493133	4.3312015379462e-4	M1_vs_M2	HSALNG0134504	sense	Q75	hsa-miR-6810-3p	Serum gamma-glutamyl transferase measurement	UPB1	ST13P21
ENSG00000226239	ENSG00000226239	5.5184484849435	0.00467487913438607	M1_vs_M2	HSALNG0129532	anti_sense	Q50	NA	Cystatin c measurement,Cognitive decline measurement,-	PDRG1	ST13P21
ENSG00000271931	PNRC1-DT	6.15903443787297	1.5398140556039e-4	M1_vs_M2	HSALNG0051848	integenic	Q50	hsa-miR-4492,hsa-miR-6803-5p,hsa-miR-6810-3p	Sleep duration	SRSF12	ST13P21
ENSG00000290041	ENSG00000290041	1.91397459567318	7.12163058708897e-13	M1_vs_M2	HSALNG0003215	anti_sense,sense	Q75	hsa-miR-619-5p	Soluble triggering receptor expressed on myeloid cells 2 measurement,Intraocular pressure measurement,-	BTBD19	HLA-U
ENSG00000228382	ITPKB-IT1	-3.17924918393602	0.0352037396797747	M1_vs_M2	HSALNG0011101	sense	Q75	NA	NA	ITPKB	ITPKB-IT1
ENSG00000291224	ENSG00000291224	-1.14375527037377	0.0121492149678088	M1_vs_M2	HSALNG0024079	anti_sense	Not conserved	hsa-miR-6736-3p	Blood protein measurement,Body weight,3-hydroxypropylmercapturic acid measurement,-	FANCD2	HDAC2-AS2
ENSG00000259540	ENSG00000259540	4.89832708918817	0.0322964216093924	M1_vs_M2	HSALNG0108586	anti_sense	Not conserved	NA	-	ASB7	HCG22
ENSG00000288819	ENSG00000288819	2.46531473711779	0.00336039486825497	M1_vs_M2	NA	NA	NA	NA	NA	CATIP	LINC02766
ENSG00000278112	ENSG00000278112	-3.12759368529656	0.0028902235474729	M1_vs_M2	HSALNG0094744	sense	Q50	hsa-miR-204-3p,hsa-miR-4508,hsa-miR-4722-5p	NA	RILPL1	LINC02800
ENSG00000242973	TDRD6-AS1	3.43232609902504	0.0024735358536243	M1_vs_M2	HSALNG0050369	anti_sense	Q50	hsa-miR-567,hsa-miR-4447	Hashimoto's thyroiditis; Autoimmune thyroid disease; Graves disease,-	PLA2G7	RPL10P6
ENSG00000275180	ENSG00000275180	1.38987418555379	9.55198139261996e-6	M1_vs_M2	HSALNG0091856	integenic	Q50	hsa-miR-4286	Waist circumference,-	MON2	RPS23P8
ENSG00000234327	ZNF232-AS1	-1.28424458344056	0.00140544048228087	M1_vs_M2	HSALNG0114103	anti_sense	Not conserved	hsa-miR-619-5p,hsa-miR-3162-5p,hsa-miR-1268b	-	ZFP3	FBXW4P1
ENSG00000272768	ENSG00000272768	-1.09659943854312	0.0163197536942506	M1_vs_M2	HSALNG0057688	anti_sense	Q50	hsa-miR-1301-3p,hsa-miR-1237-5p,hsa-miR-3960,hsa-miR-5691	Platelet count,Aging,Reaction time measurement,Reticulocyte count,-	PPIA	ENSG00000230747
ENSG00000247708	STX18-AS1	-1.10026291183571	3.01670752349413e-15	M1_vs_M2	HSALNG0032553	integenic	Q50	NA	NA	MSX1	ANKRD63
ENSG00000254545	ENSG00000254545	-1.55207068710741	0.0402031056392451	M1_vs_M2	HSALNG0002264	anti_sense	Q50	hsa-miR-1237-5p,hsa-miR-4498	-	HCRTR1	MORF4L2-AS1
ENSG00000233030	ENSG00000233030	7.52005781359756	2.1790936394755598e-11	M1_vs_M2	HSALNG0142341	anti_sense,intronic_sense	Not conserved	NA	Monocyte count,-	H2BC18	TAPBP
ENSG00000267519	MIR23AHG	1.17491231602374	3.20427885707609e-31	M1_vs_M2	HSALNG0124251	anti_sense	Q90	NA	Waist-hip ratio,Neutrophil-to-lymphocyte ratio; Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Leukocyte count; Lymphocyte count; Myeloid white cell count,Leukocyte count; Lymphocyte count,Lymphocyte count,Fev/fec ratio; Monocyte count,Leukocyte count,Myeloid white cell count; Lymphocyte count,Cortical thickness,-	BRME1	RPL4P2
ENSG00000255135	EMSY-DT	-1.71200790422995	3.9608014953303e-4	M1_vs_M2	HSALNG0085855	anti_sense	Q90	hsa-miR-30c-2-3p,hsa-miR-619-5p	Microglial activation measurement,-	THAP12	ZDHHC20P4
ENSG00000232618	HIVEP2-DT	6.5533109962135	2.703699775529e-5	M1_vs_M2	HSALNG0054003	anti_sense	Q50	hsa-miR-4279	Mean platelet volume,-	AIG1	HIVEP2-DT
ENSG00000232680	ENSG00000232680	5.52013252325184	0.0119505132390158	M1_vs_M2	HSALNG0125614	integenic	Not conserved	NA	NA	KRTDAP	ENSG00000232680
ENSG00000229922	LINC02865	5.52011788475497	0.0117270405508614	M1_vs_M2	HSALNG0053801	integenic	Q50	hsa-miR-6873-3p	Eosinophil count; Ejection fraction measurement; Eosinophil percentage of leukocytes,Cardiac troponin t measurement,Rheumatoid arthritis,Phosphatidylcholine ether measurement,-	TNFAIP3	ENSG00000232680
ENSG00000277425	ENSG00000277425	5.0452471672656	0.0277467485103035	M1_vs_M2	HSALNG0128363	sense	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6089	-	TMEM230	MARK2P9
ENSG00000254287	ENSG00000254287	10.1156607941709	1.9971057504515297e-49	M1_vs_M2	HSALNG0150387	anti_sense	Q50	NA	-	ADAM2	ENSG00000233029
ENSG00000266049	ENSG00000266049	-1.39866024027558	0.0151945985892644	M1_vs_M2	HSALNG0119656	anti_sense	Not conserved	hsa-miR-6089	Fat body mass,Nicotine withdrawal symptom count,Mathematical ability,Body height,Response to radiation,-,Conotruncal heart malformations	LPIN2	GPX1
ENSG00000267074	ENSG00000267074	2.57511060072014	3.54552641605935e-5	M1_vs_M2	HSALNG0115953	sense	Not conserved	NA	Macrophage inflammatory protein 1b measurement	SLFN12L	ENSG00000233785
ENSG00000262001	DLGAP1-AS2	1.36208547550609	0.0495017421200724	M1_vs_M2	HSALNG0119714	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4481,hsa-miR-4505,hsa-miR-1587,hsa-miR-6089,hsa-miR-7111-5p,hsa-miR-7150	Mean corpuscular volume,Mean reticulocyte volume,Blood urea nitrogen measurement; Serum urea measurement,Fat body mass,Mean reticulocyte volume; Mean corpuscular volume,Lip morphology measurement,Alanine measurement; Amino acid measurement,-	TGIF1	LINC01283
ENSG00000287893	ENSG00000287893	-3.65763137833332	0.00655933854858391	M1_vs_M2	HSALNG0057241	integenic	Not conserved	NA	-	HERPUD2	LINC02925
ENSG00000236790	LINC00299	5.79246399982484	0.00165639754122266	M1_vs_M2	HSALNG0012827	integenic	Not conserved	hsa-miR-761	NA	KIDINS220	ATP5PDP4
ENSG00000236404	VLDLR-AS1	-4.78909204431811	0.0335469039764314	M1_vs_M2	HSALNG0150761	integenic	Q50	hsa-miR-4463	NA	PUM3	EIF4BP9
ENSG00000290525	GBP1P1	7.25250771082649	1.07322688617015e-51	M1_vs_M2	NA	NA	NA	NA	NA	GBP6	LINC01358
ENSG00000270605	ENSG00000270605	1.65567206159119	0.00258946423032846	M1_vs_M2	HSALNG0002045	anti_sense	Q50	hsa-miR-19b-2-5p,hsa-miR-619-5p,hsa-miR-3620-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-1587,hsa-miR-5693,hsa-miR-5787,hsa-miR-6089	Aspartate aminotransferase measurement,-	DNAJC8	LINC01679
ENSG00000289015	ENSG00000289015	-1.00260810927787	0.0444319541433898	M1_vs_M2	HSALNG0058614	anti_sense	Not conserved	NA	-	SBDS	ASB14
ENSG00000290644	ENSG00000290644	-2.72319028612729	0.0220201488148897	M1_vs_M2	HSALNG0072753	integenic	Not conserved	hsa-miR-3178,hsa-miR-4505,hsa-miR-6514-3p	-	CENPP	ENSG00000239415
ENSG00000268355	ENSG00000268355	-1.69464253821019	0.0365968967118049	M1_vs_M2	HSALNG0126205	sense	Not conserved	hsa-miR-619-5p,hsa-miR-6803-5p	NA	CEACAM21	KMT2E-AS1
ENSG00000225465	RFPL1S	1.15150621237422	0.0152988148894551	M1_vs_M2	HSALNG0134830	anti_sense	Q90	hsa-miR-30b-3p,hsa-miR-361-3p,hsa-miR-363-5p,hsa-miR-619-5p,hsa-miR-1247-5p,hsa-miR-1268b,hsa-miR-4525,hsa-miR-6089,hsa-miR-6803-5p	Breast carcinoma,Upper aerodigestive tract neoplasm,-	THOC5	TFAP2E-AS1
ENSG00000215244	LINC02649	1.06902612026707	0.019819672025984	M1_vs_M2	HSALNG0142500	integenic	Not conserved	NA	Rheumatoid arthritis,Thyroid preparation use measurement	PFKFB3	ENSG00000242588
ENSG00000271040	TMEM242-DT	-2.55447639789586	0.00318930563451733	M1_vs_M2	HSALNG0054615	anti_sense	Not conserved	NA	-	ZDHHC14	ENSG00000243304
ENSG00000286276	ENSG00000286276	1.42175042017175	0.00775756425889036	M1_vs_M2	HSALNG0006333	integenic	Q50	hsa-miR-615-5p,hsa-miR-4519	Diastolic blood pressure,Cystatin c measurement,Leukocyte count; Neutrophil count,Creatinine measurement,Systemic lupus erythematosus,Stressful life event measurement; Depressive symptom measurement,-	ATP1A1	EFNA4
ENSG00000167920	KRT10-AS1	-1.07851999080151	0.00236161702570198	M1_vs_M2	HSALNG0116399	anti_sense	Q75	hsa-miR-3960	Leukocyte count,-	KRTAP4-7	IL10RB
ENSG00000289198	ENSG00000289198	1.99537848473735	6.48251318247911e-5	M1_vs_M2	HSALNG0052920	integenic	Q90	NA	-	MARCKS	APOBEC3D
ENSG00000236939	BAALC-AS2	3.30074385870708	4.37881154579539e-35	M1_vs_M2	HSALNG0067505	anti_sense	Q50	hsa-miR-4447	Pelvic organ prolapse,Cognitive function measurement,Myopia,Late-onset alzheimers disease,Mathematical ability,Colorectal cancer; Breast carcinoma,Triglyceride measurement; Response to diuretic,Hemoglobin a1 measurement,-	AZIN1	RN7SL832P
ENSG00000235979	ENSG00000235979	-5.51598334713299	0.0058582172980129	M1_vs_M2	HSALNG0115130	integenic	Not conserved	NA	NA	MFAP4	VTI1BP1
ENSG00000265205	ENSG00000265205	2.20054771860783	0.0190595604438582	M1_vs_M2	HSALNG0115495	anti_sense	Q90	hsa-miR-331-3p,hsa-miR-6089	-	SDF2	LINC00847
ENSG00000259407	ENSG00000259407	4.89901222107983	0.0467362560047583	M1_vs_M2	HSALNG0107883	anti_sense	Q90	hsa-miR-4492,hsa-miR-2467-3p,hsa-miR-7843-5p	Neutrophil percentage of granulocytes; Eosinophil percentage of leukocytes; Eosinophil percentage of granulocytes,Eosinophil count,Systolic blood pressure,Eosinophil count; Eosinophil percentage of leukocytes,Alkaline phosphatase measurement,Varicose veins,Idiopathic pulmonary fibrosis,-	KLHL25	A2M-AS1
ENSG00000270120	ENSG00000270120	3.70235712868562	6.42533734676275e-7	M1_vs_M2	HSALNG0111360	sense	Q50	NA	NA	NOD2	SDAD1-AS1
ENSG00000235770	LINC00607	-1.9908884039241601	4.26535041803752e-9	M1_vs_M2	HSALNG0022091	integenic	Not conserved	NA	-	MREG	TMED2-DT
ENSG00000260302	LINC01882	5.79317703913986	0.00106252340247643	M1_vs_M2	HSALNG0120126	integenic	Not conserved	hsa-miR-149-3p,hsa-miR-1268b,hsa-miR-4441,hsa-miR-8485	Interleukin 9 measurement; Macrophage inflammatory protein 1a measurement,Red blood cell density measurement,Psoriasis,Autoimmune disease; Celiac disease,Juvenile idiopathic arthritis,Sarcoidosis,Alopecia areata,-	PTPN2	LINC01093
ENSG00000259720	ENSG00000259720	-3.41475560192096	0.023923605796826	M1_vs_M2	HSALNG0144346	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-4430	NA	FAN1	PDLIM1P4
ENSG00000236846	ENSG00000236846	-6.01343986062397	8.6375459697135e-4	M1_vs_M2	HSALNG0010877	integenic	Q50	hsa-miR-22-3p,hsa-miR-3192-5p,hsa-miR-4472,hsa-miR-6780a-3p	NA	DISP1	ENSG00000249639
ENSG00000227017	ENSG00000227017	4.51799964399563	2.17633057661128e-7	M1_vs_M2	HSALNG0056985	integenic	Q50	NA	-	FKBP14	LINC02021
ENSG00000255571	MIR9-3HG	5.41322262599255	0.00924256636648547	M1_vs_M2	HSALNG0108036	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-1228-5p,hsa-miR-3178,hsa-miR-4529-5p,hsa-miR-4667-3p,hsa-miR-4710,hsa-miR-6089,hsa-miR-6736-5p,hsa-miR-6810-3p,hsa-miR-6816-5p,hsa-miR-6826-3p,hsa-miR-6887-3p	White matter microstructure measurement,Cortical surface area measurement; Cigarettes per day measurement,Mathematical ability,Body mass index,Comparative body size at age 10, self-reported,Dental caries; Dentures,-	FANCI	CDK3
ENSG00000286062	ENSG00000286062	-1.18681737329836	1.18096586081244e-5	M1_vs_M2	HSALNG0042332	integenic	Q75	hsa-miR-508-5p	Sepsis; Mortality,Systolic blood pressure,-	SGTB	ENSG00000250568
ENSG00000287576	ENSG00000287576	2.45791272206855	9.235387674628087e-11	M1_vs_M2	HSALNG0150312	integenic	Not conserved	NA	Leukocyte count	GSDMD	ENSG00000251194
ENSG00000253317	ENSG00000253317	5.41397122589519	0.00463859216592864	M1_vs_M2	HSALNG0066124	integenic	Not conserved	NA	-	KCNB2	ENSG00000253317
ENSG00000234177	LINC01114	-4.03499565849916	6.5586141235228e-4	M1_vs_M2	HSALNG0017537	anti_sense	Q90	hsa-miR-328-3p,hsa-miR-3196,hsa-miR-8485	Chronotype measurement,Pancreatic carcinoma,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Aspartate aminotransferase measurement,Body mass index,Body weight,Mean arterial pressure,Lifestyle measurement; Neuroimaging measurement; Body mass index; Brain measurement; Body height,Brain volume measurement,-	TGFBRAP1	ENSG00000253666
ENSG00000234919	LINC01827	-3.23590990244062	1.93697502705814e-7	M1_vs_M2	HSALNG0021276	anti_sense	Q50	hsa-miR-4463,hsa-miR-6825-5p,hsa-miR-1273h-5p	Neuroticism measurement; Temperament and character inventory,Intelligence,Ankle injury,Food allergy measurement,Response to benznidazole,Eye colour measurement,Gut microbiome measurement,Parental longevity,Proliferative diabetic retinopathy,Blood urea nitrogen measurement,Abnormality of chromosome segregation,Interleukin 2 measurement,Lymphoid leukemia,Bipolar disorder; Attention deficit hyperactivity disorder,Response to thiopurine; Leukopenia,Response to antimicrotubule agent; Response to antineoplastic agent,-	DNAH7	ENSG00000253667
ENSG00000233029	ENSG00000233029	5.70739779400968	0.00272486240225554	M1_vs_M2	HSALNG0142289	anti_sense	Not conserved	NA	-	FAM72B	ENSG00000254287
ENSG00000272405	ENSG00000272405	-1.27189973070313	3.18418389582136e-11	M1_vs_M2	HSALNG0007612	anti_sense	Q75	hsa-miR-4722-5p,hsa-miR-6511a-3p	Blood protein measurement,-	NES	EMSY-DT
ENSG00000272482	ENSG00000272482	-4.78872268101237	0.0228946811448651	M1_vs_M2	HSALNG0000950	integenic	Q90	hsa-miR-6756-5p	NA	DHRS3	HTD2
ENSG00000279833	ENSG00000279833	-1.3796640308734	0.00923378996862181	M1_vs_M2	NA	NA	NA	NA	NA	APOBEC3H	ENSG00000255860
ENSG00000272941	ENSG00000272941	1.1610272715294	3.4371012414363e-4	M1_vs_M2	HSALNG0061535	anti_sense	Q50	NA	-	TMEM140	ENSG00000255968
ENSG00000261373	VPS9D1-AS1	1.45227952045532	0.00488738960118579	M1_vs_M2	HSALNG0141629	anti_sense	Q50	hsa-miR-149-3p,hsa-miR-4732-3p,hsa-miR-6808-5p	Blood protein measurement,Hair colour measurement,-	ZNF276	TOMM20P2
ENSG00000250548	LINC01303	3.00612899670591	2.5604252368081e-8	M1_vs_M2	HSALNG0101771	anti_sense	Q75	NA	Susceptibility to vaginal yeast infection measurement,Asthma exacerbation measurement,-	TMEM30B	CTSO
ENSG00000228013	IL6R-AS1	2.4203950780965102	1.62196750382481e-8	M1_vs_M2	HSALNG0007394	anti_sense	Q75	hsa-miR-4710,hsa-miR-6736-5p	C-reactive protein measurement,C-reactive protein measurement; Serum non-albumin protein measurement,Albumin:globulin ratio measurement,Total blood protein measurement,Serum non-albumin protein measurement,Systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis,-	SHE	ENSG00000256196
ENSG00000247081	BAALC-AS1	2.85816303521783	1.14403661052751e-5	M1_vs_M2	HSALNG0067506	integenic	Q50	NA	NA	SLC25A32	TMEM109-DT
ENSG00000240057	NEPRO-AS1	1.41927834328348	0.0197105387974998	M1_vs_M2	HSALNG0028082	integenic	Q90	hsa-miR-296-3p	Telomere length,Myopia,Body height	GTPBP8	GLIPR1-AS1
ENSG00000257588	AQP5-AS1	-5.44078334620513	0.0051596523798504	M1_vs_M2	HSALNG0090990	anti_sense	Q50	NA	-	RACGAP1	AQP5-AS1
ENSG00000287917	ENSG00000287917	1.24714050000464	0.00409467435618242	M1_vs_M2	HSALNG0084879	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3620-3p,hsa-miR-6089,hsa-miR-6803-5p	-	SLC25A45	C17orf49
ENSG00000225138	SLC9A3-AS1	-1.20252763776833	1.14966765322155e-5	M1_vs_M2	HSALNG0039449	anti_sense	Q75	hsa-miR-762,hsa-miR-541-3p,hsa-miR-4279,hsa-miR-3619-5p,hsa-miR-4505,hsa-miR-4508,hsa-miR-4632-3p,hsa-miR-1343-5p,hsa-miR-4722-5p,hsa-miR-4749-3p,hsa-miR-5787,hsa-miR-6132,hsa-miR-6720-3p,hsa-miR-6747-5p,hsa-miR-6873-3p	-,Hemoglobin measurement	EXOC3	LINC02320
ENSG00000287255	ENSG00000287255	-2.72928562996684	6.6537435386881e-4	M1_vs_M2	HSALNG0014389	anti_sense	Q50	hsa-miR-619-5p	Qt interval; Pr interval,Qt interval,Pr interval,Protein measurement,Qt interval; Tpe interval measurement,Electrocardiography,Bone fracture,Dna methylation,Heel bone mineral density,Forced expiratory volume; Response to bronchodilator,-	TMEM178A	ENSG00000258634
ENSG00000259094	ENSG00000259094	-5.61829371044984	5.7924769234559e-4	M1_vs_M2	HSALNG0018295	anti_sense	Not conserved	NA	-	EN1	ENSG00000259094
ENSG00000255320	ENSG00000255320	-1.22112796386873	0.0164033665128209	M1_vs_M2	HSALNG0084993	anti_sense	Q50	hsa-miR-644a,hsa-miR-4508	-	YIF1A	ENSG00000259137
ENSG00000232160	RAP2C-AS1	1.27931493285761	0.0132162359902769	M1_vs_M2	HSALNG0140185	integenic	Not conserved	NA	NA	STK26	ENSG00000259212
ENSG00000267737	ENSG00000267737	4.02954326365796	1.06662299262295e-8	M1_vs_M2	HSALNG0119029	integenic	Not conserved	NA	NA	PGS1	SLC30A4-AS1
ENSG00000288743	ENSG00000288743	-2.01412456708726	0.00859809363079163	M1_vs_M2	HSALNG0097024	overlap_antisense,anti_sense	Q50	hsa-miR-4480,hsa-miR-6747-5p,hsa-miR-7155-5p	Uterine fibroid,-	CAB39L	ENSG00000259363
ENSG00000253738	OTUD6B-AS1	-1.06232350800717	8.480339312078772e-14	M1_vs_M2	HSALNG0066885	anti_sense	Q50	NA	-	PIP4P2	ENSG00000259408
ENSG00000226312	CFLAR-AS1	1.36988885289573	2.38377485199401e-6	M1_vs_M2	HSALNG0021529	anti_sense	Q50	hsa-miR-30b-3p	Total blood protein measurement,-	HYCC2	ENSG00000260257
ENSG00000249173	LINC01093	5.93809029528373	5.873672061826e-18	M1_vs_M2	HSALNG0039055	integenic	Q50	hsa-miR-619-5p,hsa-miR-4505,hsa-miR-6808-5p,hsa-miR-6769b-5p	NA	ACSL1	LINC01882
ENSG00000260630	SNAI3-AS1	-1.43014831348636	5.97450134236172e-10	M1_vs_M2	HSALNG0113528	anti_sense	Q50	hsa-miR-665,hsa-miR-3195,hsa-miR-6089	Airway imaging measurement,Hair colour measurement,Reticulocyte count; Reticulocyte measurement,-	CTU2	ENSG00000260360
ENSG00000260661	ENSG00000260661	5.04509003655421	0.0385639302982684	M1_vs_M2	HSALNG0144613	anti_sense	Q75	NA	Diastolic blood pressure,3-hydroxy-1-methylpropylmercapturic acid measurement,Self reported educational attainment,Susceptibility to chronic sinus infection measurement,Dna methylation,Seasonal gut microbiome measurement,Parahippocampal gyrus volume measurement,Smoking initiation,Oral cleft; Alcohol consumption measurement,Colorectal cancer; Diet measurement,Serum dimethylarginine measurement,-	FAM174B	ENSG00000260661
ENSG00000291233	ENSG00000291233	1.31158799450886	0.0476770801321314	M1_vs_M2	NA	NA	NA	NA	NA	NBPF9	ENSG00000261056
ENSG00000286558	ENSG00000286558	2.18836459880065	0.003134253034568	M1_vs_M2	HSALNG0148220	integenic	Not conserved	NA	-	TMEM144	VPS9D1-AS1
ENSG00000247095	MIR210HG	3.2328507943774	8.31999933332479e-5	M1_vs_M2	HSALNG0081992	anti_sense	Q50	hsa-miR-766-3p,hsa-miR-4707-5p,hsa-miR-5587-3p,hsa-miR-6735-5p,hsa-miR-6735-3p,hsa-miR-6858-5p,hsa-miR-7843-5p	Systemic lupus erythematosus,High density lipoprotein cholesterol measurement,-	LMNTD2	TEN1-CDK3
ENSG00000272079	ENSG00000272079	-1.49964887517895	0.00893770555924453	M1_vs_M2	HSALNG0109099	integenic	Q50	hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6089,hsa-miR-6784-5p,hsa-miR-6813-5p,hsa-miR-8072	-	NA	ENSG00000261468
ENSG00000186235	LINC02610	-1.46347448613064	4.12057189633449e-5	M1_vs_M2	HSALNG0023418	integenic	Not conserved	hsa-miR-3620-5p,hsa-miR-4492,hsa-miR-4505,hsa-miR-1587,hsa-miR-4685-3p,hsa-miR-6753-5p,hsa-miR-6784-5p,hsa-miR-1273h-5p,hsa-miR-7846-3p,hsa-miR-8072	Chronotype measurement	HES6	YBX3P1
ENSG00000247317	LY6E-DT	3.48283442197109	0.00775718839601821	M1_vs_M2	HSALNG0069213	anti_sense	Not conserved	hsa-miR-6132,hsa-miR-6779-5p,hsa-miR-6784-5p,hsa-miR-6869-3p,hsa-miR-8485	-	LY6S	ENSG00000262362
ENSG00000267452	LINC02073	-2.94369009119031	9.12178683556456e-7	M1_vs_M2	HSALNG0117381	integenic	Not conserved	NA	NA	UTP18	ZNF234
ENSG00000172965	MIR4435-2HG	-1.2221354576374	2.15987326989546e-11	M1_vs_M2	HSALNG0017878	integenic	Q50	NA	NA	ANAPC1	MIR4783
ENSG00000285736	ENSG00000285736	-3.5182574164325	0.0107121622172901	M1_vs_M2	HSALNG0045746	anti_sense	Not conserved	NA	-	IL17B	NOTCH2NLA
ENSG00000224116	INHBA-AS1	3.42930195904091	0.00290789740015784	M1_vs_M2	HSALNG0057482	integenic	Not conserved	hsa-miR-6124	NA	SUGCT	RBM8A
ENSG00000285761	ENSG00000285761	2.23308018433481	3.60172598729722e-6	M1_vs_M2	HSALNG0049090	integenic	Not conserved	hsa-miR-6085	Crohn's disease,Small cell lung carcinoma,Sleep duration,Lymphocyte count,Bmi-adjusted waist-hip ratio,-	HLA-F	ENSG00000265298
ENSG00000265479	DTX2P1-UPK3BP1-PMS2P11	5.17897333985195	0.01584932701753	M1_vs_M2	HSALNG0059099	anti_sense,sense	Q75	NA	Body mass index,Waist-hip ratio; Body mass index,Urinary nitrogen measurement,Response to drug,Macrovascular complications of diabetes; Diabetic eye disease,Comparative body size at age 10, self-reported,Platinum measurement; Response to cisplatin,Interleukin-6 measurement,-	CCDC146	DTX2P1-UPK3BP1-PMS2P11
ENSG00000266708	ENSG00000266708	5.04591567144297	0.0303184460291611	M1_vs_M2	HSALNG0119876	anti_sense	Q75	NA	-	PPP4R1	ENSG00000266708
ENSG00000290034	ENSG00000290034	-1.17384523108906	0.00163020885390888	M1_vs_M2	HSALNG0049994	anti_sense	Q50	hsa-miR-6728-3p,hsa-miR-8485	C-reactive protein measurement,Isoleucine measurement; Leucine measurement,Supraventricular ectopy,Family history of alzheimer’s disease; Late-onset alzheimers disease,Late-onset alzheimers disease,Aortic stenosis; Aortic valve calcification,-	TREML4	ENSG00000266783
ENSG00000260941	LINC00622	-1.26734513918281	0.00858853811142394	M1_vs_M2	HSALNG0006500	integenic	Not conserved	NA	NA	ZNF697	ENSG00000266910
ENSG00000233785	ENSG00000233785	2.38406464485279	0.00129715448388475	M1_vs_M2	HSALNG0137010	sense	Q75	hsa-miR-619-5p	Shoulder impingement syndrome; Rotator cuff tear,Ribose-5-phosphate measurement; Ribulose-5-phosphate measurement	ACOT9	ENSG00000267074
ENSG00000267130	ENSG00000267130	-3.54290920306022	0.00528608902609509	M1_vs_M2	HSALNG0125425	integenic	Q50	hsa-miR-1303,hsa-miR-6764-5p	Bmi-adjusted waist circumference,Reticulocyte count; Reticulocyte measurement,-	CEBPG	ENSG00000267130
ENSG00000256948	ENSG00000256948	1.03902568405368	4.4582806835038e-4	M1_vs_M2	HSALNG0088445	anti_sense	Not conserved	hsa-miR-939-5p	Response to candesartan	SLC6A12	ENSG00000267149
ENSG00000287245	ENSG00000287245	-1.88140789703014	0.0176522682327254	M1_vs_M2	HSALNG0087038	anti_sense	Not conserved	NA	NA	ZC3H12C	ENSG00000267219
ENSG00000258583	LINC01500	-6.11226737789574	4.3041123800836996e-45	M1_vs_M2	HSALNG0101652	integenic	Not conserved	NA	NA	DACT1	LINC02073
ENSG00000258919	ENSG00000258919	-1.96084621690505	1.11879287652404e-5	M1_vs_M2	HSALNG0103850	anti_sense	Q50	hsa-miR-5787	Malate measurement,Balding measurement,Self reported educational attainment,Pulse pressure measurement; Thyroxine measurement,Mathematical ability,Body height,Post-traumatic stress disorder symptom measurement,Eotaxin measurement,Hearing threshold measurement; Hearing measurement,Response to cisplatin; Ovarian carcinoma; Response to paclitaxel; Overall survival,-	HSP90AA1	EDDM13
ENSG00000259354	ENSG00000259354	4.29396497017908	2.7608379350575397e-44	M1_vs_M2	HSALNG0105653	intronic_antisense	Not conserved	NA	NA	C15orf48	ENSG00000267737
ENSG00000236914	LINC01852	3.21576561658927	0.0113115344221424	M1_vs_M2	HSALNG0105101	integenic	Q90	hsa-miR-7703	Body height,-	RASGRP1	ZNF460-AS1
ENSG00000255026	ENSG00000255026	2.25740937362181	0.00274735548656287	M1_vs_M2	HSALNG0081949	integenic	Not conserved	hsa-miR-615-5p,hsa-miR-766-3p	NA	PGGHG	ENSG00000269044
ENSG00000286698	ENSG00000286698	-5.50708684953393	0.00382365610580519	M1_vs_M2	HSALNG0016845	integenic	Not conserved	NA	NA	EIF2AK3	PLEKHA3P1
ENSG00000269959	SPACA6-AS1	5.18004571427892	0.0230213862275526	M1_vs_M2	HSALNG0127249	anti_sense	Q75	NA	Calcium measurement,Body height,-	HAS1	SPACA6-AS1
ENSG00000245928	SDAD1-AS1	6.93877294154788	5.40590254687869e-7	M1_vs_M2	HSALNG0035291	anti_sense	Not conserved	NA	Lung carcinoma,Blood protein measurement,-	ART3	ENSG00000270120
ENSG00000233392	UICLM	-7.9845673710705	2.2362573187431307e-15	M1_vs_M2	HSALNG0023633	anti_sense	Not conserved	hsa-miR-1227-5p,hsa-miR-4492,hsa-miR-6791-5p	NA	MAB21L4	ENSG00000270127
ENSG00000225077	ICMT-DT	5.70715723787755	0.0033852491357009	M1_vs_M2	HSALNG0000511	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-4650-5p,hsa-miR-6089	Qt interval,Resting heart rate,-	HES3	ENSG00000270681
ENSG00000206344	HCG27	1.75330294920101	0.00320217039638558	M1_vs_M2	HSALNG0049246	integenic	Not conserved	hsa-miR-4640-3p,hsa-miR-6769b-5p	Sneeze,Multiple myeloma,Platelet-to-lymphocyte ratio,Bmi-adjusted waist-hip ratio,Squamous cell lung carcinoma; Peptic ulcer and gastro-oesophageal reflux disease (gord) drug use measurement; Upper aerodigestive tract neoplasm; Susceptibility to pneumonia measurement,Blood protein measurement,Intelligence; Diastolic blood pressure; Susceptibility to mycobacterium tuberculosis infection measurement,Cytokine measurement,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Susceptibility to shingles measurement,Lymphocyte count,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Serum igg glycosylation measurement,Coronary artery disease,Platelet count,Autism spectrum disorder; Parental longevity,Von willebrand factor measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Autism spectrum disorder,High density lipoprotein cholesterol measurement,Lung carcinoma,Response to thioamide; Drug-induced agranulocytosis,Handedness,Lupus nephritis; Blood protein measurement,-	TCF19	MILR1
ENSG00000230537	LINC02937	-5.18717740787838	0.0129413351283103	M1_vs_M2	HSALNG0072707	integenic	Not conserved	NA	Eosinophil count	AUH	ENSG00000271992
ENSG00000230747	ENSG00000230747	-2.57389188358519	1.47106161979029e-9	M1_vs_M2	HSALNG0017036	sense	Not conserved	NA	Hemoglobin a1 measurement; Unipolar depression,-	SNRNP200	ENSG00000272768
ENSG00000291258	ENSG00000291258	3.21162464591236	0.00845677510633221	M1_vs_M2	HSALNG0144341	overlap_antisense	Not conserved	hsa-miR-363-5p,hsa-miR-6089	-	APBA2	ENSG00000272787
ENSG00000272839	ENSG00000272839	-1.56059670336254	0.00167099241606266	M1_vs_M2	HSALNG0062763	anti_sense	Not conserved	hsa-miR-4463	NA	DNAJB6	ENSG00000272812
ENSG00000288066	ENSG00000288066	-1.01580587540977	7.8355780480873e-4	M1_vs_M2	HSALNG0019641	anti_sense	Q90	NA	-	RIF1	ENSG00000272941
ENSG00000253593	ENSG00000253593	2.95490841806125	0.0268346031347262	M1_vs_M2	HSALNG0068775	integenic	Not conserved	hsa-miR-6873-3p	Response to alcohol	CCN4	LCDR
ENSG00000260804	LINC01963	-1.83930467546311	8.12011268945828e-9	M1_vs_M2	HSALNG0022112	integenic	Q50	NA	NA	XRCC5	TM4SF19-DYNLT2B
ENSG00000234630	ENSG00000234630	-2.23321370394939	0.0210638254251593	M1_vs_M2	HSALNG0134317	integenic	Not conserved	hsa-miR-874-3p,hsa-miR-6775-3p	NA	VPREB1	ENSG00000273486
ENSG00000253351	LINC01298	-7.87674047814882	4.84236146366368e-16	M1_vs_M2	HSALNG0067084	integenic	Q50	hsa-miR-30b-3p,hsa-miR-331-3p,hsa-miR-4308,hsa-miR-5572	Low density lipoprotein cholesterol measurement	CFAP418	ENSG00000274944
ENSG00000259871	ENSG00000259871	-6.59636048827892	1.35761002223791e-6	M1_vs_M2	HSALNG0109998	sense	Not conserved	hsa-miR-8485	NA	CLEC19A	ENSG00000274944
ENSG00000254654	LINC02685	-6.04755069232983	1.8277142686259e-4	M1_vs_M2	HSALNG0083903	integenic	Q50	hsa-miR-30b-3p	-	TSPAN18	ENSG00000274944
ENSG00000228536	LYPLAL1-AS1	-5.34830157794558	0.0140621580315197	M1_vs_M2	HSALNG0010664	integenic	Q50	hsa-miR-4492,hsa-miR-8485	Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Bmi-adjusted hip circumference,Heel bone mineral density,Triglyceride measurement; Bmi-adjusted waist circumference,Protein measurement,Bmi-adjusted waist circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lean body mass,Appendicular lean mass,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement; Sex hormone-binding globulin measurement; Low density lipoprotein triglyceride measurement; Body fat percentage; High density lipoprotein cholesterol measurement; Triglyceride measurement; Aspartate aminotransferase measurement,Body mass index,Visceral:subcutaneous adipose tissue ratio; Body mass index,Body height,Body weight,Reticulocyte measurement; Bmi-adjusted hip circumference,Insulin measurement,Pulse pressure measurement; Obesity; Osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty,Visceral:subcutaneous adipose tissue ratio,Osteoarthritis, hip; Body mass index; Physical activity measurement; Bmi-adjusted waist-hip ratio; Fasting blood insulin measurement; Osteoarthritis, hip, osteoarthritis, knee,Waist-hip ratio,Hip circumference; Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Triglyceride measurement; Reticulocyte measurement; Bmi-adjusted hip circumference; Reticulocyte count,Red blood cell density measurement; Hemorrhoid; Erythrocyte count,Sex interaction measurement; Age at assessment; Bmi-adjusted waist-hip ratio,Nose morphology measurement,Bmi-adjusted waist-hip ratio; Physical activity measurement,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Serum alanine aminotransferase measurement,High density lipoprotein cholesterol measurement,Open-angle glaucoma,Smoking behavior; Bmi-adjusted waist-hip ratio,Triglyceride measurement; High density lipoprotein cholesterol measurement,Adiponectin measurement,Apolipoprotein a 1 measurement,Body fat percentage; Bmi-adjusted hip circumference,Total blood protein measurement; High density lipoprotein cholesterol measurement,Astigmatism,Bmi-adjusted waist circumference; Drugs used in diabetes use measurement; Bmi-adjusted hip circumference,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Waist-hip ratio; Bmi-adjusted waist-hip ratio; Physical activity measurement,Bmi-adjusted waist circumference; Appendicular lean mass,Varicose veins; Inguinal hernia,Acne; Bmi-adjusted hip circumference,Serum gamma-glutamyl transferase measurement,Bmi-adjusted waist circumference; Total cholesterol measurement; Low density lipoprotein cholesterol measurement; High density lipoprotein cholesterol measurement; Bmi-adjusted waist-hip ratio; Triglyceride measurement,Body mass index; Adiponectin measurement; Fasting blood insulin measurement,Systolic blood pressure,Sex hormone-binding globulin measurement; Adiponectin measurement,-	ZC3H11B	ENSG00000274944
ENSG00000234211	ENSG00000234211	-4.99198311942997	0.0173853443783202	M1_vs_M2	HSALNG0007963	anti_sense	Q75	NA	Rheumatoid arthritis,Aspartate aminotransferase measurement,Erythrocyte count,Monocyte percentage of leukocytes,-	FCGR3B	ENSG00000274944
ENSG00000235407	CYMP-AS1	-4.75171476925695	0.0318304865250684	M1_vs_M2	HSALNG0005984	integenic	Not conserved	NA	-	KCNA10	ENSG00000274944
ENSG00000229525	DNPEP-AS1	-4.78935881632978	0.0463026126739226	M1_vs_M2	HSALNG0022376	anti_sense,sense	Q50	NA	-	DES	ENSG00000274944
ENSG00000233251	ENSG00000233251	-5.02414546330203	0.0261174719460165	M1_vs_M2	HSALNG0015066	anti_sense	Q50	hsa-miR-4279,hsa-miR-4472	Lysophosphatidylcholine 18:2 measurement; Lysophosphatidylcholine 18:1 measurement,Cleft lip,-	EFEMP1	ENSG00000274944
ENSG00000251136	RIPK2-DT	2.72828902750186	4.42529233914188e-112	M1_vs_M2	HSALNG0066822	integenic	Q50	NA	Human papilloma virus infection; Oropharynx cancer,-	NBN	MLLT6
ENSG00000260135	MMP2-AS1	2.33775404955336	2.6783333606658297e-26	M1_vs_M2	HSALNG0111641	anti_sense	Q90	NA	Abnormality of refraction,Age-related hearing impairment,-	CES1	PRAG1
ENSG00000275431	ENSG00000275431	5.30112628351464	0.00942014319552293	M1_vs_M2	HSALNG0115994	anti_sense	Q50	NA	Blood protein measurement,Eyelid sagging measurement,C-c motif chemokine 15 measurement	CCL18	ENSG00000275431
ENSG00000248693	LINC02100	3.21576979742755	0.0113163751414291	M1_vs_M2	HSALNG0040483	integenic	Not conserved	NA	NA	CDH18	BACE1-AS
ENSG00000282572	FAM157D	1.75285647920324	0.015281070401101	M1_vs_M2	HSALNG0055481	integenic	Not conserved	hsa-miR-30b-3p,hsa-miR-6089	-	PDGFA	ENSG00000278861
ENSG00000289947	ENSG00000289947	3.12471420381737	0.0200858568673023	M1_vs_M2	NA	NA	NA	NA	NA	ODF3B	ENSG00000279605
ENSG00000263164	ENSG00000263164	-3.18854163831104	0.0295656862257552	M1_vs_M2	HSALNG0114111	anti_sense,sense	Not conserved	NA	Head and neck squamous cell carcinoma,Family history of alzheimer’s disease,Sex hormone-binding globulin measurement,Leukocyte count,Red blood cell density measurement,-	SCIMP	ENSG00000279803
ENSG00000197180	ATP6AP1-DT	-1.26814306339257	1.63584215575917e-17	M1_vs_M2	HSALNG0140852	integenic	Q75	hsa-miR-619-5p,hsa-miR-4297,hsa-miR-4279	NA	DNASE1L1	ENSG00000279805
ENSG00000261094	ENSG00000261094	1.66643608729914	2.6257943564188e-4	M1_vs_M2	HSALNG0074265	integenic	Q50	NA	Birth weight; Neuroimaging measurement; Brain volume measurement,-	RABGAP1	ENSG00000279900
ENSG00000248538	PPP1R3B-DT	-5.27932363034289	0.0288524386587333	M1_vs_M2	HSALNG0063318	integenic	Q50	hsa-miR-6803-5p	NA	ERI1	DDX11L17
ENSG00000244586	WNT5A-AS1	6.39603902305217	1.4904260968448e-4	M1_vs_M2	HSALNG0147531	anti_sense	Q90	hsa-miR-7108-3p	-	CACNA2D3	LINC03032
ENSG00000286696	ENSG00000286696	-1.30211278696034	0.019275270147902	M1_vs_M2	HSALNG0144397	anti_sense	Q75	NA	NA	CCDC33	ENSG00000280181
ENSG00000284722	ENSG00000284722	-3.6852918057619	0.00269437229661855	M1_vs_M2	NA	NA	NA	NA	NA	OR2AT4	ENSG00000281530
ENSG00000282221	ENSG00000282221	5.30245271700207	0.0170685553709961	M1_vs_M2	HSALNG0009643	anti_sense	Q50	hsa-miR-23b-5p,hsa-miR-615-5p	-	PKP1	ENSG00000282221
ENSG00000259760	ENSG00000259760	-1.20622942049077	5.03603470704213e-27	M1_vs_M2	HSALNG0108537	anti_sense	Q75	NA	-	TTC23	ENSG00000283041
ENSG00000226862	ENSG00000226862	-4.75228146151692	0.0313805935034408	M1_vs_M2	HSALNG0009734	anti_sense,sense	Q75	hsa-miR-328-3p,hsa-miR-574-5p,hsa-miR-4453,hsa-miR-4486	Cortical surface area measurement,-	PPP1R12B	ENSG00000284830
ENSG00000254248	ENSG00000254248	-5.26207017460752	0.00338146616818332	M1_vs_M2	HSALNG0067071	anti_sense	Not conserved	hsa-miR-6763-5p	Serum alanine aminotransferase measurement,-	TP53INP1	ENSG00000284830
ENSG00000253924	ENSG00000253924	-4.84023878685883	0.038410777460836	M1_vs_M2	HSALNG0065257	anti_sense	Q90	NA	NA	NPBWR1	ENSG00000284830
ENSG00000289548	ENSG00000289548	-5.98174039666288	2.5451845303939e-4	M1_vs_M2	HSALNG0146881	integenic	Not conserved	hsa-miR-762,hsa-miR-6803-5p,hsa-miR-6859-3p	NA	SLCO4A1	ENSG00000284830
ENSG00000258512	LINC00239	-1.84253232146535	3.6179433776575e-4	M1_vs_M2	HSALNG0103853	integenic	Not conserved	hsa-miR-4447	NA	PPP2R5C	ENSG00000285130
ENSG00000267549	ZSCAN5A-AS1	-1.88415444719106	0.00184726314775561	M1_vs_M2	HSALNG0127749	anti_sense	Not conserved	NA	-	EDDM13	SOD2-OT1
ENSG00000251301	LINC02384	6.84630305877101	4.0427672177967296e-236	M1_vs_M2	HSALNG0092162	integenic	Not conserved	hsa-miR-6089	NA	MDM1	ENSG00000285744
ENSG00000273272	ENSG00000273272	5.04556035877686	0.0377448739812376	M1_vs_M2	HSALNG0147331	integenic	Not conserved	NA	Monocyte count	KLHDC7B	ENSG00000286707
ENSG00000237248	LINC00987	2.47682861595063	0.0442802065091232	M1_vs_M2	HSALNG0089130	integenic	Q50	hsa-miR-619-5p,hsa-miR-6769b-5p	-	KLRG1	ENSG00000286909
ENSG00000224666	ETV7-AS1	5.41379846282024	0.00528845029860469	M1_vs_M2	HSALNG0049748	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-3652,hsa-miR-4674,hsa-miR-6089	Rheumatoid arthritis,Leukocyte count,Mean platelet volume,Eczema; Allergic rhinitis,-	KCTD20	ENSG00000287335
ENSG00000287335	ENSG00000287335	5.4137037303327	0.00625897176787477	M1_vs_M2	HSALNG0130592	integenic	Not conserved	hsa-miR-619-5p,hsa-miR-6089	Seasonality measurement,-	NCOA3	ENSG00000287335
ENSG00000259225	LINC02345	-2.73265201645323	1.12012306772211e-15	M1_vs_M2	HSALNG0105099	integenic	Not conserved	NA	NA	TMCO5A	ENSG00000287378
ENSG00000260542	ENSG00000260542	-2.25567894299992	0.00190171527384764	M1_vs_M2	HSALNG0131538	integenic	Not conserved	NA	NA	GATA5	ENSG00000287691
ENSG00000225792	SNX10-AS1	4.51121131910904	5.64851054565552e-75	M1_vs_M2	HSALNG0056814	anti_sense	Q90	hsa-miR-4505,hsa-miR-1587,hsa-miR-3960	Bmi-adjusted waist-hip ratio,Blood urea nitrogen measurement; Bmi-adjusted waist circumference,Body weight; Body mass index,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio,Vaginal microbiome measurement,-	HNRNPA2B1	ENSG00000287771
ENSG00000289372	ENSG00000289372	5.30013875388646	0.0171678655552476	M1_vs_M2	HSALNG0053067	anti_sense	Q75	hsa-miR-619-5p,hsa-miR-1268b,hsa-miR-4652-5p,hsa-miR-4710,hsa-miR-6089	Pulse pressure measurement,Systolic blood pressure,-	GOPC	ENSG00000288064
ENSG00000235641	LINC00484	-4.8419764666096	0.0401834502475434	M1_vs_M2	HSALNG0072704	integenic	Q50	hsa-miR-619-5p,hsa-miR-644a,hsa-miR-4258,hsa-miR-4466,hsa-miR-4685-3p,hsa-miR-6803-5p,hsa-miR-6837-3p,hsa-miR-7704,hsa-miR-8069	Balding measurement,Platelet crit,Platelet count,Ulcerative colitis; Inflammatory bowel disease,Eczema,Bmi-adjusted waist-hip ratio,Waist-hip ratio,Neutrophil percentage of granulocytes,Eosinophil percentage of leukocytes,Eosinophil count,Parental genotype effect measurement; Gestational blood glucose measurement; Glycosuria,Leukocyte count,-	SYK	ENSG00000288111
ENSG00000271952	LINC01954	-2.60027771172812	0.00700273314541345	M1_vs_M2	HSALNG0146022	overlap_sense	Not conserved	NA	Childhood aggressive behaviour measurement,Chronotype measurement,Exploratory eye movement measurement,Neuropsychological test,Mathematical ability,Fev/fec ratio; Response to bronchodilator,-	KCNF1	ENSG00000288545
ENSG00000229484	LINC02766	-2.17907957992584	9.64490751038477e-5	M1_vs_M2	HSALNG0000944	integenic	Not conserved	NA	-	VPS13D	ENSG00000288819
ENSG00000251586	TET2-AS1	-1.99085105458443	0.0197885045120426	M1_vs_M2	HSALNG0036166	anti_sense	Not conserved	NA	Ulcerative colitis; Intelligence; Body height,Intelligence; Testosterone measurement; Insomnia measurement; Body height; Body weight,Bmi-adjusted waist circumference; Glomerular filtration rate,Heel bone mineral density,Uric acid measurement,Leukocyte count,Forced expiratory volume,Pulse pressure measurement; Bmi-adjusted hip circumference,Self reported educational attainment; Intelligence,Intelligence,Body height,Lifestyle measurement,Colorectal cancer; Household income; Colorectal adenoma,Forced expiratory volume; Chronic obstructive pulmonary disease,Trauma exposure measurement; Primary biliary cirrhosis,Fev/fec ratio; Primary biliary cirrhosis,Bmi-adjusted hip circumference; Bmi-adjusted waist-hip ratio,Lymphocyte percentage of leukocytes; Glomerular filtration rate; Lymphocyte count; Creatinine measurement; Neutrophil percentage of leukocytes,Neutrophil count,Bmi-adjusted waist-hip ratio,Bmi-adjusted waist circumference,Neutrophil percentage of leukocytes; Lymphocyte percentage of leukocytes,Self reported educational attainment; Intelligence; Risk-taking behaviour; Hemorrhoid,Melanoma,Self reported educational attainment; Intelligence; Mathematical ability,Self reported educational attainment; Intelligence; Birth weight,Age at menarche,Tonsillectomy risk measurement,Attention deficit hyperactivity disorder; Risk-taking behaviour; Antisocial behaviour measurement; Substance abuse,Intelligence; Bmi-adjusted waist-hip ratio,Risk-taking behaviour,Self reported educational attainment,Appendicular lean mass,Platelet count,Prostate carcinoma,Waist-hip ratio; Bmi-adjusted waist-hip ratio,Risky sexual behaviour measurement,Intelligence; Risk-taking behaviour,Platelet crit,Breast carcinoma,Self reported educational attainment; Intelligence; Mathematical ability; Coffee consumption measurement; Cognitive function measurement,Intelligence; Household income,Intelligence; Lean body mass,Body weight,Neutrophil-to-lymphocyte ratio; Total blood protein measurement; Intelligence; Lymphocyte count,Health study participation,Verbal-numerical reasoning measurement,Myeloid white cell count,Testosterone measurement,Response to vaccine,Household income,Social interaction measurement,Obesity,Wellbeing measurement,Bmi-adjusted hip circumference,Forced expiratory volume; Response to bronchodilator,Fev/fec ratio; Response to bronchodilator,Nevus count; Cutaneous melanoma,Body height; Pulse pressure measurement; Chronic obstructive pulmonary disease,-,Forced expiratory volume; Birth weight; Chronic obstructive pulmonary disease; Fev/fec ratio; Peak expiratory flow; Smoking status measurement,Coffee consumption measurement; Tea consumption measurement,Bmi-adjusted waist circumference; Bmi-adjusted waist-hip ratio; Waist-hip ratio,Bmi-adjusted waist circumference; Hba1c measurement; Bmi-adjusted waist-hip ratio,Serum non-albumin protein measurement	PPA2	ENSG00000288927
ENSG00000272986	ENSG00000272986	5.04446717448387	0.0465798212553831	M1_vs_M2	HSALNG0035038	anti_sense	Q50	NA	NA	JCHAIN	ENSG00000288952
ENSG00000272269	NUP153-AS1	1.47334259581889	0.00666918427471972	M1_vs_M2	HSALNG0048366	anti_sense	Q90	hsa-miR-619-5p,hsa-miR-3960,hsa-miR-4787-5p,hsa-miR-6769b-5p	-	FAM8A1	ENSG00000289071
ENSG00000287091	ENSG00000287091	-1.53423917434757	0.0144958129483907	M1_vs_M2	HSALNG0146641	sense	Q50	hsa-miR-1203	NA	CD302	ENSG00000289294
ENSG00000289331	ENSG00000289331	4.89857025898256	0.0422034048458514	M1_vs_M2	HSALNG0148005	anti_sense,sense	Q90	hsa-miR-4467	-	BCL6	ENSG00000289331
ENSG00000291186	ENSG00000291186	-1.27016777579585	7.8946228186316e-4	M1_vs_M2	NA	NA	NA	NA	NA	DEFB108B	ENSG00000289470
ENSG00000289530	ENSG00000289530	5.41308529873357	0.0112656144444099	M1_vs_M2	HSALNG0035158	integenic	Q50	NA	-	RASSF6	ENSG00000289530
ENSG00000285239	ENSG00000285239	5.4132133427653	0.0093575304868224	M1_vs_M2	HSALNG0142409	anti_sense	Not conserved	NA	NA	CD34	ENSG00000289530
ENSG00000290735	ENSG00000290735	4.03551743555723	1.1371519527805e-4	M1_vs_M2	HSALNG0006949	integenic	Not conserved	NA	NA	H3-7	ENSG00000289701
ENSG00000286248	ENSG00000286248	1.17715036481515	0.0052629581707288	M1_vs_M2	HSALNG0094569	anti_sense	Not conserved	hsa-miR-1268b	Interleukin-8 measurement; C-reactive protein measurement; Chronic obstructive pulmonary disease,C-reactive protein measurement,C-reactive protein measurement; Serum gamma-glutamyl transferase measurement,-	CAMKK2	ENSG00000289745
ENSG00000289958	ENSG00000289958	-4.78860488268675	0.0205294657453177	M1_vs_M2	HSALNG0048244	integenic	Not conserved	NA	-	MCUR1	ENSG00000289958
ENSG00000237499	WAKMAR2	2.3580404768836	1.35914724446473e-10	M1_vs_M2	HSALNG0053791	anti_sense	Q50	hsa-miR-619-5p,hsa-miR-4472,hsa-miR-4492,hsa-miR-6728-3p,hsa-miR-6803-5p,hsa-miR-6842-3p	Systemic lupus erythematosus,Total blood protein measurement,Eosinophil count,Eczema; Allergic rhinitis,Rheumatoid arthritis; Systemic lupus erythematosus,C-reactive protein measurement,-	PERP	ENSG00000290041
ENSG00000253535	ADAM7-AS1	4.7548271257608	3.1770251230592e-9	M1_vs_M2	HSALNG0064058	integenic	Not conserved	NA	NA	NEFL	TPTEP1
ENSG00000237352	LINC01358	3.87903777544339	9.0877684434253e-27	M1_vs_M2	HSALNG0003970	integenic	Q50	NA	Serum albumin measurement,Response to lithium ion; Bipolar disorder,Hematocrit; Pulse pressure measurement,-	FGGY	GBP1P1
ENSG00000232310	LINC03002	-2.41124709252602	0.00100655452593123	M1_vs_M2	HSALNG0053635	integenic	Q75	hsa-miR-6838-5p	NA	SGK1	ENSG00000290600
ENSG00000291155	CT75	5.11314512186777	3.8402795063466495e-11	M1_vs_M2	HSALNG0022522	integenic	Q50	hsa-miR-4308,hsa-miR-4467,hsa-miR-3960	Susceptibility to scarlet fever measurement,-	SGPP2	NCF1B
ENSG00000285533	RELA-DT	-1.0927291094324	6.3578701818842e-4	M1_vs_M2	HSALNG0084930	anti_sense	Q50	hsa-miR-30b-3p,hsa-miR-619-5p,hsa-miR-762,hsa-miR-665,hsa-miR-4508,hsa-miR-6086	Urate measurement,Heel bone mineral density,Platelet count,-	SIPA1	ENSG00000290867
ENSG00000204971	ENSG00000204971	-2.9084222108935	6.79916012247342e-25	M1_vs_M2	HSALNG0085534	integenic	Not conserved	hsa-miR-412-3p,hsa-miR-6769b-5p	NA	PHOX2A	ZNF252P
ENSG00000289582	ENSG00000289582	5.14213840784646	4.6130947924026e-30	M1_vs_M2	NA	NA	NA	NA	NA	GBP2	ENSG00000291086
ENSG00000203709	MIR29B2CHG	1.82980936521683	2.5713781954706e-67	M1_vs_M2	HSALNG0010132	integenic	Q50	NA	Febrile seizure (within the age range of 3 months to 6 years); Mmr-related febrile seizures,Reaction time measurement,Pulse pressure measurement,Red blood cell distribution width	CD34	ENSG00000291135
ENSG00000269446	ENSG00000269446	-1.3773485880874	1.86714530480468e-5	M1_vs_M2	HSALNG0062712	integenic	Not conserved	NA	NA	UBE3C	ENSG00000291153
ENSG00000290838	NCF1B	7.36015717159021	1.80603874280621e-9	M1_vs_M2	HSALNG0058823	integenic	Not conserved	hsa-miR-619-5p	NA	FKBP6	CT75
ENSG00000228624	HDAC2-AS2	-1.43950362611933	4.9631548797617e-7	M1_vs_M2	HSALNG0052943	integenic	Not conserved	NA	NA	MARCKS	ENSG00000291224
